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Table S1. Relevant data and activity of synthesized antiplasmodials. 



























1#  369.93  3.09          4  9  8  3437      859 
9  383.97  3.40  6.75± 0.03 
8.18± 
0.03      1  1  3  (2901)  10  11  (2901) 
10  383.97  3.17  6.51± 0.01 
8.13± 
0.01      2  9  10  (3771)  10  13  (1886) 
11  383.97  3.55          4  19  44  (1809)      (452) 
12  349.51  3.70          584  934  1713  4111      7 
20  401.96  3.02          585  948  1367  4252      7 
21  401.96  3.09          1261  3082  2269  6436  6  13  5 
22  398.00  3.93          4  15  22  (3161)  11  16  (790) 
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51  424.00  2.94          75  137  231  3054  8  5  41 
52  414.00  2.57          14  29  41  4435      317 
53  396.00  2.63          20  37  45  866      43 
54  379.50  2.94          32  177  240  3227      101 
55  367.90  2.44          30  19  22  6120  23  24  204 
56  381.90  2.82        0.66±0.04  7  17  24  7780      1111 
57  396.00  3.06          8  68  31  2258      282 
58  399.90  2.63        0.41±0.04  28  78  50  2463      88 
59  399.90  2.76        0.50±0.05  33  20  28  5543      168 
60  406.90  2.11        0.99±0.07  5  25  32  3971      794 
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61  406.90  2.24        0.78±0.06  17  52  47  3880      228 
62  347.50  3.18        1.54±0.10  89  280  283  5144      58 
63  414.00  2.82        0.38±0.03  10  19  27  1649      165 
64  421.00  2.31          12  36  40  2929      244 
65  421.00  2.51        1.07±0.08  10  24  40  3808      381 
66  361.50  3.30          65  299  275  4673      72 
67  442.00  2.88          20  32  36  3871      194 
68  401.96  3.40          3192  2918  1577  4048      1 
69  415.99  3.70          731  990  950  5481      7 
70  430.01  4.01          751  963  588  3639  60  60  5 










72  444.04  5.26          2241  3432  1212  22992      10 




0.08  1601  1354  1797  34983      22 




0.09  405  412  565  18815      46 
75  309.82  4.01          800  626  423  30948      39 






























































































77  31   <1    27.67  39.14   
78  0.55  0.33 0.05  40 (50); 9 
(100)  4.74  11.83  50 
79   13  1‐5    0.58  1.17  50 
80   16   1‐5    14.10  20.04  50 
81   6  1‐5    6.80  14.76  200 
82   11  3‐4    14.49  28.16  40 
83   21   1‐5    7.54  9.40  37.5 
84   ~1   ~1    2.00  2.33  80 
85   100      6.54  15.18   
86   90      6.07  9.87  150 
87   N.A.      7.79  12.84  37.5 
88   28  1‐5    6.17  11.18  37.5 
89   ~1   1‐5    5.76  9.05  80 
PQ  62 (10µM)       
CQ    ca. 91         
ART  >752  ca. 121         
Artemisone    ca. 0.041         
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analyses were done using electrospray ionization in positive ion mode on a Surveyor 
separations module coupled to a ThermoFinnigan TSQ AM triple quadrupole mass 
spectrometer. Compounds were analyzed for purity using: Agilent 1200 HPLC system 
equipped with Quat Pump (G1311B), Injector (G1329B) 1260 ALS, TCC 1260 (G1316A) 
and Detector 1260 DAD VL+ (G1315C), and Waters 1525 HPLC dual pump system equipped 
with an Alltech Select degasser system, and a dual k 2487 UV–Vis detector. All compounds 
were >95% pure.  For each compound HPLC analysis was performed in two diverse systems: 
 
Method A: Zorbax Eclipse Plus C18 4.6 × 150 mm, 1.8 µ, S.N. USWKY01594 was used as 
the stationary phase. Eluent was made from the following solvents: 0.2% formic acid in water 
(A) and methanol (B). Analyses were performed at the UV max of the compounds (at 330 nm 
for compounds 9, 10, 11, 12, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 
37, 38, 39, 40, 41, 42, 43, 44, 46, 48, 49, 50, 51, 52, 53, 54, 55, 56, 58, 59, 60, 61, 62, 63, 64, 
65, 66, 67, 70, 73, 74, 75, 76 and at 254 nm for compounds 45, 47, 57, 68, 69, 71, 72 to 
maximize selectivity. Compounds were dissolved in methanol, final concentrations were ~1 
mg/mL. Flow rate was 0.5 mL/min 
Compounds 9, 10, 11, 20, 21, 22, 23, 25, 27, 28, 29, 30, 31, 32, 33, 34, 36, 40, 41, 42, 43, 66, 
67, 68, 71, 72, 73, 74, 75 and 76 were eluted using gradient protocol: 0-1.5 min 95%A, 1-5 
min 95%A→ 5%A, 5-16 min 5%A, 16-18 min 5%A→ 95%A, 18-20 min 5%A. 
Compounds 26, 38 and 39 were eluted using gradient protocol: 0-1 min 95%A, 1-6 min 
95%A→ 5%A, 6-11 min 5%A, 11-14 min 5%A→ 95%A, 14-15 min 5%A. 
Compounds 24, 35 and 44 were eluted using gradient protocol: 0-3 min 25%A, 3-4 min 
25%A→ 5%A, 4-5 min 5%A, 5-7 min 5%A→ 25%A, 7-8 min 25%A. 
Compounds 12 and 37 were eluted using gradient protocol 0-3 min 30%A, 3-6 min 30%A→ 
5%A, 6-9 min 5%A, 9-10 min 5%A→ 30%A, 10-11 min 30%A. 
Compound 45 was eluted using gradient protocol 0-3 min 50%A→ 30%A, 3-6 min 30%A→ 
0%A, 6-9 min 0%A→ 50%A, 9-12 min 50%A. 
Compounds 47, 48, 50, 51, 55, 56, 57 and 66 were eluted using gradient protocol: 0-1 min 
95%A, 1-6 min 95%A→ 5%A, 6-11 min 5%A, 11-14min 5%A→ 95%A, 14-15 min 95%A. 
Compounds 52, 53, 54, 61, 62 and (65) were eluted using gradient protocol: 0-1 min 95%A, 
1-6 min 95%A→ 5%A, 6-11 min 5%A, 11-14 min 5%A→ 95%A.Compounds 46, 58, 59, 63, 
64 and 67 were eluted using gradient protocol: 0-1 min 95%A, 1-6 min 95%A→ 5%A, 6-11 
min 5%A, 11-14 min 5%A→ 95%A, 14-16 min 95%A. 
Compounds 49 and 60 were eluted using gradient protocol: 0-1 min 95%A, 1-6 min 95%A→ 
5%A, 6-11 min 5%A, 11-14 min 5%A→ 95%A, 14-18 min 95%A. 
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Method B: Zorbax Eclipse Plus C18 4.6 x 150 mm, 1.8 µ, S.N. USWKY01594 was used as 
the stationary phase. Eluent was made from the following solvents: 0.2% formic acid in water 
(A) and acetonitrile (B). Analyses were performed at the UV max of the compounds (at 330 
nm for compounds 9, 10, 11, 12, 20, 21, 22, 23, 24, 25, 26, 27, 28), 29, 30, 31, 32, 33, 34, 35, 
36, 37, 38, 39, 40, 41, 42, 43, 44, 46, 47, 48, 50, 51, 52, 53, 54,55, 56, 57, 58, 61, 62, 64, 66, 
67, 70, 73, 74, 75, 76 and at 254 nm for compounds 45, 59, 63, 65, 68, 69, 71, 72to maximize 
selectivity. Compounds were dissolved in methanol, final concentrations were ~1 mg/mL. 
Flow rate was 0.5 mL/min 
Compounds 9, 10, 11, 12, 20, 21, 22, 23, 24, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 40, 41, 
42, 43, 44, 67, 68, 71, 72, 74, 73, 75 and 76 were eluted using gradient protocol: 0-1.5 min 
95%A, 1-5 min 95%A→ 5%A, 5-16 min 5%A, 16-18 min 5%A→ 95%A, 18-20 min 5%A. 
Compounds 45, 25, 66,38) were eluted using gradient protocol: 0-1 min 95%A, 1-6 min 
95%A→ 5%A, 6-11 min 5%A, 11-14 min 5%A→ 95%A, 14-15 min 5%A. 
Compound 37 was eluted using gradient protocol 0-2 min 30%A, 2-6 min 30%A→ 5%A, 6-9 
min 5%A, 9-10 min 5%A→ 30%A, 10-11 min 30%A. 
Compounds 26 and 39 were eluted using gradient protocol 0-1 min 95%A, 1-5 min 95%A→ 
5%A, 5-14 min 5%A, 14-15 min 5%A→ 95%A, 15-16 min 5%A. 
Compounds 46, 52, 53, 54,58, 61, 62, 64, 65 and 67 were eluted using gradient protocol: 0-1 
min 95%A, 1-6 min 95%A→ 5%A, 6-11 min 5%A, 11-14 min 5%A→ 95%A. 
Compounds 47, 48, 50, 51, 55, 56, 57, 59,63 and 66 were eluted using gradient protocol: 0-1 
min 95%A, 1-6 min 95%A→ 5%A, 6-11 min 5%A, 11-14 min 5%A→ 95%A, 14-15 min 
95%A. 
Method C: Poroshell 120 EC-C18, 4.6 x 50mm, 2.7µ, S.N. USCFU07797 was used as the 
stationary phase. Eluent was made from the following solvents: 0.2% formic acid in water (A) 
and acetonitrile (B). Analyses were performed at the UV max of the compounds (at 254 nm 
for compounds 49, 60) to maximize selectivity. Compounds were dissolved in methanol, final 
concentrations were ~ 1mg/mL. Flow rate was 0.5 mL/min 
Compounds 49 and 60 were eluted using gradient protocol: 0-1 min 95%A, 1-6 min 95%A→ 
5%A, 6-11 min 5%A, 11-14 min 5%A→ 95%A, 14-17 min 95%A. 
N1-(7-Chloroquinolin-4-yl)ethane-1,2-diamine (AQ2), N1-(7-chloroquinolin-4-yl)propane-
1,3-diamine (AQ3), N1-(7-chloroquinolin-4-yl)butane-1,4-diamine (AQ4), N1-(7-
chloroquinolin-4-yl)-ethane-1,6-hexane (AQ6) and N-(quinolin-4-yl)propane-1,3-diamine 







Method A: General synthetic procedure for mono-protection of the asymmetrical diamines 
with Boc.10 
Tert-butyl phenyl carbonate (2 equiv) was added to a stirred solution of unsymmetrical 
diamine (1 equiv) in absolute EtOH. The reaction mixture was refluxed overnight (18 h), 
followed by removal of the volatiles in vacuo. Water was added and 2M HCl was added until 
pH3, followed by extraction with CH2Cl2. The aqueous phase was then made strongly alkaline 
by addition of aqueous NaOH (2M) and extracted with CH2Cl2. The combined organic 
extracts were dried over anh. Na2SO4 and solvent was evaporated under reduced pressure to 
get the final product. 
Method B: General procedure for the synthesis of N-Boc protected aminoquinolines11 
A mixture of 4,7-dichloroquinoline (1 equiv) and monoprotected diaminoalkane (2 equiv) was 
gradually warmed to 80 C over 1 h with stirring and the stirring was continued for 6-8 h at 
120-130 C . The reaction mixture was cooled to r.t. and taken up in CH2Cl2. The organic 
layer was washed with NaHCO3, water and brine. The organic layer was dried over anh. 
Na2SO4 and solvent was evaporated under reduced pressure to get final product. 
Method C: Removal of the Boc-protecting groups with TFA. 
A solution of N-Boc-protected amine in TFA/CH2Cl2 (v:v; 1:10), was stirred at r.t. for 6 h. 
Solvents were evaporated under reduced pressure and the remaining residue was treated with 
CH2Cl2/2.5M NaOH. The organic layer was dried over anh. MgSO4, and the solvent was 
evaporated under reduced pressure.  
Method D: General procedure for reductive amination. 
To a solution of an amine in CH2Cl2 were added the appropriate aldehyde (1 equiv) and 
NaHB(OAc)3 (2 equiv). After stirring the reaction mixture at r.t. for 24 h, aqueous NaOH was 
added. The organic layer was separated, and the aqueous layer was washed with CH2Cl2. The 
organic layer was dried over anh. Na2SO4, and the solvent was evaporated under reduced 
pressure. 
Method E: General procedure for reductive amination. 
Amine (1.25-1.5 equiv) and appropriate aldehyde (1 equiv) were dissolved in MeOH/CH2Cl2 
mixture (v:v; 2:1), anh. AcOH (1.25-1.5 equiv) was added, and the mixture was stirred under 
Ar at r.t. for 3 h. Then, NaBH4 (6 equiv) was added and stirring was continued for another 18 
h. The solvent was removed under reduced pressure, and the residue was dissolved in CH2Cl2. 
The organic layer was washed with 2M NH4OH, water and brine, and dried over Na2SO4. 
Finally, the solvent was evaporated under reduced pressure. 
Method F: General procedure for the synthesis aminoquinolines. 
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A mixture of diamine linker (1.2 equiv), 4,7-dichloroquinoline/4-chloroquinoline (1 equiv) 
and phenol (15 equiv) were heated at 120-130 C, with stirring for 24 h or the reaction 
mixture was subjected to MW irradiation using a Biotage Initiator 2.5 apparatus. The 
reaction mixture was cooled to r.t. and taken up in CH2Cl2. The organic layer was 
successively washed several times with NaOH and finally with brine. The organic layer was 
dried over anh. Na2SO4 and solvent was removed under reduced pressure to get a final 
product. 
Method G: General procedure for reductive amination.12 
A mixture of appropriate aldehyde/ketone (1 equiv), amine (1.2 equiv) and Ti(OiPr)4 (1.5 
equiv) reaction mixture was stirred at r.t. overnight. Following, absolute EtOH and NaBH4 (2 
equiv) were added to the mixture and stirring was continued for 24 h. The reaction was 
quenched with 2M NaOH, and solvent was removed under reduced pressure. Aqueous layer 
was washed with CH2Cl2, and organic layer was dried over anh. Na2SO4. The solvent was 
evaporated, and the residue was purified by chromatography to yield the desired product. 
Method H: General procedure for palladium catalyzed amination of quinolines.13 
Vial was charged with mixture of Pd(OAc)2 (4 mol%) and DPEphos (8 mol%)/SPhos (8 
mol%) in dioxane and stirred for a few minutes underAr at r.t. Subsequently, a haloquinoline 
(1.0 equiv), amine (1.2 equiv) and K3PO4 (2.5 equiv) were added to the reaction mixture. 
Resulting suspension was flushed with argon for several minutes. The vial was quickly 
capped, heated to 85 oC overnight and then cooled down to r.t. The mixture was adsorbed 
onto silica gel and purified. 
Method I: General procedure for protection of amine with Cbz.14 
Mono-Boc-protected diamine was dissolved in CH2Cl2followed by addition of 
benzylchloroformate (1.95 equiv) and triethylamine (2.05 equiv). The reaction mixture was 
stirred at r.t. for 3 h and then quenched with aqueous NH4OH. Aqueous layer was extracted 
several times with EtOAc. The organic layer was dried over anh. Na2SO4, and solvent was 
evaporated under reduced pressure to give crude product. 
Method J: General procedure for removal of the Cbz-protecting group by hydrogenization. 
The Cbz-protected amine was hydrogenated using 10% Pd/C as catalyst under 2 atm of 
hydrogen MeOH. The mixture was stirred at r.t. for 8 h, the catalyst was removed by filtration 
and the solvent was evaporated under reduced pressure. 
Method K: General procedure for N-methylation of aminoquinolines.15 
To a stirred solution of aminoquinolines (1equiv) in MeOH containing 37% aqueous 
formaldehyde/acetone (2 equiv) was added mixture of ZnCl2 (2 equiv) and NaHB3CN (4 
equiv) in MeOH. After the reaction mixture was stirred at r.t. for 4 h, the solution was taken 
up in 0.1M NaOH and most of methanol was evaporated under reduced pressure. Aqueous 
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solution was extracted with CH2Cl2, the combined extracts were washed with water and brine, 
dried over anh. Na2SO4 and the solvent was evaporated under reduced pressure. 
Method L: Synthesis of methyl esters.16 
Difluorobenzaldehyde or bromofluorobenzaldehyde (1 equiv) was dissolved in DMSO, 
followed by dropwise addition of methyl thioglycolate (1 equiv) and triethylamine (3 equiv). 
The resulting mixture was stirred under argon atmosphere at 80 °C for 2 h and then allowed to 
cool to room temperature. The reaction mixture was transferred to a separation funnel, water 
was added and extracted with EtOAc. Combined organic layers were washed with brine and 
dried over anh. Na2SO4. After filtration, the solvent was removed under reduced pressure. The 
product was purified using column chromatography. 
Method M: Preparation of carboxylic acids.17 
A mixture of the methyl ester (1 equiv), KOH (3 equiv), water and EtOH (1:8, v:v) was 
stirred at room temperature for 3 h. The mixture was concentrated under reduced pressure, 
acidified with conc. HCl at 0 °C and transferred to a separation funnel. Product was extracted 
with EtOAc/THF (4:1, v:v) and dried over anh. Na2SO4. After filtration, the solvent was 
removed under reduced pressure. The product was purified using column chromatography. 
Method N:Experimental procedure for decarboxylation by microwave heating.18 
A mixture of the carboxylic acid (1 equiv) and DBU (2.5 equiv) in N,N-dimethylacetamide 
was heated in a sealed vessel in microwave reactor at 200 °C for 2 h. The product was 
purified using column chromatography. 
Method O: General experimental procedure for Rieche formylation.19 
TiCl4 (5 equiv) was dissolved in DCM at -10 °C, and then solution of dichloromethyl methyl 
ether (10 equiv) in DCM was added dropwise, followed by a solution of substituted 
benzothiophene(1 equiv) in DCM. After stirring for 1 h, the mixture was warmed to room 
temperature and then stirred for 24 h. The reaction mixture was poured onto ice-water, and 
conc. HCl was added. It was stirred for 30 min and then transferred to a separation funnel. 
Organic layer was washed well with saturated NaHCO3, brine and dried over anh. Na2SO4. 
After filtration, the solvent was removed under reduced pressure. The product was purified 
using column chromatography. 
Method P: Sythesis of cyano derivatives.20 
Bromobenzothiophene (1 equiv) and CuCN (2 equiv) were suspended in NMP and heated for 
12 h at 190 °C. The mixture was cooled to 0 °C and 33% aq. ethylendiamine was added. After 
dilution with ether, the mixture was transferred to a separation funnel. Organic layer was 
washed with brine and dried over anh. Na2SO4. After filtration, the solvent was removed 



















i) NaN3, DMF, 60 
oC, for 24 h; ii) Ph 3P, PhMe, 120 
oC; MeOH(HCl sat.), destillation; iii) diamine, Boc 2O, r.t., CH2Cl2; iv) diamine, 
tert-butyl phenyl carbonate, absolute EtOH, 90 oC, 24 h;  v) 4,7-dichloroquinoline, 80 oC, for 1 h; 120-130 oC, for 6-8 h; vi) 
CF3COOH/CH2Cl2, r.t., for 24 h; 2.5 M NaOH; vii) aldehyde, NaBH(OAc) 3, CH2Cl2, r.t., 24 h; viii) aldehyde, MeOH/CH 2Cl2 (2:1), 
AcOH, NaBH4, r.t., for 24 h
Br
Br







S13: n=1, R=Me (92%)
S14: n=2, R=Me (76%)
S15: n=3, R=Me (81%)
S16: n=2, R=Et (88%)
9: n=1, m=1, R=Me (83%)
23: n=2, m=1, R=Me (89%)
29: n=3, m=1, R=Me (80%)
27: n=2, m=1, R=Et (68%)
33: n=1, m=2, R=Me (75%)
36: n=2, m=2, R=Me (77%)
42: n=3, m=2, R=Me (61%)
40: n=2, m=2, R=Et (67%) 
i) ii) iii)/iv)
S3: n=2, R=Me (78%)
S4: n=3, R=Me (81%)
pentane-1,3-diamine: n=2, R=Et
S9: n=1, R=Me (88%)
S10: n=2, R=Me (73%)
S11: n=3, R=Me (69%)








S5: n=1, R=Me (69%)
S6: n=2, R=Me (73%)
S7: n=3, R=Me (68%)









Sodium azide (15.06 g, 231.58 mmol) was added to a solution of 1,3-
dibromobutane (10 g, 46.31 mmol) in DMF (100 mL).Reaction mixture was 
stirred for 24 h at 60 oC cooled to r.t., and water was added to dissolve excess of NaN3 and 
compound was extracted with EtOAc (3× 70 mL). The organic phase was dried over anh. 
Na2SO4, filtered and concentrated under reduced pressure to afford the desired product S1as 
colorless oil (6.30 g, 97%). IR(ATR): 3336w, 2975m, 2934m, 2877w, 2498w, 2099s, 1456m, 
1380w, 1355w, 1323w, 1267m, 1134w, 1088w, 1020w, 904w, 869w, 780w, 634w cm-1. 1H-
NMR (200 MHz, CDCl3, δ): 3.70-3.50 (m, 1H, N3CH(CH3)-), 3.50-3.35 (m, 2H, -CH2N3), 
1.80-1.60 (m, 2H, N3CH(CH3)CH2-), 1.32 (d, 3H, J = 6.2, CH3). 13C-NMR (50 MHz, CDCl3, 
δ): 54.86; 48.05; 35.16; 19.23. 
1,4-Diazidopentane (S2). 
Sodium azide (14.14 g, 217.44 mmol) was added to a solution of 1,4-
dibromopentane (10 g, 43.68 mmol) in DMF (100 mL). The mixture was 
stirred for 24 h at 60 oC. After cooling to r.t., water was added to dissolve excess of NaN3 and 
compound was extracted with EtOAc (3× 70 mL). The organic phase was dried over anh. 
Na2SO4, filtered and concentrated under reduced pressure to afford the desired product S2 as 
colorless oil (6.2 g, 93%). IR(ATR): 3336w, 2973m, 2936m, 2874m, 2500w, 2097s, 1456m, 






3.60-3.40 (m, 1H, N3CH(CH3)-), 3.40-3.20 (m, 2H, -CH2N3), 1.80-1.40 (m, 4H, 
N3CH(CH3)CH2CH2-, N3CH(CH3)-), 1.29 (d, 3H, J = 6.8, CH3). 13C-NMR (50 MHz, CDCl3, 
δ): 57.32; 50.96; 33.16; 25.38; 19.27.  
Butane-1,3-diamine (S3). 
Mixture of 1,3-diazidobutane S1 (13.50 g, 96.6 mmol) and Ph3P (50.7 g, 
193.2 mmol, 2 equiv) in toluene (150 mL) was stirred at 120 oC for 15 min, 
and cooled to r.t. Then H2O (18 mL) was added, and the resulting mixture 
was stirred overnight at 120 oC. Reaction mixture was transferred into a separation funnel, 
lower layer was collected and transformed in salt using MeOH(HCl sat.).Solvent was 
evaporated and dried crystals of 1,3-butanediamine dihydrochloride (11.1 g, 68.9 mmol) were 
mixed with NaOH powder (18 g, 450 mmol). Distillation afforded colorless oil (4.8 g, 78%, 
b.p. 138.6 oC/760 Torr).IR(ATR): 3354s, 3281s, 3194m, 2956s, 2922s, 2869m, 2757w, 
2664w, 1600s, 1456m, 1376m, 1348w, 1141w, 1091w, 1064w, 881m, 835m cm-1. 1H-NMR 
(500 MHz, CDCl3, δ): 3.05-2.95 (m, 1H, NH2CH(CH3)-), 2.85-2.75 (m, 2H, -CH2NH2), 1.60-
1.40 (m, 2H, -CH2CH2NH2), 1.08 (d, 3H, J = 6.3, CH3). 13C-NMR (125 MHz, D2O, δ): 44.92; 
43.48; 39.44; 24.35. Anal. (C4H14Cl2N2) Calcd: C, 29.83; H, 8.76; N, 17.39. Found: C, 29.86; 
H, 8.91; N, 17.48. 
Pentane-1,4-diamine (S4). 
Mixture of 1,4-diazidopentane S2 (16.41 g, 106.3 mmol) and Ph3P (55.7 
g, 212.6 mmol, 2 equiv) in toluene (150 mL) was stirred at 120 oC 15 
min, and cooled to r.t.. Then H2O (23 mL) was added, the resulting mixture was stirred 
overnight at 120 oC. Reaction mixture was transferred into a separation funnel, lower layer 
was collected and transformed in salt using MeOH(HCl sat.). Solvent was evaporated and 
dried crystals of 1,4-pentanediamine dihydrochloride (15.6 g, 89.3 mmol) were mixed with 
NaOH powder (22 g, 550 mmol). Distillation afforded colorless oil (7.3 g, 81%, b.p. 162.4 
oC/760 Torr). IR (ATR): 3427s, 3035s, 2440m, 1994w, 1604m, 1482s, 1469s, 1454s, 1392m, 
1334w, 1290w, 1266m, 1201m, 1167m, 1103m, 1044m, 991w, 948m, 946m, 846, 759w, 
508m, 437w, 421w cm-1. 1H-NMR (500 MHz, CDCl3): 2.95-2.70 (m, 1H, NH2CH(CH3)-), 
2.70-2.95 (m, 2H, -CH2NH2), 1.60-1.40 (m, 2H, -CH2CH2NH2), 1.40-1.25 (m, 2H, 
NH2CH(CH3)CH2-), 1.07 (d, 3H, J = 6.2, -CH3). 13C-NMR (125 MHz, D2O): 47.85; 42.85; 
37.96; 30.86; 23.35.  
Tert-butyl (2-aminopropyl)carbamate (S5). 
Compound S5 was prepared from 1,2-propanediamine (2 mL, 23.48 
mmol) and tert-butyl phenyl carbonate (8.7 mL, 46.95 mmol) by method 
A and was obtained after dry-flash chromatography: SiO2, eluent: CH2Cl2/MeOH(NH3sat.) = 








2933m, 1686s, 1528s, 1458w, 1391w, 1367m, 1325w, 1274m, 1250m, 1172s, 1057w, 991w, 
909w, 861w, 815w, 783w, 723w, 627m, cm-1. 1H-NMR (500 MHz, CDCl3, δ): 5.04 (bs, H-
N), 3.20-3.10 (m, 1H, -CH2NHBoc), 3.05-2.95 (m, 1H, NH2CH(CH3)-), 2.95-2.85 (m, 1H, -
CH2NHBoc), 1.44 (s, 9H, -NHCOO-C(CH3)3), 1.34 (bs, 2H-N), 1.07 (d, 3H, J = 6.2, CH3). 
13C-NMR(125 MHz, CDCl3, δ): 156.19; 79.06; 48.46; 46.81; 28.33; 21.44. HRMS: m/z 
175.14451 corresponds to molecular formula C8H18N2O2H+ (error in ppm: + 2.30). 
Anal.(C8H18N2O2 × 1/3 CH2Cl2) Calcd: C, 49.41; H, 9.29; N, 13.83. Found: C, 49.27; H, 9.09; 
N, 13.83. 
Tert-butyl (3-aminobutyl)carbamate (S6). 
Compound S6 was prepared by method A from 1,3-butandiamine (1.91 
g, 21.55 mmol) and tert-butyl phenyl carbonate (8.0 mL, 43.11 mmol) 
and was obtained after dry-flash chromatography: SiO2, eluent: 
CH2Cl2/MeOH(NH3sat.) = 95/5,as colorless viscous oil (2.96 g, 73%). IR (ATR): 3344w, 
2973m, 2929w, 1686s, 1519m, 1452w, 1390w, 1364m, 1275m, 1249m, 1168s, 1041w, 
1015w, 946w, 898w, 868w, 846w, 779w, 758w, 717w, 704w, 6814w, 659w, 644w, 596w, 
578w, 566w, 539w, 530w cm-1. 1H-NMR (500 MHz, CDCl3, δ): 5.04 (bs, 1H, -NH), 3.35-
3.20 (m, 1H, -CH2NHBoc), 3.20-3.05 (m, 1H, -CH2NHBoc), 3.05-2.90 (m, 1H, 
NH2CH(CH3)-), 1.60-1.50 (m, 1H, NH2CH(CH3)CH2-), 1.50-1.35 (m, 10H, 
NH2CH(CH3)CH2-, -NHCOO-C(CH3)3), 1.31 (bs, 2H, -NH2), 1.10 (d, 3H, J = 6.4, CH3). 13C-
NMR (125 MHz, CDCl3, δ): 156.04; 78.82; 44.93; 39.33; 37.98; 28.29; 24.24. HRMS: m/z 
189.15990 corresponds to molecular formula C8H20N2O2H+ (error in ppm: + 0.79). 
Tert-butyl (4-aminopentyl)carbamate (S7). 
Compound S7 was prepared by method A from 1,4-pentandiamine 
(3.00 g, 29.33 mmol) and tert-butyl phenyl carbonate (10.88 mL, 
58.63 mmol) and was obtained after dry-flash chromatography: SiO2, 
eluent: CH2Cl2/MeOH(NH3sat.) = 95/5,as colorless viscous oil (4.03 g, 68%). IR(ATR): 
3256w, 2897s, 2844m, 1610w, 1571s, 1535s, 1449m, 1376m, 1331m, 1277w, 1263w, 1201w, 
1050w, 1119w, 1079w, 904w, 876w, 851w, 806w, 767w, 735m, 703w, 645w, 623w, 597w, 
559w, 532w, 510w cm-1. 1H-NMR (500 MHz, CDCl3, δ): 5.00 (bs, H-N), 3.20-3.00 (m, 2H, -
CH2NHBoc), 3.00-2.85 (m, 1H, NH2CH(CH3)CH2-), 2.04 (bs, H-N), 1.60-1.50 (m, 2H, -
CH2CH2NHBoc 1.50-1.40 (m, 9H, -NHCOO-C(CH3)3), 1.40-1.30 (m, 2H, NH2CH(CH3)CH2-
), 1.08 (d, 3H, J = 6.4, CH3). 13C-NMR (125 MHz, CDCl3, δ): 155.88; 78.68; 46.45; 40.38; 
36.69; 28.23; 26.71; 23.59. HRMS: m/z203.17601 corresponds to molecular formula 








Tert-butyl (3-aminopentyl)carbamate (S8). 
Compound S8 was prepared by method A from 1,3-diaminopentane (4 
mL, 33.47 mmol) and tert-butyl phenyl carbonate (12.5 mL, 66.94 
mmol) and was obtained after dry-flash chromatography: SiO2, eluent: 
CH2Cl2/MeOH(NH3 sat.) = 95/5 as colorless solid (4.87 g, 72%); m.p. = 77-79 C (Hex). IR 
(ATR): 3363m, 2966m, 2931m, 2876w, 1683s, 1524m, 1457w, 1389w, 1364m, 1328w, 
1272m, 1248m, 1169s, 1042w, 1022w, 953w, 921w, 870w, 816w, 780w, 741w, 509w cm-1. 
1H-NMR (500 MHz, CDCl3, δ): 5.21 (bs, H-N), 3.40-3.25 (m, 1H, -CH2NHBoc), 3.25-3.15 
(m, 1H, -CH2NHBoc), 2.75-2.65 (m, 1H, H2NCH(CH2CH3)-), 5.34 (bs, 2H-N), 1.70-1.60 (m, 
1H, -CH2CH2NHBoc), 1.50-1.40 (m, 10H, -CH2CH3, -NHCOO-C(CH3)3), 1.40-1.30 (m, 2H, 
-CH2CH3, -CH2CH2NHBoc), 0.92 (t, 3H, J = 7.4, -CH2CH3). 13C-NMR (125 MHz, CDCl3, 
δ): 156.04; 78.76; 51.07; 38.16; 36.70; 31.01; 28.33; 10.17. HRMS: m/z203.17540 
corresponds to molecular formula C10H22N2O2H+ (error in ppm: + 4.11). Anal.(C10H22N2O2  
2/3 H2O) Calcd: C, 56.05; H, 10.97; N, 13.07. Found: C, 56.12; H, 10.47; N, 12.67. 
Tert-butyl {2-[(7-chloroquinolin-4-yl)amino]propyl}carbamate (S9). 
Compound S9 was prepared from 4,7-dichloroquinoline (3.18 g, 
16.70 mmol) and mono-N-Boc-protected 1,2-diaminopropane S5 
(5.60 g, 32.14 mmol) by method B and was obtained after 
multiple chromatography: dry-flash SiO2, eluent: 
CH2Cl2/MeOH(NH3 sat.) = 95/5 and flash chromatography (Biotage SP1 RP column, 
gradient: MeOH/H2O = 6/4→7/3) as colorless solid (4.75 g, 88%); m.p. = 227-229 C (Hex). 
IR (ATR): 3372s, 3187s, 2978s, 2933m, 1674s, 1612m, 1578s, 1537m, 1488w, 1452m, 
1429w, 1380w, 1366w, 1335w, 1295m, 1252m, 1200w, 1172m, 1154m, 1082w, 1055w, 
988w, 957w, 904w, 875w, 855w, 819w, 769w, 648w, 625w, 594w, 511w, 454w, 439w cm-1. 
1H-NMR (500 MHz, CD3OD, δ): 8.29 (d, J = 5.5, H-C(2)), 8.01 (d, J = 9.0, H-C(5)), 7.72 (d, 
J = 2.0, H-C(8)), 7.30 (dd, J1 = 1.5, J2= 9.0, H-C(6)), 6.54 (d, J = 5.5, H-C(3)), 3.95-3.80 (m, 
1H, ArNHCH(CH3)-), 3.35-3.25 (m, 1H, -CH2NHBoc), 3.25-3.10 (m, 1H, -CH2NHBoc), 1.36 
(s, 9H, -NHCOO-C(CH3)3), 1.27 (d, 3H, J = 6.5, CH3). 13C-NMR (125 MHz, CD3OD, δ): 
159.33; 152.41; 152.13; 149.75; 136.34; 127.65; 125.96; 124.42; 118.76; 100.02; 80.40; 
46.25; 28.86; 17.78. HRMS: m/z 336.14733 corresponds to molecular formula 
C17H22ClN3O2H+ (error in ppm: - 0.41).Anal.(C17H22ClN3O2) Calcd: C, 60.80; H, 6.60; N, 
12.51. Found: C, 60.57; H, 6.70; N, 12.71. 
Tert-butyl {3-[(7-chloroquinolin-4-yl)amino]butyl}carbamate (S10). 
Compound S10 was prepared by method Bfrom 4,7-










protected butane-1,3-diamine S6(3.82 g, 20.18 mmol) and was obtained after dry-flash 
chromatography SiO2, gradient: CH2Cl2/MeOH(NH3 sat.) = 95/5→8/2 as colorless solid (4.29 
g, 73%); m.p. = 168-171 C (Hex). IR (ATR): 3342m, 3192m, 2972m, 1677s, 1611m, 1579s, 
1538m, 1488w, 1450w, 1434m, 1378w, 1366w, 1334w, 1284m, 1251w, 1228w, 1152m, 
1131w, 1088w, 1066w, 1039w, 1017w, 985w, 956w, 930w, 885w, 855w, 808m, 764m, 
737m, 645w, 624w, 600w, 576w, 551w, 515w cm-1. 1H-NMR (500 MHz, CDCl3, δ): 8.50 (d, 
J = 5.4, H-C(2)), 7.94 (d, J = 2.1, H-C(8)), 7.78 (d, J = 7.6, H-C(5)), 7.35 (dd, J1 = 2.2, J2 = 
9.0, H-C(6)), 6.39 (d, J = 5.4, H-C(3)), 5.36 (bs, H-N), 4.82 (bs, H-N), 3.85-3.75 (m, 1H, 
ArNHCH(CH3)-), 3.35-3.27 (m, 1H, -CH2NHBoc), 3.27-3.15 (m, 1H, -CH2NHBoc), 2.00-
1.80 (m, 2H, ArNHCH(CH3)CH2-), 1.45 (s, 9H, -NHCOO-C(CH3)3), 1.34 (d, 3H, J = 6.4, 
CH3). 13C-NMR (125 MHz, CDCl3, δ): 156.18; 151.91; 149.33; 148.93; 134.84; 128.74; 
125.18; 121.29; 117.33; 99.10; 79.71; 46.46; 37.53; 36.83; 28.39; 20.20.HRMS: 
m/z350.16298 corresponds to molecular formula C18H24ClN3O2H+ (error in ppm: + 
0.87).Anal.(C18H24ClN3O2 3/2 H2O) Calcd: C, 59.74; H, 7.06; N, 11.61. Found: C, 59.66; H, 
7.00; N, 11.60. 
 Tert-butyl {4-[(7-chloroquinolin-4-yl)amino]pentyl}carbamate (S11). 
Compound S11 was prepared by method B from 4,7-
dichloroquinoline (881 mg, 4.45 mmol) and mono-N-Boc-
protected pentane-1,4-diamine S7 (1.80 g, 8.90 mmol) and 
was obtained after dry-flash chromatography SiO2, eluent: 
CH2Cl2/MeOH(NH3sat.) = 95/5→8/2, as colorless solid (1.12 g, 69%); m.p. = 137-139 C 
(Hex). IR (ATR): 3290w, 3183w, 2967w, 2925w, 2835w, 1677s, 1613w, 1570s, 1541m, 
1492w, 1450w, 1438, 1432w, 1383w, 1364w, 1331w, 1294m, 1283m, 1254w, 1212w, 
1165w, 1149m, 1105w, 1082w, 1068w, 1056w, 1026w, 978w, 912w, 900w, 878w, 863w, 
852w, 819w, 805, 770w, 749w, 719w, 683w, 654w, 635w, 622w, 599w, 550w cm-1. 1H-NMR 
(500 MHz, CDCl3, δ): 8.51 (d, J = 5.4, H-C(2)), 7.94 (d, J = 2.2, H-C(8)), 7.75 (d, J = 8.7, H-
C(5)), 7.34 (dd, J1 = 2.2, J2 = 8.9, H-C(6)), 6.40 (d, J = 5.5, H-C(3)), 5.16 (bs, H-N), 4.66 (bs, 
H-N), 3.80-3.65 (m, 1H, ArNHCH(CH3)-), 3.25-3.15 (m, 1H, -CH2NHBoc), 3.15-3.05 (m, 
1H, -CH2NHBoc), 1.75-1.65 (m, 1H, ArNHCH(CH3)CH2-), 1.65-1.55 (m, 3H, 
ArNHCH(CH3)CH2-, -CH2CH2NHBoc), 1.45 (s, 9H, -NHCOO-C(CH3)3), 1.31 (d, 3H, J = 
6.4, CH3). 13C-NMR (125 MHz, CDCl3, δ): 156.26; 151.97; 149.36; 148.92; 134.79; 128.79; 
125.12; 121.17; 117.25; 79.41; 99.14; 48.43; 40.24; 33.22; 28.38; 27.28; 20.46. HRMS: m/z 
364.17863 corresponds to molecular formula C19H26ClN3O2H+ (error in ppm: - 2.43). 
Anal.(C19H26ClN3O2  1/2 H2O) Calcd: C, 61.20; H, 7.30; N, 11.27. Found: C, 60.76; H, 6.88; 
N, 11.46. 






Compound S12 was prepared by method B from 4,7-
dichloroquinoline (4.08 g, 20.60 mmol) and mono-N-Boc-
protected 1,3-diaminopentane S8 (5.00 g, 24.72 mmol) and was 
obtained after dry-flash chromatography SiO2, eluent: 
CH2Cl2/MeOH(NH3sat.) = 95/5 and flash chromatography 
(Biotage SP1 RP column, eluent: MeOH/H2O = 6/4) as colorless solid (7.82 g, 87%); m.p. = 
58-60 C (Hex). IR (ATR): 3325m, 2971m, 2932m, 2877w, 1687s, 1612w, 1574s, 1538m, 
1453m, 1365m, 1332w, 1279m, 1248m, 1165m, 1147m, 1081w, 1042w, 903w, 853m, 805m, 
766m, 643w, 599w, 496w cm-1. 1H-NMR (500 MHz, CD3COOD, δ): 8.47 (d, J = 5.5, H-
C(2)), 7.94 (d, J = 2.0, H-C(8)), 7.80 (d, J = 8.5, H-C(5)), 7.34 (dd, J1 = 2.5, J2 = 9.0, H-C(6)), 
6.36 (d, J = 5.5, H-C(3)), 5.37 (bs, H-N), 4.95 (bs, H-N), 3.70-3.50 (m, 1H, 
ArNHCH(CH2CH3)-), 3.35-3.25 (m, 1H, -CH2NHBoc), 3.25-3.10 (m, 1H, -CH2NHBoc), 
2.00-1.85 (m, 1H, -CH2CH2NHBoc), 1.85-1.70 (m, 1H, -CH2CH2NHBoc), 1.75-1.60 (m, 2H, 
-CH2CH3), 1.44 (s, 9H, -NHCOO-C(CH3)3), 0.98 (t, 3H, J = 7.5, -CH2CH3). 13C-NMR (125 
MHz, CD3COOD, δ): 156.18; 151.85; 149.42; 149.30; 134.82; 128.64; 125.13; 121.29; 
117.27; 98.98; 79.59; 52.17; 37.54; 34.18; 28.37; 27.12; 10.22. HRMS: m/z364.17865 
corresponds to molecular formula C19H26ClN3O2H+ (error in ppm: + 0.06). Anal. 
(C19H26ClN3O2  1/2 H2O) Calcd: C, 61.20; H, 7.30; N, 11.27. Found: C, 61.20; H, 7.22; N, 
11.43. 
N2-(7-Chloroquinolin-4-yl)propane-1,2-diamine (S13). 
Compound S13 was prepared by method C from S9 (1.00 g, 2.98 
mmol) and was obtained after dry-flash chromatography: SiO2, 
gradient: CH2Cl2/MeOH(NH3sat.) = 9/1→7/3 and flash 
chromatography (Biotage SP1 RP column, eluent: MeOH/H2O = 6/4), 
asyellow powder softens at 158-159 C. Yield: 646 mg (92%). IR (ATR): 3312s, 2966s, 
2906s, 2157w, 1611m, 1580s, 1541m, 1491w, 1450m, 1426w, 1368w, 1329w, 1283w, 
1250w, 1205w, 1171w, 1152w, 1133w, 1050w, 1034w, 1014w, 906w, 872w, 861w, 798m, 
762w, 739w, 669w, 645w, 622w, 603w, 567w, 531w, 516w, 491w, 428w cm-1. 1H-NMR(200 
MHz, CDCl3/CD3OD, δ): 8.38 (d, J = 5.6, H-C(2)), 7.91 (d, J = 9.0, H-C(8)) 7.87 (d, J = 2.2, 
H-C(5)), 7.34 (dd, J1 = 2.3, J2 = 8.9, H-C(6)), 6.41 (d, J = 5.6, H-C(3)), 3.95-3.85 (m, H, 
ArNHCH(CH3)-), 3.00-2.90 (m, 2H, -CH2NH2), 1.35-1.25 (d, 3H, J = 6.0, CH3). 13C-NMR 
(50 MHz, CD3OD, δ): 151.16; 149.81; 148.46; 134.99; 127.31; 125.03; 121.88; 117.28; 
98.83; 45.72; 21.43; 17.17. HRMS: m/z 236.09395 corresponds to molecular formula 
C12H14ClN3H+ (error in ppm: - 4.03). Anal. (C12H14ClN3  1/3 CH2Cl2) Calcd: C, 56.11; H, 












Compound S14 was prepared by method Cfrom S10 (650 mg, 1.86 
mmol) and was obtained after dry-flash chromatography: SiO2, 
gradient: CH2Cl2/MeOH(NH3sat.) = 95/5→8/2, as colorless powder 
softens at 106-108 C. Yield: 353 mg (76%). IR (ATR): 3243m, 
2969m, 2927m, 2866w, 1609m, 1569s, 1537m, 1487w, 1448m, 1426m, 1365m, 1329m, 
1279w, 1244w, 1198w, 1145m, 1078w, 873w, 854m, 806m, 766w, 731m, 701w, 643w, 
622w, 596w, 571w cm-1. 1H-NMR (500 MHz, CDCl3, δ): 8.48 (d, J = 5.4, H-C(2)), 7.91 (d, J 
= 2.1, H-C(8)), 7.72 (d, J = 9.0, H-C(5)), 7.30 (dd, J = 2.1, J = 9.0, H-C(6)), 7.22 (bs, H-N), 
6.37 (d, J = 5.4, H-C(3)), 3.95-3.80 (m, 1H, ArNHCH(CH3)-), 3.15-3.05 (m, 1H, -CH2NH2), 
3.05-2.90 (m, 1H, -CH2NH2), 1.95-1.80 (m, 1H, -CH2CH2NH2), 1.80-1.70 (m, 1H, -
CH2CH2NH2), 1.63 (bs, 2H-N), 1.32 (d, 3H, J = 6.4, CH3). 13C-NMR (125 MHz, CDCl3, δ): 
151.94; 149.55; 149.33; 134.61; 128.52; 124.84; 121.94; 117.65; 98.58; 48.05; 38.64; 37.65; 
19.27. HRMS: m/z 250.11106 corresponds to molecular formula C13H16ClN3H+ (error in ppm: 
+ 2.04). Anal. (C13H16ClN3  1/3 CH2Cl2) Calcd: C, 61.05; H, 6.57; N, 16.43. Found: C, 
61.35; H, 6.34; N, 16.18. 
N4-(7-Chloroquinolin-4-yl)pentane-1,4-diamine (S15). 
Compound S15 was prepared by method Cfrom S11 (300 mg, 
0.86 mmol) and was obtained after dry-flash chromatography: 
SiO2, gradient: CH2Cl2/MeOH(NH3sat.) = 95/5→8/2, as 
colorless powder softens at132-136 C. Yield: 176 mg (81%). IR 
(ATR): 3238m, 3063w, 2968w, 2932m, 2851w, 1568w, 1570s, 
1491w, 1452m, 1423m, 1384w, 1363w, 1329w, 1280w, 1251w, 1200w, 1156w, 1128w, 
1084w, 941w, 903w, 869w, 842w, 818w, 796m, 771w, 700w, 682w, 643w, 621w, 598w, 
561w, 534w cm-1. 1H-NMR (500 MHz, CDCl3, δ): 8.51 (d, J = 5.4, H-C(2)), 7.94 (d, J = 2,2, 
H-C(8)), 7.70 (d, J = 9.0, H-C(5)), 7.33 (dd, J1 = 2.2, J2 = 8.9, H-C(6)), 6.45-6.35 (m, H-
C(3)), 5.42 (d, J = 6.7, H-N), 3.75-3.65 (m, 1H, ArNHCH(CH3)-), 2.80-2.70 (m, 2H, -
CH2NH2), 1.85-1.65 (m, 2H, -ArNHCH(CH3)CH2-), 1.65-1.50 (m, 2H, -CH2CH2NH2), 1.32 
(d, 3H, J = 6.2, CH3). 13C-NMR (125 MHz, CDCl3, δ): 152.02; 149.41; 149.03; 134.72; 
128.85; 125.01; 121.13; 117.34; 99.14; 48.28; 41.80; 33.83; 29.57; 20.21. HRMS: m/z 
264.12589 corresponds to molecular formula C14H18ClN3H+ (error in ppm: - 1.19). 
Anal.(C14H18ClN3) Calcd: C, 63.75; H, 6.88; N, 15.93. Found: C, 63.59; H, 6.80; N, 15.96. 
 
N3-(7-chloroquinolin-4-yl)pentane-1,3-diamine (S16). 
Compound S16 was prepared by method C from S12 (540 mg, 1.37 












gradient: CH2Cl2/MeOH(NH3sat.) = 9/1→7/3 and flash chromatography (Biotage SP1 RP 
column, eluent: MeOH/H2O = 65/35) asyellow powder softens at 142-144 C. Yield: 318 mg 
(88%). IR (ATR): 3265m, 2898s, 2844s, 1610w, 1573s, 1536m, 1486w, 1448m, 1427w, 
1366w, 1330w, 1282w, 1263w, 1247w, 1201w, 1136w, 1096w, 1078w, 903w, 876w, 853m, 
804m, 763w, 736m, 702w, 644w, 622w, 600w, 539w, 499w, 456w, 429w, 407w cm-1. 1H-
NMR (500 MHz, CDCl3, δ): 8.48 (d, J = 5.4, H-C(2)), 7.92 (d, J = 2.2, H-C(8)), 7.72 (d, J = 
8.9, H-C(5)), 7.32 (dd, J1 = 2.2, J2 = 8.9, H-C(6)), 6.92 (d, J = 5.4, H-N), 6.36 (d, J = 5.5, H-
C(3)), 3.75-3.65 (m, 1H, ArNHCH-), 3.10-3.00 (m, 1H, -CH2NH2), 3.00-2.90 (m, 1H, -
CH2NH2), 1.95-1.85 (m, 1H, -CH2CH2NH2), 1.85-1.70 (m, 2H, -CH2CH2NH2, -CH2CH3), 
1.70-1.60 (m, 1H, -CH2CH3), 1.41 (s, 2H-N), 0.98 (t, 3H, J = 7.4, -CH2CH3). 13C-NMR (125 
MHz, CD3OD, δ): 152.03; 149.73; 149.47; 134.61; 128.68; 124.84; 121.75; 117.59; 98.58; 
53.75; 38.64; 34.83; 26.16; 10.30. HRMS: m/z 264.12636 corresponds to molecular formula 
C14H18ClN3H+ (error in ppm: + 0.59). Anal.(C14H18ClN3) Calcd: C, 63.75; H, 6.88; N, 15.93. 
Found: C, 63.46; H, 6.98; N, 15.74. 
N1-(1-Adamantylmethyl)-N2-(7-chloroquinolin-4-yl)propane-1,2-diamine (9). 
Compound 9 was prepared by method Dfrom amine S13 
(254 mg, 1.08 mmol) and adamantane-1-carboxaldehyde 
(177 mg, 1.08 mmol) using NaBH(OAc)3 (458 mg, 2.16 
mmol) and was obtained after dry-flash chromatography: 
SiO2, eluent: CH2Cl2/MeOH(NH3sat.) = 100/2, as colorless 
foam (343 mg, 83%)softens at 153-155 °C. IR (ATR): 3230m, 2897m, 9842w, 2804m, 
1612w, 1586s, 1541m, 1488w, 1447m, 1370w, 1352w, 1332w, 1308w, 1282w, 1242w, 
1198w, 1153m, 1138m, 1110w, 1097w, 1073w, 1029w, 1007w, 986m, 948w, 897w, 874w, 
860w, 852w, 835m, 794m, 759m, 718w, 562w, 633w, 610m, 501m, 475w, 443w, 425w, 
403w cm-1. λmax(ε) = 330 (10259), 254 (15366), 237 (13922) nm. 1H-NMR (500 MHz, CDCl3, 
δ): 8.51 (d, J = 5.0, H-C(2)), 7.94 (d, J = 1.5, H-C(8)), 7.72 (d, J = 9.0, H-C(5)), 7.34 (dd, J1 = 
1.8, J2 = 8.8, H-C(6)), 6.42 (d, J = 5.0, H-C(3)), 6.08 (d, J = 5.0, H-N), 3.75-3.65 (m, 1H, 
ArNHCH(CH3)-), 2.90-2.80 (d, 2H, ArNHCH(CH3)CH2-), 2.32 (ABq, HA, J = 11.5, -CH2Ad), 
2.24 (ABq, HB, J = 11.5, -CH2Ad), 1.95 (bs, 3H, -Ad), 1.75-1.55 (m, 6H, -Ad), 1.55-1.45 (m, 
6H, -Ad), 1.29 (d, 3H, J = 6.5, CH3). 13C-NMR (125 MHz, CDCl3, δ): 151.94; 149.41; 
149.26; 134.68; 128.64; 125.02; 121.28; 117.70; 99.45; 62.60; 55.14; 47.20; 40.83; 37.14; 
33.61; 28.35; 18.07. HRMS: m/z 384.21930 corresponds to molecular formula 
C23H30ClN3H+(error in ppm: - 2.09). Anal. (C23H30ClN3 ×1/2 H2O) Calcd: C, 70.30; H, 7.95; 
N, 10.69. Found: C, 70.62; H, 7.90; N, 10.85. HPLC purity (λ = 330 nm): method A: RT 







Compound 23 was prepared by method E from amine S14 
(430 mg, 1.72 mmol) and adamantane-1-carboxaldehyde 
(283 mg, 1.72 mmol) using AcOH (141 µL, 2.15 mmol) 
and NaBH4 (390 mg, 10.32 mmol) and was obtained after 
dry-flash chromatography: SiO2, eluent: CH2Cl2/MeOH(NH3sat.) = 95/5, as colorless foam 
(610 mg, 89%)softens at 135-138 oC. IR(ATR): 3250m, 3061w, 2962w, 2897s, 2842m, 
1611w, 1570s, 1542m, 1490w, 1450m, 1430m, 1365m, 1345w, 1330m, 1283w, 1253w, 
1206w, 1184w, 1136w, 1079w, 928w, 901w, 870m, 850m, 821w, 801m, 770w, 756m, 637w, 
612w, 602w, 502w cm-1. λmax(ε) = 326 (10000), 254 (16260) nm. 1H-NMR (500 MHz, 
CDCl3, δ): 8.49 (d, J = 5.4, H-C(2)), 7.92 (d, J = 2.0, H-C(8)), 7.80 (d, J = 8.9, H-C(5)), 7.35-
7.20 (m, H-C(6)), 7.08 (d, J = 5.1, H-N), 6.40 (d, J = 5.4, H-C(3)), 3.90-3.80 (m, 1H, 
ArNHCH(CH3)-), 2.95-2.85 (m, 1H, -CH2NHCH2Ad), 2.85-2.70 (m, 1H, -CH2NHCH2Ad), 
2.30 (s, 2H, -CH2Ad), 2.01 (s, 3H, -Ad), 1.95-1.85 (m, 1H, ArNHCH(CH3)CH2-), 1.85-1.65 
(m, 7H, ArNHCH(CH3)CH2-, -Ad), 1.65-1.50 (m, 7H, -Ad, H-N-), 1.32 (d, 3H, J = 6.3, CH3). 
13C-NMR (125 MHz, CDCl3, δ): 152.05; 149.61; 149.40; 134.59; 128.60; 124.54; 122.30; 
117.67; 98.90; 63.68; 48.32; 47.81; 41.16; 37.17; 35.22; 33.36; 28.43; 19.36. HRMS: m/z 
398.23673 corresponds to molecular formula C24H32ClN3H+ (error in ppm: + 2.45). Anal. 
(C24H32ClN3 × 1/2H2O) Calcd: C, 70.83; H, 8.17; N, 10.32. Found: C, 70.71; H, 7.91; N, 
10.53. HPLCpurity (λ = 330 nm): method A: RT 7.989 min, area 99.68%; method B: RT 
9.636 min, area 99.31%. 
N1-(1-Adamantylmethyl)-N4-(7-chloroquinolin-4-yl)pentane-1,4-diamine (29). 
Compound 29 was prepared by method E from amine 
S15 (75 mg, 0.28 mmol) and adamantane-1-
carboxaldehyde (47 mg, 0.28 mmol) using AcOH (120 
µL, 0.35 mmol) and NaBH4 (64 mg, 1.68 mmol) and 
was obtained after multiple chromatography: dry-flash 
SiO2, eluent: CH2Cl2/MeOH(NH3sat.) = 95/5, and flash chromatography (Biotage SP1 NH 
column, eluent: Hex/EtOAc = 7/3) as colorless foam (94 mg, 80%)softens at 131-132 °C. IR 
(ATR): 3256w, 2897s, 2844m, 1610w, 1571s, 1535m, 1449m, 1377m, 1331m, 1277w, 
1263w, 1201w, 1150m, 1119w, 1079w, 904w, 876w, 851w, 806m, 767w, 735m, 702w, 
645w, 623w, 597w, 559w, 532w, 510w cm-1. λmax(ε) = 329 (11176), 255 (16882) nm. 1H-
NMR (500 MHz, CDCl3, δ): 8.51 (d, J = 5.4, H-C(2)), 7.94 (d, J = 2.1, H-C(8)), 7.70 (d, J = 
9.0, H-C(5)), 7.32 (dd, J1 = 2.2, J2 = 8.9, H-C(6)), 6.41 (d, J = 5.5, H-C(3)), 5.29 (d, J = 7.0, 
H-N), 3.80-3.65 (m, 1H, ArNHCH(CH3)-), 2.70-2.55 (m, 2H, -CH2NHCH2Ad), 2.24 (s, 2H, -
CH2Ad), 1.97 (s, 3H, -Ad), 1.85-1.60 (m, 10H, ArNHCH(CH3)CH2-, -CH2CH2NHCH2Ad, -








152.02; 151.10; 148.96; 134.35; 128.87; 124.99; 121.13; 117.29; 99.22; 62.69; 50.14; 48.36; 
41.00; 37.19; 33.77; 33.37; 28.44; 26.12; 20.25. HRMS: m/z 412.25177 corresponds to 
molecular formula C25H34ClN3H+ (error in ppm: + 0.89). Anal. (C25H34ClN × 1/2H2O) Calcd: 
C, 71.32; H, 8.38; N, 9.98. Found: C, 71.13; H, 8.11; N, 9.99. HPLC purity (λ = 330 nm): 
method A: RT 8.010 min, area 97.89%; method B: RT 9.514 min, area 95.43%. 
N1-(1-Adamantylmethyl)-N3-(7-chloroquinolin-4-yl)pentane-1,3-diamine (27). 
Compound 27 was prepared by method D from amine S16 
(51 mg, 0.19 mmol) and 1-adamantylacetaldehyde(32 mg, 
0.19 mmol) using NaBH(OAc)3 (80 mg, 0.38 mmol) and 
was obtained after multiple chromatography: dry-flash 
SiO2, eluent: CH2Cl2/MeOH(NH3sat.) = 100/4, and flash 
chromatography (Biotage SP1 NH column, eluent: Hex/EtOAc = 7/3) as yellow foam (54 mg, 
68%),softens at 121-123 °C. IR (ATR): 3242m, 3063w, 2928m, 2869w, 1661w, 1610w, 
1570s, 1541m, 1490w, 1452m, 1426m, 1366m, 1329m, 1283w, 1250m, 1200w, 1143m, 
1127m, 1080m, 1005w, 978w, 903w, 874w, 852m, 804m, 869m, 641w, 622w, 599w, 528w, 
497m, 447w, 426w cm-1. 1H-NMR (500 MHz, CDCl3, δ): 8.48 (d, J = 5.4, H-C(2)), 7.92 (d, J 
= 2.0, H-C(8)), 7.80 (d, J = 9.0, H-C(5)), 7.26 (dd, J1 = 2.1, J2 = 8.8, H-C(6)), 6.82 (d, J = 6.0, 
H-N), 6.38 (d, J = 5.8, H-C(3)), 3.70-3.60 (m, 1H, ArNHCH(CH2CH3)-), 2.87-2.78 (m, 1H, -
CH2NHCH2Ad), 2.78-2.70 (m, 1H, -CH2NHCH2Ad), 2.30 (ABq, HA, J = 11.6, -CH2Ad), 2.24 
(ABq, HB, J = 11.6, -CH2Ad), 2.00 (m, 3H, -Ad), 1.95-1.85 (m, 1H, -CH2CH2NHCH2Ad), 
1.85-1.60 (m, 9H, -Ad, -CH2CH3, -CH2CH2NHCH2Ad), 1.60-1.50 (m, 6H, -Ad), 0.97 (t, 3H, 
J = 7.5, CH3). 13C-NMR (125 MHz, CDCl3, δ): 152.02; 149.79; 149.42; 134.59; 128.61; 
124.55; 122.12; 117.59; 98.84; 63.62; 54.00; 47.75; 41.11; 37.15; 33.33; 32.17; 28.41; 26.15; 
10.31. HRMS: m/z412.25140 corresponds to molecular formula C25H34ClN3H+ (error in ppm: 
- 0.31).Anal.(C25H34ClN3 × 1/2H2O) Calcd: C, 71.32; H, 8.38; N, 9.98. Found: C, 71.52; H, 
7.88; N, 10.15. HPLC purity (λ = 330 nm): method A: RT 8.009 min, area 98.18%; method B: 
RT 9.508 min, area 97.79%. 
N1-[2-(1-Adamantyl)ethyl]-N2-(7-chloroquinolin-4-yl)propane-1,2-diamine (33). 
Compound 33 was prepared by method D from amine S13 
(180 mg, 0.76 mmol) and 1-adamantylacetaldehyde(136 mg, 
0.76 mmol) using NaBH(OAc)3 (58 mg, 1.52 mmol) and was 
obtained after dry-flash chromatography: SiO2 eluent: 
CH2Cl2/MeOH(NH3sat.) = 95/5, and flash chromatography (Biotage SP1 RP column, 
gradient: MeOH/H2O = 7/3→9/1) as colorless solid (227 mg, 75%),softens at 46-47 °C. IR 
(ATR): 3252m, 3063w, 2896s, 2843m, 1610w, 1573s, 1537m, 1447m, 1426w, 1376m, 








645w, 623w, 600w, 540w, 513w, 490w, 421w cm-1. λmax(ε) = 327 (10189), 253 (16143) nm. 
1H-NMR (500 MHz, CDCl3, δ): 8.48 (d, J = 5.5, H-C(2)), 7.92 (d, J = 1.0, H-C(8)), 7.74 (d, J 
= 9.0, H-C(5)), 7.32 (dd, J1 = 1.8, J2 = 8.8, H-C(6)), 6.40 (d, J = 5.5, H-C(3)), 5.90 (bs, H-N), 
3.75-3.65 (m, 1H, ArNHCH(CH3)-), 2.95-2.85 (m, 2H,ArNHCH(CH3)CH2-), 2.70-2.60 (m, 
2H, -CH2CH2Ad), 1.92 (bs, 3H, -Ad), 1.75-1.55 (m, 6H, -Ad), 1.48 (bs, 6H, -Ad), 1.35-1.20 
(m, 6H, -CH2Ad, CH3, H-N-). 13C-NMR (125 MHz, CDCl3, δ): 151.82; 149.31; 149.13; 
134.75; 128.46; 125.04; 121.44; 117.55; 99.31; 54.36, 47.41; 44.59; 44.44; 42.62; 37.03; 
31.86; 28.58; 18.11. HRMS: m/z 398.23435 corresponds to molecular formula C24H32ClN3H+ 
(error in ppm: - 3.51). Anal.(C24H32ClN3  1/2 H2O) Calcd: C, 70.83; H, 8.17; N, 10.32. 
Found: C, 70.44; H, 7.91; N, 10.27. HPLC purity (λ = 330 nm): method A: RT 7.891 min, 
area 97.79%; method B: RT 9.904 min, area 95.06%. 
N1-[2-(1-Adamantyl)ethyl]-N3-(7-chloroquinolin-4-yl)butane-1,3-diamine (36). 
Compound 36 was prepared by method E from amine 
S14 (90 mg, 0.36 mmol) and 1-adamantylacetaldehyde 
(64.3 mg, 0.36 mmol) using AcOH (26 µL, 0.45 
mmol) and NaBH4 (82 mg, 2.16 mmol) and was 
obtained after multiple chromatography: dry-flash: 
SiO2, eluent: CH2Cl2/MeOH(NH3sat.) = 95/5, and flash chromatography (Biotage SP1 NH 
column, eluent: Hex/EtOAc = 6/4) as colorless foam (596 mg, 77%),softens at 62-64 °C. IR 
(ATR): 3219w, 2897s, 2843m, 1737m, 1610w, 1573s, 1538m, 1448m, 1427w, 1368m, 
1330m, 1280w, 1242m, 1199w, 1149m, 1077w, 1046w, 976w, 849m, 804m, 764w, 716w, 
644w, 604w, 518w, 505w cm-1. λmax(ε) = 328 (10358), 254 (16434) nm. 1H-NMR (500 MHz, 
CDCl3, δ): 8.47 (d, J = 5.4, H-C(2)), 7.91 (d, J = 2.2, H-C(8)), 7.87 (d, J = 4.5, H-N), 7.75 (d, 
J = 9.0, H-C(5)), 7.29 (dd, J1 = 2.2, J2 = 9.0, H-C(6)), 6.34 (d, J = 5.6, H-C(3)), 3.90-3.80 (m, 
1H, ArNHCH(CH3)-), 3.05-2.95 (m, 1H, -CH2NHCH2CH2Ad), 2.85-2.75 (m, 1H, -
CH2NHCH2CH2Ad-), 2.70-2.60 (m, 2H, -CH2CH2Ad), 2.00-1.90 (m, 4H, 
ArNHCH(CH3)CH2-, -Ad), 2.00-1.90 (m, 7H, ArNHCH(CH3)CH2-, -Ad), 1.55-1.45 (m, 6H, -
Ad), 1.40-1.30 (m, 2H, -CH2Ad), 1.32 (d, 3H, J = 6.4, CH3). 13C-NMR (125 MHz, CDCl3, δ): 
152.01; 149.81; 149.40; 134.53; 128.52; 124.54; 122.41; 117.84; 98.51; 48.45; 46.40; 44.98; 
44.50; 42.70; 37.09; 34.83; 31.87; 28.62; 19.05. HRMS: m/z 398.23435 corresponds to 
molecular formula C25H34ClN3H+ (error in ppm: - 1.75). Anal.(C25H34ClN3  1/2 H2O) Calcd: 
C, 71.32; H, 8.38; N, 9.98. Found: C, 71.11; H, 8.07; N, 10.08. HPLC purity (λ = 330 






Compound 42 was prepared by method E from amine 
S15 (320 mg, 1.21 mmol) and 1-
adamantylacetaldehyde (216 mg, 1.21 mmol) using 
AcOH (86 µL, 1.51 mmol) and NaBH4 (92 mg, 2.42 
mmol) and was obtained after dry-flash 
chromatography: SiO2, eluent: CH2Cl2/MeOH(NH3sat.) = 9/1, as colorless foam (314 mg, 
61%)softens at 49-51 °C. IR (ATR): 3422m, 2901s, 2845m, 1611w, 1578s, 1540w, 1450m, 
1426w, 1379w, 1332w, 1280w, 1253w, 1201w, 1150w, 1081w, 905w, 877w, 854w, 806w, 
768w, 646w, 601w, 401w cm-1. λmax(ε) = 328 (11161), 255 (17040) nm. 1H-NMR (500 MHz, 
CDCl3, δ): 8.50 (d, J = 5.4, H-C(2)), 7.93 (d, J = 2.1, H-C(8)), 7.73 (d, J = 9.0, H-C(5)), 7.33 
(dd, J1 = 2.2, J2 = 8.9, H-C(6)), 6.39 (d, J = 5.5, H-C(3)), 5.52 (bs, H-N), 3.75-3.60 (m, 1H, 
ArNHCH(CH3)-), 2.75-2.65 (m, 2H, -CH2NHCH2CH2Ad), 2.65-2.55 (m, 2H, -CH2CH2Ad), 
1.93 (bs, 3H, -Ad), 1.85-1.75 (m, 1H, ArNHCH(CH3)CH2-), 1.75-1.50 (m, 10H, 
ArNHCH(CH3)CH2-, -CH2CH2NHCH2CH2Ad, -Ad, H-N-), 1.45 (m, 6H, -Ad), 1.35-1.25 (m, 
5H, CH3, -CH2Ad). 13C-NMR (125 MHz, CDCl3, δ): 151.95; 149.32; 149.11; 134.72; 128.68; 
124.96; 121.35; 117.35; 99.12; 49.57; 48.30; 44.48; 44.33; 42.60; 37.08; 34.05; 31.82; 28.61; 
26.33; 20.16. HRMS: m/z 426.26752 corresponds to molecular formula C26H36ClN3H+ (error 
in ppm: + 1.10). Anal.(C26H36ClN3  3/2 H2O) Calcd: C, 68.93; H, 8.68; N, 9.27. Found: C, 
69.08; H, 9.04; N, 9.48. HPLCpurity (λ = 330 nm): method A: RT 8.000 min, area 95.37%; 
method B: RT 9.821 min, area 95.54%. 
N1-[2-(1-Adamantyl)ethyl]-N3-(7-chloroquinolin-4-yl)pentane-1,3-diamine (40). 
Compound 40 was prepared by method Dfrom amine 
S16 (157 mg, 0.60 mmol) and 1-
adamantylacetaldehyde(106 mg, 0.60 mmol) using 
NaBH(OAc)3 (254 mg, 1.20 mmol) and was obtained 
after multiple chromatography: dry-flash SiO2, eluent: 
CH2Cl2/MeOH(NH3sat.) = 95/5, and flash chromatography (Biotage SP1 NH column, eluent: 
Hex/EtOAc = 6/4) as colorless foam (171 mg, 67%),softens at 121-123 °C. IR (ATR): 3236m, 
2897s, 2843m, 1610w, 1573s, 1538m, 1488w, 1448m, 1428m, 1366m, 1330m, 1281w, 
1245w, 1198w, 1166w, 1141m, 1078w, 901w, 876w, 852m, 804m, 763w, 735m, 701w, 
643w, 599w, 539w cm-1. 1H-NMR (500 MHz, CDCl3, δ): 8.45 (d, J = 5.4, H-C(2)), 7.91 (d, J 
= 2.2, H-C(8)), 7.67 (d, J = 8.9, H-C(5)), 7.76 (d, J = 5.6, H-N), 7.29 (dd, J1 = 2.2, J2 = 8.9, 
H-C(6)), 6.32 (d, J = 5.8, H-C(3)), 3.61 (m, 1H, ArNHCH(CH2CH3)-), 3.00-2.90 (m, 1H, -
CH2NHCH2CH2Ad), 2.85-2.75 (m, 1H, -CH2NHCH2CH2Ad), 2.65-2.55 (m, 2H, -
CH2CH2Ad), 2.00-1.85 (m, 4H, -Ad, -CH2CH2NHCH2CH2Ad), 1.85-1.75 (m, 2H, -CH2CH3, -








(t, J = 7.5, CH3). 13C-NMR (125 MHz, CDCl3, δ): 151.91; 149.97; 149.36; 134.56; 128.43; 
124.55; 122.30; 117.74; 98.46; 54.19; 46.53; 44.87; 44.49; 42.65; 37.06; 31.83; 31.62; 28.59; 
25.79; 10.33. HRMS: m/z 426.26855 corresponds to molecular formula C26H36ClN3H+ (error 
in ppm: + 3.51). Anal. (C26H36ClN3  H2O) Calcd: C, 70.32; H, 8.63; N, 9.46. Found: C, 
70.71; H, 8.48; N, 9.24. HPLC purity (λ = 330 nm): method A: RT 8.003 min, area 98.19%; 




i) ketone/aldehyde, Ti(OiPr)4, absolute EtOH, NaBH4, 18 h, r.t.; ii)  aldehyde, MeOH/CH2Cl2 (v:v, 2:1), AcOH, NaBH4, r.t., 24 h; iii) TFA/CH2Cl2, 
r.t., 24 h; 2.5 M NaOH; iv) 4,7-dichloroquinoline/4-chloroquinoline, PhOH, 110 oC, 8 h; v) 4,7-dichloroquinoline, MW, 130 oC, 2 h; vi) 











S20: n=1, R=Me (81%)
S21: n=3, R=Me (74%)









S29: n=1, R=Me (87%)
S30: n=3, R=Me (90%)




S32: n=1, R=Me (92%)
S33: n=3, R=Me (91%)






10: n=1, R=Me (71%)
31: n=3, R=Me (64%)










S23: n=1, R=Me (75%)
S24: n=3, R=Me (77%)






34: n=1, R=Me (74%)
43: n=3, R=Me (67%)














S5: n=1, R=Me 
S6: n=2, R=Me 
S7: n=3, R=Me 

















tert-Butyl (2-{[1-(1-adamantyl)ethyl]amino}ethyl)carbamate (S17). 
Compound S17 was prepared by method G from tert-butyl (2-
aminoethyl)carbamate(330 mg, 2.06 mmol) and 1-(1-
adamantyl)ethanone(306 mg, 1.72 mmol) using Ti(OiPr)4 (610 
µL, 2.06 mmol) and NaBH4 (130 mg, 3.44 mmol) and was obtained after dry-flash 
chromatography: SiO2, eluent:CH2Cl2/MeOH(NH3sat.) = 95/5, as colorless oil (410 mg, 
74%). IR (ATR): 3346m, 2973w, 2899s, 2846s, 1689s, 1518m, 1449m, 1390w, 1364m, 
1345w, 1315w, 1271m, 1248m, 1153s, 1040w, 1015w, 991w, 926w, 863w, 812w, 777w, 





cm-1. 1H-NMR (500 MHz, CDCl3, δ): 4.96 (bs, H-N), 3.25-3.10 (m, 2H, -CH2NHBoc), 2.90-
2.80 (m, 1H, -CH2CH2NHBoc), 2.65-2.50 (m, 1H, -CH2CH2NHBoc), 2.05-2.00 (m, 1H,-
CH(CH3)Ad), 1.97 ( bs, 3H, -Ad), 1.75-1.40 (m, 21H, -Ad, -NHCOO-C(CH3)3), 0.94 (d, J = 
6.5, CH3). 13C-NMR (125 MHz, CDCl3, δ): 156.18; 79.02; 62.01; 47.84; 40.61; 38.67; 37.34; 
36.14; 28.56; 28.43; 13.55. HRMS: m/z 323.26854 corresponds to molecular formula 
C19H34N2O2H+ (error in ppm: - 2.38).  
tert-Butyl (3-{[1-(1-adamantyl)ethyl]amino}propyl)carbamate (S18). 
Compound S18 was prepared by method Gfrom tert-butyl (3-
aminopropyl)carbamate (380 mg, 2.18 mmol) and 1-(1-
adamantyl)ethanone (325 mg, 1.85 mmol), using Ti(OiPr)4 (645 
µL, 2.18 mmol) and NaBH4 (140 mg, 3.70 mmol) and was obtained after dry-flash 
chromatography: SiO2, eluent: CH2Cl2/MeOH(NH3sat.) = 95/5,as colorless oil (475 mg, 
76%). IR(ATR): 3313m, 2903s, 2847s, 2676w, 1574m, 1450m, 1362w, 1344w, 1316w, 
1248w, 1103w, 1012w, 974w, 934w, 815w, 735w cm-1. 1H-NMR (500 MHz, CDCl3, δ): 5.88 
(bs, H-NBoc), 3.35-2.40 (m, 4H, -CH2NHBoc, -CH2NHCH(CH3)Ad), 2.10-2.20 (m, 1H,- 
(CH3)CHAd), 1.98 (m, 3H, -Ad), 1.75-1.40 (m, 23H, -Ad, -NHCOO-C(CH3)3, -
CH2CH2CH2NHBoc), 0.95 (d, J = 6.6, CH3). 13C-NMR (125 MHz, CDCl3, δ): 156.16, 78.64; 
62.61; 47.47; 40.36; 38.69, 37.30; 36.09, 29.56; 28.56; 28.45; 13.19. HRMS: m/z337.28334 
corresponds to molecular formula C20H36N2O2H+ (error in ppm: - 4.79).  
tert-Butyl (4-{[1-(1-adamantyl)ethyl]amino}butyl)carbamate (S19). 
Compound S19 was prepared by method G from tert-butyl 
(4-aminobutyl)carbamate(231 mg, 1.23 mmol) and 1-(1-
adamantyl)ethanone (110 mg, 0.61 mmol) using Ti(OiPr)4 
(364 µL, 2.23 mmol) and NaBH4 (45 mg, 1.22 mmol) and was obtained after dry-flash 
chromatography: SiO2, eluent: CH2Cl2/MeOH(NH3sat.) = 95/5,as colorless oil (152 mg, 
71%). IR (ATR): 3330m, 2971w, 2900s, 2846m, 1692s, 1520m, 1449m, 1389w, 1364m, 
1345w, 1315w, 1271w, 1248m, 1171s, 1118w, 1066w, 1039w, 993w, 870w, 781w, 735w, 
702w, 670w, 654w, 647w, 640w, 595w, 589w, 561w, 548w, 511w, 503w cm-1. 1H-NMR (500 
MHz, CDCl3, δ): 4.99 (bs, H-N), 3.20-2.05 (m, 2H, -CH2NHBoc), 2.80-2.65 (m, 1H, -
CH2NHCH(CH3)Ad), 2.50-2.40 (m, 1H, -CH2NHCH(CH3)Ad), 2.10-2.00 (m, 2H, -
CH(CH3)Ad), 1.97 (m, 3H, -Ad), 1.75-1.40 (m, 25H, -Ad, -CH2CH2NHBoc, -
CH2CH2CH2NHBoc, -NHCOO-C(CH3)3), 0.94 (d, 3H, J = 6.5, CH3). 13C-NMR (125 MHz, 
CDCl3, δ): 155.98; 78.79; 62.49; 48.34; 40.48; 38.65; 37.30; 35.96; 28.52; 28.39; 27.83; 
27.71; 13.40. HRMS: m/z351.30112 corresponds to molecular formula C21H38N2O2H+ (error 
in ppm: + 1.48).  






Compound S20 was prepared by method Efrom mono-N-Boc-
protected amine S5 (340 mg, 1.95 mmol) and adamantane-1-
carboxaldehyde (320 mg, 1.95 mmol) using AcOH (139 µL, 2.4 
mmol) and NaBH4 (443 mg, 11.7 mol) and was obtained after dry-flash chromatography: 
SiO2, eluent: CH2Cl2/MeOH(NH3sat.) = 95/5,as colorless oil (509 mg, 81%). IR (ATR): 
3355m, 2972w, 2897s, 2845m, 1694s, 1500m, 1450m, 1390w, 1364m, 1345w, 1248m, 1165s, 
1103w, 986m, 908w, 865w, 777w, 751w, 644w, 620w, 576w, 556w, 545w, 520w cm-1. 1H-
NMR (500 MHz, CDCl3, δ): 4.99 (bs, H-N), 3.20-3.10 (m, 1H, -CH2NHBoc), 3.05-2.90 (m, 
1H, -CH2NHBoc), 2.75-2.60 (m, 1H,-CH(CH3)NHCH2Ad), 2.31 (ABq, HA, J = 11.5, -
CH2Ad), 2.12 (ABq, HB, J = 11.5, -CH2Ad), 1.96 (s, 3H, -Ad), 1.75 -1.60 (m, 6H, -Ad), 1.55-
1.40 (m, 15H, -Ad, -NHCOO-C(CH3)3), 1.03 (d, 3H, J = 6.4, CH3). 13C-NMR (125 MHz, 
CDCl3, δ): 157.06; 77.57; 61.55; 59.68; 53.35; 40.81; 37.24; 33.37; 28.47; 28.469; 18.62. 
HRMS: m/z 323.26937corresponds to molecular formula C19H34N2O2H+ (error in ppm: + 
0.19).  
tert-Butyl {4-[(1-adamantylmethyl)amino]pentyl}carbamate (S21). 
Compound S21 was prepared by method Efrom mono-N-Boc-
protected amine S7 (396 mg, 1.96 mmol) and adamantane-1-
carboxaldehyde (321 mg, 1.96 mmol) using AcOH (140 µL, 
2.4 mmol) and NaBH4 (445 mg, 11.8 mol) and was obtained after dry-flash chromatography: 
SiO2, eluent: CH2Cl2/MeOH(NH3sat.) = 95/5,as colorless oil (508 mg, 74%). IR (ATR): 
3196m, 3004w, 2962w, 2897s, 2846m, 2795w, 1710s, 1566m, 1465m, 1451m, 1383w, 
1362m, 1343w, 1319w, 1302w, 1272m, 1245m, 1168m, 1138s, 1097w, 1076w, 1047w, 
1036w, 1002w, 979m, 900w, 884w, 866w, 785w, 756m, 715w, 609w, 561w, 503w cm-1. 1H-
NMR (500 MHz, CDCl3, δ): 4.87 (bs, H-N), 3.20-3.00 (m, 1H, -CH2NHBoc), 2.55-2.45 (m, 
1H, -CH(CH3)NHCH2Ad), 2.74 (ABq, HA, J = 11.3, -CH2Ad), 2.15 (ABq, HB, J = 11.3, -
CH2Ad), 1.96 (bs, 3H, -Ad), 1.75-1.60 (m, 6H, -Ad), 1.55-1.48 (8H, -Ad, -CH2CH2NHBoc), 
1.48-1.40 (m, 11H, -CH2CH2CH2NHBoc, -NHCOO-C(CH3)3), 1.40-1.25 (m, 1H, -
CH2CH2CH2NHBoc), 1.02 (d, 3H, J = 6.3, CH3). 13C-NMR (125 MHz, CDCl3, δ): 156.01; 
78.89; 60.18; 53.59; 40.95; 40.82; 37.27; 34.32; 33.30; 28.50; 28.44; 26.43; 20.58. HRMS: 
m/z351.29958 corresponds to molecular formula C21H38N2O2H+ (error in ppm: - 2.91).  
tert-Butyl {3-[(1-adamantylmethyl)amino]pentyl}carbamate (S22). 
Compound S22 was prepared by method Efrom mono-N-Boc-
protected amine S8 (370 mg, 1.96 mmol) and adamantane-1-
carboxaldehyde (321 mg, 1.96 mmol) using AcOH (139 µL, 
2.4 mmol) and NaBH4 (443 mg, 11.7 mol) and was obtained after dry-flash chromatography: 








3331m, 2963w, 2898s, 2845m, 1692s, 1504m, 1451m, 1389w, 1363m, 1273w, 1247m, 1170s, 
1087w, 1041w, 1022w, 932w, 871w, 808w, 778w, 751w, 623w, 648w, 608w, 588w, 551w, 
530w, 521w, 509w, cm-1. 1H-NMR (500 MHz, CDCl3, δ): 6.64 (bs, H-N), 3.40-3.25 (m, 1H, -
CH2NHBoc), 3.25-3.05 (m, 1H, -CH2NHBoc), 2.55-2.40 (m, 1H, -CH(CH2CH3)NHCH2Ad), 
2.29 (ABq, HA, J = 11.2, -CH2Ad), 2.21 (ABq, HB, J = 11.2, -CH2Ad), 1.97 (s, 3H, -Ad), 
1.80-1.60 (m, 7H, -Ad, -CH2CH2NHBoc), 1.60-1.50 (m, 7H, -CH2CH3, -Ad), 1.50-1.30 (m, 
11H, -CH2CH2NHBoc, -CH2CH3, -NHCOO-C(CH3)3), 0.86 (t, 3H, J = 7.5, -CH2CH3). 13C-
NMR (125 MHz, CDCl3, δ): 156.21; 78.30; 59.74; 59.48; 40.89; 39.27; 37.21; 33.29; 31.30; 
28.48; 26.18; 9.87. HRMS: m/z351.30038 corresponds to molecular formula C21H38N2O2H+ 
(error in ppm: - 0.63).  
tert-Butyl (2-{[2-(1-adamantyl)ethyl]amino}propyl)carbamate (S23). 
Compound S23 was prepared by method Gfrom mono-N-Boc-
protected amine S5 (275 mg, 1.58 mmol) and 1-
adamantylacetaldehyde (280 mg, 1.58 mmol) using Ti(OiPr)4 
(560 µL, 0.90 mmol) and NaBH4 (120 mg, 3.16 mmol) and was obtained after dry-flash 
chromatography: SiO2, eluent: CH2Cl2/MeOH(NH3sat.) = 95/5,as colorless oil (398 mg, 
75%). IR(ATR): 2972w, 2897s, 2844m, 1698s, 1499m, 1449m, 1390w, 1364m, 1345w, 
1315w, 1268w, 1248m, 1166s, 1099w, 1050w, 1038w, 964w, 928w, 902w, 864w, 838w, 
812w, 777w, 736m, 704w, 687w, 667w, 503w, 487w, 430w cm-1. 1H-NMR (500 MHz, 
CDCl3, δ): 4.94 (bs, H-N), 3.20-3.05 (m, 1H, -CH2NHBoc), 3.05-3.00 (m, 1H, -CH2NHBoc), 
2.85-2.75 (m, 1H, -CH(CH3)NHCH2CH2Ad), 2.70-2.60 (m, 1H, -CH2CH2Ad), 2.55-2.45 (m, 
1H, -CH2CH2Ad), 1.94 (bs, 3H, -Ad), 1.75-1.55 (m, 6H, -Ad), 1.53-1.47 (m, 6H, -Ad), 1.47-
1.40 (m, 9H, -NHCOO-C(CH3)3), 1.30-1.15 (m, 2H, -CH2Ad), 1.04 (d, 3H, J = 6.4, CH3). 
13C-NMR (125 MHz, CDCl3, δ): 156.24, 79.02; 52.83; 45.54; 45.08; 42.68; 41.47, 37.14; 
31.90; 28.67; 28.40; 18.52. HRMS: m/z337.28422 corresponds to molecular formula 
C20H36N2O2H+ (error in ppm: - 2.17).  
tert-Butyl (4-{[2-(1-adamantyl)ethyl]amino}pentyl)carbamate (S24). 
Compound S24 was prepared by method G from mono-N-
Boc-protected amine S7 (360 mg, 1.78 mmol) and 1-
adamantylacetaldehyde (317 mg, 1.78 mmol) using 
Ti(OiPr)4 (632 µL, 2.13 mmol) and NaBH4 (135 mg, 3.56 mmol) and was obtained after dry-
flash chromatography: SiO2, eluent: CH2Cl2/MeOH(NH3sat.) = 95/5,as colorless oil (499 mg, 
77%). IR (ATR): 3343w, 2967w, 2898s, 2844m, 1690s, 1520m, 1449m, 1389w, 1363m, 
1345w, 1269m, 1248m, 1169s, 1041w, 1017w, 989w, 967w, 920w, 867w, 812w, 779w, 
523w, 504w cm-1. 1H-NMR (500 MHz, CDCl3, δ): 4.84 (bs, H-N), 3.20-3.05 (m, 2H, -







CH2CH2Ad), 1.94 (bs, 3H, -Ad), 1.75-1.60 (m, 6H, -Ad), 1.60-1.30 (m, 18H, -Ad, -
CH2CH2NHBoc, -CH2CH2 CH2NHBoc, -NHCOO-C(CH3)3), 1.40-1.30 (m, 1H, -CH2CH2 
CH2NHBoc), 1.30-1.20 (m, 2H, -CH2Ad), 1.04 (d, 3H, J = 6.2, CH3). 13C-NMR (125 MHz, 
CDCl3, δ): 156.00; 78.95; 53.12; 44.93; 42.66; 41.52; 40.78; 37.15; 34.31; 31.90; 28.68; 
28.43; 26.51; 20.32. HRMS: m/z 365.31654 corresponds to molecular formula C22H40N2O2H+ 
(error in ppm: + 0.78).  
tert-Butyl (3-{[2-(1-adamantyl)ethyl]amino}pentyl)carbamate (S25). 
Compound S25 was prepared by method G from mono-N-
Boc-protected amine S8 (350 mg, 1.73 mmol) and 1-
adamantylacetaldehyde (308 mg, 1.73 mmol) using Ti(OiPr)4 
(616 µL, 2.08 mmol) and NaBH4 (131 mg, 3.46 mmol) and was obtained after dry-flash 
chromatography: SiO2, eluent: CH2Cl2/MeOH(NH3sat.) = 95/5,as colorless oil (479 mg, 
76%). IR (ATR): 3330m, 2964m, 2899s, 2845m, 1692s, 1504m, 1449m, 1389w, 1363m, 
1315w, 1271m, 1248m, 1170s, 1098w, 1041w, 1022w, 993w, 965w, 918w, 869w, 812w, 
780w, 758w, 691w, 681w, 667w, 654w, 618w, 600w, 579w, 557w, 548w, 540w, 503w, 520w 
cm-1. 1H-NMR (500 MHz, CDCl3, δ): 5.74 (bs, H-NBoc), 3.30-3.20 (m, 1H, -CH2NHBoc), 
3.20-3.10 (m, 1H, -CH2NHBoc), 2.65-2.55 (m, 1H, -CH2CH2Ad), 2.55-2.45 (m, 2H, -
CH2CH2Ad, -CH(CH2CH3)NHCH2CH2Ad), 1.94 (s, 3H, -Ad), 1.75-1.60 (m, 7H, -Ad, -
CH2CH2NHBoc), 1.60-1.35 (m, 18H, -Ad, -CH2CH2NHBoc, -CH2CH3, -NHCOO-C(CH3)3), 
1.30-1.20 (m, 2H, -CH2CH2Ad), 0.88 (t, 3H, J = 7.5, -CH2CH3). 13C-NMR (125 MHz, CDCl3, 
δ): 156.16; 78.69; 58.14; 45.02; 42.68; 40.97; 38.39; 37.16; 32.36; 31.90; 28.68; 28.47; 26.30; 
10.00. HRMS: m/z 365.31603 corresponds to molecular formula C22H40N2O2H+ (error in 
ppm: - 0.61).  
N-[1-(1-Adamantyl)ethyl]ethane-1,2-diamine (S26). 
Compound S26 was prepared using method C from S17 (400 mg, 
1.24 mmol) and was obtainedafter dry-flash chromatography: SiO2, 
eluent: CH2Cl2/MeOH(NH3sat.) = 9/1 as a light yellow viscous oil 
(239 mg, 87%). IR(ATR): 3238m, 3063w, 2968w, 2932m, 2851m, 1608w, 1570s, 1491w, 
1452m, 1423m, 1384w, 1363m, 1329w, 1280w, 1251m, 1200w, 1156w, 1128w, 1084w, 
941w, 903w, 869w, 842w, 818w, 796m, 770m, 700m, 682w, 643m, 621w, 598w, 561w, 
534w cm-1. 1H-NMR (500 MHz, CDCl3, δ): 2.85-2.75 (m, 2H, -CH2NH2, -CH2CH2NH2), 
2.75-2.65 (m, 1H, -CH2CH2NH2), 2.55-2.45 (m, 1H, -CH2NH2), 2.05-2.00 (m, 1H, -
CH(CH3)Ad), 1.97 (s, 3H, -Ad), 1.75-1.45 (m, 12H, -Ad), 1.31 (bs, 2H-N), 0.95 (d, 3H, J = 
6.5, CH3). 13C-NMR (125 MHz, CDCl3, δ): 62.31; 51.41; 42.07; 38.73; 37.37; 36.17; 28.59; 








Compound S27was prepared using method C from S18(450 mg, 
1.34 mmol) and was obtained after dry-flash chromatography: 
SiO2, eluent: CH2Cl2/MeOH(NH3sat.) = 9/1 as light yellow 
viscous oil (266 mg, 84%). IR (ATR): 3322w, 2896s, 2844s, 2675w, 1636w, 1564m, 1444s, 
1403w, 1372w, 1355m, 1345w, 1330w, 1298w, 1251w, 1149w, 1119w, 1100w, 1086w, 
1064w, 1012w, 916w, 890w, 814w, 781w, 728w, 704w, 617w, 602m, 572w, 522w, 508w cm-
1. 1H-NMR (500 MHz, CDCl3, δ): 2.85-2.70 (m, 3H, -CH2NH2, -CH2NHCH(CH3)Ad), 2.55-
2.40 (m, 1H, -CH2NHCH(CH3)Ad), 2.10-2.00 (m, 2H,-CH(CH3)Ad), 1.97 (bs, 3H, -Ad), 
1.75-1.40 (m, 14H, -CH2CH2NH2, -Ad), 1.14 (bs, 2H-N and H-N), 0.94 (d, 3H, J = 6.5, CH3). 
13C-NMR (125 MHz, CDCl3, δ): 62.64; 46.92; 40.76; 38.72; 37.37; 36.04; 34.18; 28.58; 
13.50. HRMS: m/z 237.23171 corresponds to molecular formula C15H28N2H+ (error in ppm: - 
3.44).  
N-[1-(1-Adamantyl)ethyl]butane-1,4-diamine (S28). 
Compound S28was prepared using method C from S19(280 mg, 
0.80 mmol) and was obtained after dry-flash chromatography: 
SiO2, eluent: CH2Cl2/MeOH(NH3sat.) = 9/1 as light yellow 
viscous oil (166 mg, 83%). IR (ATR): 2897s, 2844s, 1572m, 1447s, 1374m, 1358w, 1344w, 
1313m, 1248w, 1188w, 1146w, 1116m, 1104m, 1064w, 1045w, 1016w, 813w, 776w, 737w, 
698w, 628w, 598w, 586w, 546w, 533w, 512w, 501w cm-1. 1H-NMR (500 MHz, CDCl3, δ): 
2.80-2.65 (m, 3H, -CH2NH2, -CH2NHCH(CH3)Ad), 2.50-2.35 (m, 1H, -CH2NHCH(CH3)Ad), 
2.10-2.00 (m, 1H, -CH(CH3)Ad), 1.97 (bs, 3H, -Ad), 1.75-1.45 (m, 16H, -Ad, -CH2CH2NH2, -
CH2CH2CH2NH2), 1.42 (bs, H-N and 2H-N), 0.94 (d, 3H, J = 6.5, CH3). 13C-NMR (125 MHz, 
CDCl3, δ): 62.41; 48.71; 42.03; 38.59; 37.24; 35.88; 31.51; 28.46; 27.59; 13.41. HRMS: 
m/z251.24786 corresponds to molecular formula C16H30N2H+ (error in ppm: - 1.24).  
N2-(1-Adamantylmethyl)propane-1,2-diamine (S29). 
Compound S29 was prepared using method C from S20 (500 mg, 
1.55 mmol) and was obtained afterdry-flash chromatography: SiO2, 
eluent: CH2Cl2/MeOH(NH3sat.) = 9/1 as light yellow viscous oil 
(299 mg, 87%). IR (ATR): 2895s, 2844s, 1449m, 1370w, 1344w, 1315w, 1222w, 1152w, 
1087w, 1052w, 998w, 987w, 951w, 932w, 853w, 813w, 778w, 734m, 625w, 600w, 586w, 
542w, 521w cm-1. 1H-NMR (500 MHz, CDCl3, δ): 2.75-2.65 (m, 1H, -CH2NH2), 2.55-2.45 
(m, 2H, -CH2NH2, NH2CH(CH3)-), 2.34 (ABq, HA, J = 11.4, -CH2Ad), 2.12 (ABq, HB, J = 
11.4, -CH2Ad), 1.96 (s, 3H, -Ad), 1.75-1.60 (m, 6H, -Ad), 1.55-1.45 (m, 6H, -Ad), 1.00 (d, 







28.52; 18.50.HRMS: m/z 223.21628 corresponds to molecular formula C14H26N2H+ (error in 
ppm: - 2.65).  
N4-(1-Adamantylmethyl)pentane-1,4-diamine (S30). 
Compound S30 was prepared by method C from S21 (300 mg, 
0.85 mmol) and was obtained after dry-flash chromatography: 
SiO2, eluent: CH2Cl2/MeOH(NH3sat.) = 9/1 as light yellow 
viscous oil (214 mg, 90%). IR (ATR): 3280w, 2895s, 2843s, 2675w, 2150w, 1577m, 1447m, 
1369w, 1339w, 1311m, 1220w, 1150m, 1085m, 993w, 950w, 808m, 719m, 610w, 549w, 
523w cm-1. 1H-NMR (500 MHz, CDCl3, δ): 2.75-2.65 (m, 2H, -CH2NH2), 2.60-2.55 (m, 1H, -
CH(CH3)NHCH2Ad), 2.28 (ABq, HA, J = 11.4, -CH2Ad), 2.17 (ABq, HB, J = 11.4, -CH2Ad), 
1.96 (bs, 3H, -Ad), 1.75-1.60 (m, 6H, -Ad), 1.55-1.50 (m, 6H, -Ad), 1.50-1.40 (m, 3H, -
CH2CH2NH2, -CH2CH2CH2NH2), 1.35-1.25 (m, 1H, -CH2CH2CH2NH2), 1.02 (d, 3H, J = 6.4, 
CH3). 13C-NMR (125 MHz, CDCl3, δ): 60.29; 54.00; 42.53; 40.96; 37.27; 34.33; 33.29; 
30.45; 28.50; 20.58. HRMS: m/z251.24818 corresponds to molecular formula C16H30N2H+ 
(error in ppm: - 4.72).  
N3-(1-Adamantylmethyl)pentane-1,3-diamine (S31). 
Compound S31 was prepared from S22 (350 mg, 1.00 mmol) by 
method Cand was obtained after dry-flash chromatography: SiO2, 
eluent: CH2Cl2/MeOH(NH3sat.) = 9/1as a yellow viscous oil 
(223 mg, 89%). IR (ATR): 3311m, 2903s, 2847s, 2678w, 2235w, 
1644m, 1559m, 1448m, 1402w, 1367m, 1306w, 1223w, 1169w, 1134w, 1099w, 993w, 813w, 
727w cm-1. 1H-NMR (500 MHz, CDCl3, δ): 2.85-2.70 (m, 2H, -CH2NH2), 2.50-2.35 (m, 1H, -
CH(CH2CH3)NHCH2Ad), 2.25 (ABq, HA, J = 11.3, -CH2Ad), 2.15 (ABq, HB, J = 11.3, -
CH2Ad), 1.95 (s, 3H, -Ad), 1.75-1.60 (m, 6H, -Ad), 1.60-1.45 (m, 8H, -CH2CH2NH2, -Ad), 
1.45-1.35 (m, 2H, -CH2CH3), 0.87 (t, 3H, J = 7.5, -CH2CH3). 13C-NMR (125 MHz, CDCl3, 
δ): 59.65; 58.25; 40.93; 39.77; 37.29; 33.44; 28.51; 26.66; 9.92. HRMS: m/z 251.24754 
corresponds to molecular formula C16H30N2H+ (error in ppm: - 2.51).  
N2-[2-(1-adamantyl)ethyl]propane-1,2-diamine (S32). 
Compound S32 was prepared from S23 (350 mg, 1.04 mmol) by 
method C and was obtained after dry-flash chromatography: SiO2, 
eluent: CH2Cl2/MeOH(NH3sat.) = 9/1 as a yellow viscous oil (226 
mg, 92%). IR (ATR): 2897s, 2844s, 1495w, 1449m, 1370w, 1345w, 1316w, 1265w, 1183w, 
1150w, 1099m, 812w, 728s, 695m, 631w, 617w, 600w, 590w, 530w, 522w, 506w cm-1. 1H-
NMR (500 MHz, CDCl3, δ): 2.75-2.67 (m, 2H, -CH2NH2, -CH2CH2Ad), 2.67-2.57 (m, 1H, -
CH(CH3)NHCH2CH2Ad), 2.57-2.45 (m, 2H, -CH2NH2, -CH2CH2Ad), 1.94 (bs, 3H, -Ad), 







6.2, CH3). 13C-NMR (125 MHz, CDCl3, δ): 55.56; 47.61; 45.13; 42.70; 41.66; 37.17; 31.90; 
28.70; 18.31. HRMS: m/z 237.23151 corresponds to molecular formula C15H28N2H+ (error in 
ppm: - 4.29).  
N4-[2-(1-Adamantyl)ethyl]pentane-1,4-diamine (S33). 
Compound S33 was prepared from S24 (300 mg, 0.82 
mmol) by method C and was obtained after dry-flash 
chromatography: SiO2, eluent: CH2Cl2/MeOH(NH3sat.) = 
9/1 as a yellow viscous oil (198 mg, 91%). IR (ATR): 2896s, 2843s, 2656w, 1572m, 1448m, 
1372w, 1314m, 1141w, 1098w, 988w, 967w, 922w, 879w, 812w, 703w, 619w, 591w, 572w, 
533w, 512w cm-1. 1H-NMR (500 MHz, CDCl3, δ): 2.75-2.65 (m, 2H, -CH2NH2), 2.65-2.60 
(m, 2H, -CH(CH3)NHCH2CH2Ad, -CH2CH2Ad), 2.60-2.50 (m, 1H, -CH2CH2Ad), 1.94 (bs, 
3H, -Ad), 1.75-1.60 (m, 6H, -Ad), 1.55-1.40 (m, 9H, -CH2CH2NH2, -CH2CH2CH2NH2, -Ad), 
1.35-1.25 (m, 1H, -CH2CH2CH2NH2), 1.25-1.20 (m, 2H, -CH2Ad), 1.05 (d, 3H, J = 6.2, CH3). 
13C-NMR (125 MHz, CDCl3, δ): 53.37; 45.07; 42.67; 42.50; 41.58; 37.16; 34.45; 31.89; 
30.37; 28.68; 20.40. HRMS: m/z256.26328 corresponds to molecular formula C17H32N2H+ 
(error in ppm: - 2.05).  
N3-[2-(1-Adamantyl)ethyl]pentane-1,3-diamine(S34). 
Compound S34 was prepared from S25 (250 mg, 0.74 mmol) by 
method C and was obtained after dry-flash chromatography 
(SiO2, eluent: CH2Cl2/MeOH(NH3sat.) = 9/1) as a yellow viscous 
oil (147 mg, 75%). IR (ATR): 2957w, 2905s, 2844s, 1574m, 1448s, 1379w, 1344w, 1314m, 
1099m, 812m, 775w, 722w, 700w, 680w, 620w, 608w, 599w, 590w, 582w, 501w cm-1. 1H-
NMR (500 MHz, CDCl3, δ): 2.85-2.70 (m, 2H, -CH2NH2), 2.70-2.50 (m, 3H, -
CH(CH2CH3)NHCH2CH2Ad, -CH2CH2Ad), 1.94 (s, 3H, -Ad), 1.75-1.60 (m, 6H, -Ad), 1.60-
1.50 (m, 8H, -CH2CH2NH2, -Ad), 1.50-1.40 (m, 2H, -CH2CH3), 1.30-1.20 (m, 2H, -CH2Ad), 
0.87 (t, 3H, J = 7.5, -CH2CH3,). 13C-NMR (125 MHz, CDCl3, δ): 57.63; 45.08; 42.68; 41.31; 
39.52; 37.42; 37.17; 31.91; 28.69; 26.48; 9.87. HRMS: m/z 265.26347 corresponds to 
molecular formula C17H32N2H+ (error in ppm: - 1.33).  
N-[1-(1-Adamantyl)ethyl]-N'-(7-chloroquinolin-4-yl)ethane-1,2-diamine (11). 
Amine S26 (180 mg, 0.81 mmol) and 4,7-dichloroquinoline (481 
mg, 2.43 mmol) were mixed in a MW cuvette under Ar. Reaction 
mixture was subjected to MW irradiation using a Biotage 
Initiator 2.5 apparatus, 4h, 130 oC. Compound 11 was obtained 
after multiple chromatographydry-flash (SiO2, eluent: CH2Cl2/MeOH(NH3sat.) = 95/5), and 
flash chromatography (Biotage SP1 NH column, eluent: Hex/EtOAc = 7/3) as colorless 








1577s, 1524m, 1446m, 1367m, 1327m, 1281w, 1240w, 1197w, 1159w, 1136m, 1101m, 
1077m, 1014w, 968w, 921w, 876m, 846w, 804m, 761w, 736m, 702w, 643w, 623w, 600w, 
542w, 527w, 506w cm-1. 1H-NMR (500 MHz, CDCl3, δ): 8.53 (d, J = 5.0, H-C(2)), 7.95 (d, J 
= 2.0, H-C(8)), 7.72 (d, J = 8.5, H-C(5)), 7.35 (dd, J1 = 2.0, J2 = 9.0, H-C(6)), 6.38 (d, J = 5.5, 
H-C(3)), 6.17 (bs, H-N), 3.35-3.25 (m, 1H, ArNHCH2-), 3.25-3.15 (m, 2H, ArNHCH2-, 
ArNHCH2CH2-), 2.90-2.80 (m, 1H, ArNHCH2CH2-), 2.15-2.05 (m, 1H, -CH(CH3)Ad), 1.98 
(m, 3H, -Ad), 1.80-1.45 (m, 12H, -Ad), 1.03 (d, 3H, J = 6.5, CH3). 13C-NMR (125 MHz, 
CDCl3, δ): 152.11; 150.00; 149.15; 134.73; 128.73; 125.13; 121.19; 117.46; 99.26; 61.64; 
45.96; 42.14; 38.89; 37.31; 36.32; 28.52; 13.62. HRMS: m/z384.22025 corresponds to 
molecular formula C23H30ClN3H+ (error in ppm: + 0.39). Anal.(C23H30ClN3) Calcd: C, 71.95; 
H, 7.88; N, 10.94. Found: C, 71.76; H, 8.15; N, 10.88. HPLC purity (λ = 330 nm): method A: 
RT 7.986 min, area 99.01%; method B: RT 9.475 min, area 98.26%. 
N-[1-(1-Adamantyl)ethyl]-N'-(7-chloroquinolin-4-yl)propane-1,3-diamine (22). 
Amine S27 (230 mg, 0.97 mmol) and 4,7-
dichloroquinoline (385 mg, 1.95 mmol) were mixed in a 
MW cuvette under Ar. The reaction mixture was subjected 
to MW irradiation using a Biotage Initiator 2.5 apparatus, 
4h, 130 oC. Compound 22 was obtained after multiple 
chromatography: dry-flash(SiO2, eluent: CH2Cl2/MeOH(NH3sat.) = 95/5) and flash 
chromatography (Biotage SP1 NH column, eluent: Hex/EtOAc = 75/25) as colorless 
powder,softens at 90-92 C. Yield: 174 mg (74%). IR(ATR): 3243m, 3067w, 2897s, 2844m, 
1610w, 1583s, 1534m, 1447m, 1427m, 1365m, 1344m, 1328m, 1281w, 1241w, 1211w, 
1158w, 1137m, 1097w, 1075m, 1042w, 1015w, 995w, 970w, 899m, 876m, 852m, 801m, 
763m, 703w, 673w, 642w, 631w, 620w, 598w, 570w, 554w, 542w, 532w, 515w cm-1. 1H-
NMR (500 MHz, CDCl3, δ): 8.50 (d, J = 5.4, H-C(2)), 7.92 (d, J = 2.2, H-C(8)), 7.81 (d, J = 
8.9, H-C(5)), 7.40 (bs, H-N), 7.26 (dd, J1 = 2.2, J2 = 8.8, H-C(6)), 6.32 (d, J = 5.4, H-C(3)), 
3.50-3.40 (m, 1H, ArNHCH2-), 3.35-3.25 (m, 1H, ArNHCH2-), 2.95-2.85 (m, 1H, 
ArNHCH2CH2CH2-), 2.85-2.80 (m, 1H, ArNHCH2CH2CH2-), 2.10-2.05 (m, 1H, -
CH(CH3)Ad), 2.03 (m, 3H, -Ad), 2.00-1.85 (m, 2H, ArNHCH2CH2-), 1.80-1.55 (m, 12H, -
Ad), 0.98 (d, 3H, J = 6.4, CH3). 13C-NMR (125 MHz, CDCl3, δ): 152.19; 150.42; 149.19; 
134.57; 128.59; 124.52; 122.38; 117.49; 98.41; 63.84; 48.97; 44.22; 38.88; 37.23; 36.00; 
28.51; 28.24; 13.74. HRMS: m/z 398.23424corresponds to molecular formula C24H32ClN3H+ 
(error in ppm: - 3.80). Anal. (C24H32ClN3) Calcd: C, 72.43; H, 8.10; N, 10.56. Found: C, 
72.14; H, 8.27; N, 10.42. HPLC purity (λ = 330 nm): method A: RT 8.586 min, area 99.59%; 






Amine S28 (263 mg, 1.05 mmol) and 4,7-
dichloroquinoline (624 mg, 3.15 mmol) were mixed 
in a MW cuvette under Ar. The reaction mixture was 
subjected to MW irradiation using a Biotage Initiator 
2.5 apparatus, 4h, 130 oC. Compound 30 was 
obtained after multiple chromatography: dry-flash SiO2, eluent: CH2Cl2/MeOH(NH3sat.) = 
95/5, and flash chromatography (Biotage SP1 NH column, eluent: Hex/EtOAc = 55/45) as 
colorless powder,softens at 146-148 C. Yield: 298 mg (69%). IR (ATR): 3254m, 2900m, 
2844m, 2755w, 1609w, 1569s, 1536m, 1475w, 1448m, 1367m, 1344w, 1325m, 1285w, 
1252w, 1228w, 1196w, 1161w, 1134m, 1116w, 1076m, 1019w, 978w, 902m, 875m, 850m, 
825m, 804m, 763m, 741w, 645w, 621w, 598m, 553w, 516m cm-1. 1H-NMR (500 MHz, 
CDCl3, δ): 8.53 (d, J = 5.0, H-C(2)), 7.95 (d, J = 2.0, H-C(8)), 7.71 (d, J = 9.0, H-C(5)), 7.34 
(dd, J1 = 2.0, J2 = 9.0, H-C(6)), 6.40 (d, J = 5.5, H-C(3)), 5.41 (bs, H-N), 3.40-3.25 (m, 2H, 
ArNHCH2-), 2.85-2.75 (m, 1H, -CH2NHCH(CH3)Ad), 2.60-2.50 (m, 1H, -
CH2NHCH(CH3)Ad), 2.15-2.05 (m, 1H, -CH2NHCH(CH3)Ad), 1.98 (m, 3H, -Ad), 1.90-1.80 
(m, 2H, ArNHCH2CH2-), 1.75-1.45 (m, 14H, -Ad, ArNHCH2CH2CH2-), 0.96 (d, 3H, J = 6.5, 
CH3). 13C-NMR (125 MHz, CDCl3, δ): 152.10; 149.75; 149.21; 134.73; 128.86; 125.05; 
121.13; 117.19; 99.01; 62.28; 47.85; 43.20; 38.82; 37.33; 36.10; 28.56; 27.83; 26.34; 13.43. 
HRMS: m/z 412.24953corresponds to molecular formula C25H34ClN3H+ (error in ppm: - 
4.55). Anal.(C25H34ClN3  1/2 H2O) Calcd: C, 71.32; H, 8.38; N, 9.98. Found: C, 71.16; H, 
7.88; N, 10.16. HPLCpurity (λ = 330 nm): method A: RT 7.952 min, area 96.65%; method B: 
RT 9.593 min, area 97.85%. 
N2-(1-Adamantylmethyl)-N1-(7-chloroquinolin-4-yl)propane-1,2-diamine (10). 
Compound 10 was prepared from amine S29(150 mg, 0.67 
mmol) and 4,7-dichloroquinoline (111 mg, 0.56 mmol) in 
phenol (790 mg, 8.40 mmol) by method Fand was 
obtained after multiple chromatography: dry-flash: SiO2, 
eluent: CH2Cl2/MeOH(NH3sat.) = 95/5, and flash 
chromatography (Biotage SP1 NH column, eluent: Hex/EtOAc = 7/3) as colorless 
foam,softens at 148-150 C. Yield: 149 mg (71%). IR (ATR): 3362w, 3335w, 3032w, 2958w, 
2905s, 2842m, 1605w, 1578s, 1562s, 1520m, 1472m, 1444m, 1361w, 1345w, 1333w, 1295w, 
1273w, 1246w, 1207w, 1183w, 1155m, 1136w, 1098w, 1083m, 1018w, 998w, 986w, 964w, 
940w, 929w, 899m, 848m, 806m, 762m, 748m, 672w, 647w, 560m, 546w, 523m cm-1. 1H-
NMR (500 MHz, CDCl3, δ): 8.52 (d, J = 5.0, H-C(2)), 7.95 (d, J = 2.0, H-C(8)), 7.72 (d, J = 
9.0, H-C(5)), 7.35 (dd, J1 = 2.0, J2 = 9.0, H-C(6)), 6.34 (d, J = 5.5, H-C(3)), 6.25 (bs, H-NAr), 









ArNHCH2-), 2.43 (ABq, HA, J = 11.5, -CH2Ad), 2.14 (ABq, HB, J = 11.5, -CH2Ad), 1.99 (s, 
3H, -Ad), 1.80-1.45 (m, 12H, -Ad), 1.22 (d, 3H, J = 6.5, CH3). 13C-NMR (125 MHz, CDCl3, 
δ): 152.14; 150.02; 149.18; 134.70; 128.74; 125.06; 121.24; 117.51; 99.20; 59.07; 52.16; 
46.73; 40.94; 37.21; 33.47; 28.42; 19.54. HRMS: m/z 384.21824 corresponds to molecular 
formula C23H30ClN3H+ (error in ppm: - 4.85). Anal.(C23H30ClN3) Calcd: C, 71.95; H, 7.88; N, 
10.94. Found: C, 71.76; H, 8.12; N, 11.12. HPLC purity (λ = 330 nm): method A: RT 8.000 
min, area 99.64%; method B: RT 9.433 min, area 99.22%. 
N4-(1-Adamantylmethyl)-N1-(7-chloroquinolin-4-yl)pentane-1,4-diamine (31). 
Compound 31 was prepared from amine S30 (239 
mg, 0.95 mmol) and 4,7-dichloroquinoline (157 mg, 
0.79 mmol) in phenol (1115 mg, 11.85 mmol) by 
method F and was obtained after multiple 
chromatography: dry-flash SiO2, eluent: 
CH2Cl2/MeOH(NH3sat.) = 95/5, and flash chromatography (Biotage SP1 NH column, eluent: 
Hex/EtOAc = 75/25) as colorless foam softens at 148-150 C. Yield: 250 mg (64%). IR 
(ATR): 3200w, 3061w, 3007w, 2896s, 2841s, 2003w, 1609w, 1576s, 1548m, 1488w, 1449m, 
1430m, 1366m, 1333w, 1302w, 1280w, 1250w, 1213m, 1150w, 1135m, 1098w, 1078w, 
1018w, 979w, 951w, 897w, 882w, 868w, 848w, 816w, 800w, 764w, 748w, 724w, 714w, 
667w, 643w, 620w, 599w, 573w, 557w, 505w cm-1. 1H-NMR (500 MHz, CDCl3, δ): 8.52 (d, 
J = 5.5, H-C(2)), 7.93 (d, J = 2.0, H-C(8)), 7.72 (d, J = 8.5, H-C(5)), 7.34 (dd, J1 = 2.5, J2 = 
9.0, H-C(6)), 6.39 (d, J = 5.5, H-C(3)), 5.66 (bs, H-NAr), 3.40-3.30 (m, 1H, ArNHCH2-), 
3.30-3.20 (m, 1H, ArNHCH2-), 2.75-2.65 (m, 1H, -CH(CH3)NHCH2Ad), 2.29 (ABq, HA, J = 
11.3, -CH2Ad), 2.20 (ABq, HB, J = 11.3, -CH2Ad), 1.97 (m, 3H, -Ad), 1.90-1.75 (m, 16H, 
ArNHCH2CH2-), 1.75-1.60 (m, 6H, -Ad), 1.60-1.45 (m, 8H, ArNHCH2CH2CH2-, -Ad), 1.07 
(d, 3H, J = 6.0, CH3). 13C-NMR (125 MHz, CDCl3, δ): 152.13; 149.83; 149.24; 134.70; 
128.86; 125.01; 121.24; 117.28; 98.97; 59.40; 52.98; 43.50; 41.04; 37.23; 34.23; 33.34; 
28.46; 24.90; 20.71. HRMS: m/z412.24972 corresponds to molecular formula C25H34ClN3H+ 
(error in ppm: - 4.08). Anal. (C25H34ClN3) Calcd: C, 72.88; H, 8.32; N, 10.20. Found: C, 
72.68; H, 8.53; N, 9.95. HPLC purity (λ = 330 nm): method A: RT 8.054 min, area 97.97%; 
method B: RT 9.525 min, area 99.50%. 
 
N3-(1-Adamantylmethyl)-N1-(7-chloroquinolin-4-yl)pentane-1,3-diamine (28). 
Compound 28 was prepared from amine S28 (350 mg, 1.40 
mmol) and 4,7-dichloroquinoline (231 mg, 1.17 mmol) in 








obtained after multiple chromatography: dry-flash SiO2, eluent: CH2Cl2/MeOH(NH3sat.) = 
95/5, and flash chromatography (Biotage SP1 NH column, eluent: Hex/EtOAc = 65/35) as 
colorless foam,softens at 121-123 C. Yield 409 mg (71%). IR(ATR): 3254m, 2897s, 2844m, 
1610w, 1584s, 1537m, 1449m, 1428w, 1366m, 1329m, 1281w, 1243w, 1168w, 1140m, 
1103w, 1077m, 902w, 876w, 849m, 805m, 765w, 737m, 701w, 644w, 623w, 606w, 687w, 
673w, 643w, 514w, 506w cm-1. 1H-NMR (500 MHz, CDCl3, δ): 8.50 (d, J = 5.2, H-C(2)), 
7.93 (bs, H-C(8)), 7.91 (d, J = 8.9, H-C(5)), 7.54 (bs, H-NAr), 7.30-7.20 (m, H-C(6)), 6.33 (d, 
J = 5.4, H-C(3)), 3.45-3.38 (m, 1H, ArNHCH2-), 3.38-3.30 (m, 1H, ArNHCH2-), 2.70-2.60 
(m, 1H, ArNHCH2CH2CH(CH2CH3)-), 2.41 (ABq, HA, J = 11.4, -CH2Ad), 2.39 (ABq, HB, J = 
11.4, -CH2Ad), 2.05-1.95 (m, 8H, -Ad, ArNHCH2CH2-), 1.85-1.45 (m, 16H, -Ad, 
ArNHCH2CH2-, -CH2CH3), 0.94 (t, 3H, J = 7.4, -CH2CH3). 13C-NMR (125 MHz, CDCl3, δ): 
152.17, 150.49, 149.17, 134.56, 128.54, 124.50, 122.42, 117.53, 98.48, 60.67; 60.32; 41.79; 
41.22; 37.17; 33.38; 29.65; 28.43; 25.84; 10.38. HRMS: m/z412.25061 corresponds to 
molecular formula C25H34ClN3H+ (error in ppm: -1.92). Anal. (C25H34ClN3) Calcd: C, 72.88; 
H, 8.32; N, 10.20. Found: C, 72.50; H, 7.97; N, 10.06. HPLC purity (λ = 330 nm): method A: 
RT 9.632 min, area 96.33%; method B: RT 9.550 min, area 95.41%;  
N2-[2-(1-Adamantyl)ethyl]-N1-(7-chloroquinolin-4-yl)propane-1,2-diamine (34). 
Compound 34was prepared from amine S32(140 mg, 0.59 
mmol) and 4,7-dichloroquinoline (97 mg, 0.49 mmol) in 
phenol (692 mg, 7.35 mmol) by method F and was 
obtained after multiple chromatography: dry-flash SiO2, 
eluent: CH2Cl2/MeOH(NH3sat.) = 95/5, and flash chromatography (Biotage SP1 NH column, 
eluent: Hex/EtOAc = 1/1) as colorless powder,softens at 134-136 C. Yield: 174 mg (74%). 
IR (ATR): 3245w, 2895s, 2842m, 1737m, 1670w, 1566s, 1489w, 1449m, 1427m, 1367m, 
1331w, 1304w, 1284w, 1238m, 1202w, 1156w, 1136m, 1076m, 1046m, 989w, 966w, 897w, 
869w, 843m, 804m, 769m, 704w, 646w, 622w, 594w, 570w, 544w, 524w, 517w, 509w cm-1. 
1H-NMR (500 MHz, CDCl3, δ): 8.52 (d, J = 5.3, H-C(2)), 7.95 (d, J = 2.1, H-C(8)), 7.70 (d, J 
= 8.9, H-C(5)), 7.36 (dd, J1 = 2.2, J2 = 8.9, H-C(6)), 6.36 (d, J = 5.4, H-C(3)), 6.01 (bs, H-
NAr), 3.35-3.25 (m, 1H, ArNHCH2CH(CH3)-), 3.15-3.05 (m, 1H, ArNHCH2CH(CH3)-), 
3.05-2.95 (m, 1H, ArNHCH2CH(CH3)-), 2.80-2.70 (m, 1H, -NHCH2CH2Ad), 2.65-2.55 (m, 
1H, -NHCH2CH2Ad), 1.94 (bs, 3H, -Ad), 1.75-1.55 (m, 6H, -Ad), 1.55-1.45 (m, 6H, -Ad), 
1.35-1.25 (m, 3H, -NHCH2CH2Ad, H-N- ), 1.22 (d, 3H, J = 6.0, CH3). 13C-NMR (125 MHz, 
CDCl3, δ): 152.12; 150.01; 149.19; 134.75; 128.76; 125.14; 121.25; 117.47; 99.20; 51.74; 
47.22; 45.24; 42.77; 41.27; 37.10; 32.00; 28.64; 19.30. HRMS: m/z 398.23395 corresponds to 






H, 8.10; N, 10.56. Found: C, 71.98; H, 8.49; N, 10.59. HPLC purity (λ = 330 nm): method A: 
RT 8.017 min, area 99.00%; method B: RT 9.696 min, area 98.87%. 
N4-[2-(1-Adamantyl)ethyl]-N1-(7-chloroquinolin-4-yl)pentane-1,4-diamine (43). 
Compound 43 was prepared from amine S33(145 mg, 
0.55 mmol) and 4,7-dichloroquinoline (91 mg, 0.46 
mmol) in phenol (649 mg, 6.90 mmol) by method F 
was obtained after multiple chromatography: dry-
flash SiO2, eluent: CH2Cl2/MeOH(NH3sat.) = 95/5, and flash chromatography (Biotage SP1 
NH column, eluent: Hex/EtOAc = 7/3) as colorless powder,softens at 140-143 C. Yield: 157 
mg, (67%). IR (ATR): 3252m, 3063w, 2898s, 2844s, 2017s, 1610w, 1587s, 1539m, 1449m, 
1429w, 1367m, 1330m, 1279w, 1248w, 1204w, 1135m, 1098w, 1078w, 890w, 877w, 853w, 
804w, 764w, 737w, 701w, 692w, 668w, 659w, 643w, 619w, 602w, 582w, 563w, 552w, 
542w, 529w cm-1. 1H-NMR (500 MHz, CDCl3): 8.52 (d, J = 5.4, H-C(2)), 7.94 (d, J = 2.2, H-
C(8)), 7.70 (d, J = 9.0, H-C(5)), 7.34 (dd, J1 = 2.2, J2 = 8.9, H-C(6)), 6.38 (d, J = 5.4, H-C(3)), 
5.87 (bs, H-NAr), 3.40-3.20 (m, 2H, ArNHCH2-), 2.80-2.70 (m, 1H, -
CH(CH3)NHCH2CH2Ad), 2.70-2.60 (m, 1H, -CH2CH2Ad), 2.60-2.50 (m, 1H, -CH2CH2Ad), 
1.93 (m, 3H, -Ad), 1.90-1.75 (m, 2H, ArNHCH2CH2-), 1.75-1.52 (m, 8H, ArNHCH2CH2CH2-
, -Ad), 1.48 (m, 6H, -Ad), 1.35-1.20 (m, 2H, -CH2Ad), 1.25 (d, 3H, J = 5.0, CH3). 13C-NMR 
(125 MHz, CDCl3, δ): 152.12; 149.93; 149.25; 134.69; 128.81; 125.01; 121.34; 117.33; 
98.93; 52.84; 45.09; 43.56; 42.68; 41.35; 37.12; 34.70; 31.90; 28.65; 24.93; 20.50. HRMS: 
m/z426.26530 corresponds to molecular formula C26H36ClN3H+ (error in ppm: - 4.11).Anal. 
(C26H36ClN3  1/3 H2O) Calcd: C, 72.28; H, 8.55; N, 9.73. Found: C, 72.02; H, 8.86; N, 9.40. 
HPLC purity (λ = 330 nm): method A: RT 8.089 min, area 99.50%; method B: RT 9.746 min, 
area 96.70%. 
N3-[2-(1-Adamantyl)ethyl]-N1-(7-chloroquinolin-4-yl)butane-1,3-diamine (41). 
Compound 41 was prepared from amine linker 
S34(123 mg, 0.47 mmol) and 4,7-dichloroquinoline 
(77 mg, 0.39 mmol) in phenol (550 mg, 5.85 mmol) 
by method F and was obtained after multiple 
chromatography: dry-flash SiO2, eluent: 
CH2Cl2/MeOH(NH3sat.) = 95/5, and flash chromatography (Biotage SP1 NH column, eluent: 
Hex/EtOAc = 65/35) as colorless foam,softens at 131-134 C. Yield: 139 mg (70%). IR 
(ATR): 3213w, 2897s, 2843m, 1738w, 1610w, 1578s, 1537m, 1448m, 1429w, 1365m, 
1329m, 1282w, 1240w, 1218w, 1168w, 1140m, 1098w, 1077w, 1047w, 990w, 972w, 906w, 
876w, 850w, 801m, 765w, 735w, 641w, 582w, 538w, 513w cm-1. 1H-NMR (500 MHz, 








H-C(5)), 7.28 (dd, J1 = 8.9, J2 = 2.2, H-C(6)), 6.27 (d, J = 5.4, H-C(3)), 3.50-3.35 (m, 1H, 
ArNHCH2-), 3.35-3.25 (m, 1H, ArNHCH2-), 2.80-2.70 (m, 2H, -(CH2CH3)CH-, -
CH2CH2Ad), 2.70-2.60 (m, 1H, -CH2CH2Ad), 2.00-1.90 (m, 4H, -Ad, ArCH2CH2-), 1.75-1.55 
(m, 8H, -Ad, -CH2CH3, ArCH2CH2-), 1.55-1.14 (m, 7H, -CH2CH3, -Ad), 1.45-1.35 (m, 1H, -
CH2Ad), 1.35-1.20 (m, 1H, -CH2Ad), 0.94 (t, 3H, J = 7.4, CH3). 13C-NMR (125 MHz, CDCl3, 
δ): 151.99; 150.72; 148.96; 134.57; 128.26; 124.50; 122.55; 117.63; 98.03; 59.81; 45.37; 
42.68; 42.08; 41.21; 37.04; 31.88; 29.29; 28.57; 25.96; 10.14. HRMS: m/z 426.26759 
corresponds to molecular formula C26H36ClN3H+ (error in ppm: - 1.26).Anal.(C26H36ClN3 × 
1/3 H2O) Calcd: C, 72.28; H, 8.55; N, 9.73. Found: C, 72.76; H, 8.48; N, 9.70. HPLC purity 































i) glac. CH3COOH, 125 
oC, 1 h; NaOH, CH3COOH; ii) HNO3, CH3CH2COOH, 125 
oC, 24 h; iii) POCl3, 115 
oC, 18 h; iv)  
p-toluenesulfonylhydrazine, CHCl3, 24 h, r.t.; 0.5 M NaOH, 80 
oC, 1 h; v) SnCl2 x 2H2O, MeOH, 80 
oC; vi) 48% aq HBF4, 
NaNO2; 1,2-dichlorbenzen, 2 h, 110 
oC vii) LDA, THF, 4 h, -85 oC; I2, THF, 2 h, -78 
oC viii) amine, Pd(OAc)2, DPEphos,  








73: R=H, n=1 (63%)






75: R=H, n=1 (72%)














A mixture of 4,7-dichloroquinoline (10 g, 50 mmol) and 6.5 equiv of glacial 
acetic acid (18.8 mL, 325 mmol) was refluxed at 125 oC for one hour. Dry 
ether was added to the cooled reaction mixture and the colorless solid was 
filtered off. Obtained crude product was dissolved in conc. NaOH, reaction mixture was 
filtered and acidified with acetic acid. Formedprecipitate was collected by filtration, washed 





91%); m.p. = 276-279 °C (Et2O). IR (ATR): 3228w, 3116w, 3057m, 2945m, 2877m, 2799m, 
2635w, 1629m, 1599s, 1558s, 1507s, 1455s, 1414m, 1356m, 1300w, 1244w, 1206m, 1143w, 
1080w, 1056w, 904w, 862m, 822m, 796s, 572m, 479m cm-1. 1H-NMR (200 MHz, DMSO, δ): 
8.07 (d, J = 8.6, H-C(5)), 7.93 (d, J = 7.4, H-C(2)), 7.61 (d, J = 2.0, H-C(8)), 7.30 (dd, J1 = 
2.0, J2 = 7.4, H-C(6)), 6.05 (d, J = 7.4, H-C(3)). 13C-NMR (125 MHz, CDCl3, δ): 176.17; 
141.19; 140.39; 136.04; 127.24; 124.44; 123.29; 117.73; 109.21. HRMS: m/z180.02100 
corresponds to molecular formula C9H6ClNOH+ (error in ppm: - 0.40). 
7-Chloro-3-nitroquinolin-4-ol (S36).22 
A mixture of 7-chloroquinolin-4-ol S35 (2.00 g, 11.13 mmol) in 
propionic acid (20 mL) was heated to 125 oC with stirring. Nitric acid 
(65%, 964 µL, 13.92 mmol) was added dropwise to a stirred solution 
while maintaining the reaction mixture temperature at 125 oC. Upon completedaddition the 
mixture was stirred for 18h and cooled to ambient temperature. The mixture was diluted with 
ethanol, and the solid was collected by filtration. 7-Chloro-3-nitroquinolin-4-olwas obtained 
after chromatography: SiO2, eluent: CH2Cl2/MeOH(NH3sat.) = 8/2 as light-yellow 
solid,softens at 199-202 °C (Hex). Yield: 1.95 g (79%). IR(ATR): 3442m, 3194w, 3156w, 
3071w, 3039w, 2919m, 2852m, 1628s, 1557w, 1533m, 1499m, 1460w, 1404w, 1336s, 
1267w, 1234w, 1198w, 1158w, 1113w, 1078w, 879w, 831w, 781m, 673w, 618m, 516w, 
441w, 420w cm-1. 1H-NMR (500 MHz, MeOD, δ): 10.03 (s, H-C(2)), 9.03 (d, J = 8.4, H-
C(5)), 8.55 (s, H-C(8)), 8.33 (d, J = 8.2, H-C(6)). 13C-NMR (125 MHz, CDCl3, δ): 176.73; 
152.97; 149.19; 147.29; 140.99; 137.80; 136.52; 135.63; 128.64. HRMS: m/z225.00527 
corresponds to molecular formula C9H5ClN2O2H+ (error in ppm: - 3.89). 
4,7-Dichloro-3-nitroquinoline (S37). 
The mixture of 7-chloro-3-nitroquinolin-4-ol S36 (1.00 g, 4.45 mmol) 
and POCl3 (4 mL) was heated to 115 oC overnight. The resulting 
solution was cooled to ambient temperature and poured into an ice/water 
mixture (50 mL). A solid was collected by vacuum filtration, washed with water and dried. 
4,7-Dichloro-3-nitroquinolin was obtained after dry-flash chromatography: SiO2, eluent: 
Hex/EtOAc = 9/1 as light-yellow solid,softens at 153-155 °C (hexane). Yield: 974 mg, (90%). 
IR (ATR): 3064m, 1604m, 1581s, 1556s, 1531s, 1479m, 1438w, 1397w, 1373w, 1355s, 
1333s, 1294m, 1253m, 1207m, 1168m, 1144w, 1080s, 1021m, 973w, 962w, 926m, 898m, 
875m, 818s, 810s, 772m, 740w, 700m, 650w, 605m, 562w, 540m, 486w, 466w, 444m, 422m 
cm-1. 1H-NMR (500 MHz, CDCl3, δ): 9.27 (s, H-C(2)), 8.38 (d, J = 9.0, H-C(5)), 8.22 (d, J = 
2.0, H-C(8)), 7.77 (dd, J1 = 2.0, J2 = 9.0, H-C(6)). 13C-NMR (125 MHz, CDCl3, δ): 149.51; 









corresponds to molecular formula C9H4Cl2N2O2H+ (error in ppm: - 0.38).Anal.(C9H4Cl2N2O2) 
Calcd: C, 44.48; H, 1.66; N, 11.53. Found: C, 44.57; H, 1.36; N, 11.06. 
7-Chloro-3-nitroquinoline (S38).23 
A solution of 4,7-dichloro-3-nitroquinoline S37 (1.65 g, 6.79 mmol) and 
p-toluenesulfonylhydrazine (1.39 g, 7.47 mmol) in 60 mL of CHCl3 was 
stirred at r.t. for 24 h and filtered to collect the cream-colored hydrazino 
intermediate. The precipitate was washed with cold CHCl3 and air dried. The intermediate 
was dissolved in 0.5N NaOH (150 mL) andheated to 80 oC for 1h. The dark-red mixture was 
cooled to r.t., filtered, and the brown solid was washed thoroughly with water. Crude product 
was further purified by dry-flash chromatography: SiO2, eluent: Hex/EtOAc = 8/2 as light-
yellow solid,softens at 136-138 °C (Hex). Yield: 892 mg (63%). IR (ATR): 3085m, 2960w, 
2928w, 2857w, 2762w, 1606s, 1563m, 1539m, 1479m, 1437w, 1411w, 1380w, 1351s, 1320s, 
1256w, 1219w, 1170m, 1142w, 1094w, 1064m, 975w, 933m, 914w, 875w, 831s, 787w, 
770w, 740w, 677w, 633w, 544w, 521w, 470w, 446w cm-1. 1H-NMR (500 MHz, CDCl3, δ): 
9.65 (d, J = 2.4, H-C(2)), 9.02 (d, J = 2.4, H-C(4) or H-C(8)), 8.24 (d, J = 1.2, H-C(8) or H-
C(4)), 8.00 (d, J = 8.7, H-C(5)), 7.70-7.60 (m, H-C(6)). 13C-NMR (125 MHz, CDCl3, δ): 
150.34; 145.11; 140.96; 139.82; 132.02; 130.75; 130.04; 128.98; 124.38. HRMS: 
m/z209.01116 corresponds to molecular formula C9H5ClN2O2H+ (error in ppm: - 0.32). 
7-Chloroquinolin-3-amine (13). 
A solution of 7-chloro-3-nitroquinoline S38 (200 mg, 0.96 mmol) and 
SnCl2 (910 mg, 4.80 mmol) in MeOH was heated toreflux for 1 h under 
Ar atmosphere. Thereafter the excess MeOH was evaporated and the 
residue was dissolved in EtOAc and sat. NaHCO3 solution was added. The resulting mixture 
was filtered through a celite followed by separation of organic layer via partitioning. Organic 
layer was collected, dried over anh.Na2SO4 and concentrated under reduced pressure to obtain 
the crude product which was purifiedby dry-flash chromatography: SiO2, eluent: Hex/EtOAc 
= 1/1 as yellow solid softens at 126-129 °C (Hex). Yield: 168 mg (98%). IR (ATR): 3315s, 
3171s, 1637m, 1607s, 1566m, 1510w, 1489s, 1458m, 1364m, 1341m, 1282m, 1206s, 1135m, 
1068m, 986m, 917m, 884m, 862m, 829m, 801m, 763m, 647m, 544w, 521w cm-1. 1H-NMR 
(500 MHz, CDCl3, δ): 8.50 (d, J = 2.8, H-C(2)), 7.95 (d, J = 2.0, H-C(8)), 7.52 (d, J = 8.9, H-
C(5)), 7.40-7.35 (m, H-C(6)), 7.20 (d, J = 2.6, H-C(4)), 3.96 (bs, 2H-N). 13C-NMR (125 
MHz, CDCl3, δ): 143.94; 142.92; 139.90; 130.99; 128.08; 127.89; 127.55; 127.02; 114.64. 








The mixture of amine 13 (500 mg, 2.80 mmol) and48% tetrafluoroboric 
acid (730 µL, 5.60 mmol) was stirred on ice bath. Solution of sodium 
nitrite (193 mg, 2.80 mmoL) in water (1 mL) was added dropwise after 15 
min. The reaction mixture was stirred as the temperature rose to r.t. Thendiazonium 
tetrafluoroborate precipitate was filteredoff,washed with cold EtOH and Et2O then dried 
under reduced pressure. Diazonium salt was suspendedin 1,2-dichlorobenzene and the 
mixture was stirred for2 h at 110 oC. 7-Chloro-3-fluoroquinoline15was obtained after dry-
flash chromatography SiO2, eluent: Hex/EtOAc = 9/1, as light-yellow solid,softens at 76-80 
°C (Hex). Yield: 356 mg (70%). IR (ATR): 3076m, 3053m, 2957w, 2857w, 1615m, 1596s, 
1565m, 1485m, 1443m, 1414w, 1359w, 1333s, 1263m, 1184s, 1149w, 1129w, 1094w, 
1071m, 988m, 961w, 935w, 913m, 891s, 812m, 776m, 645m, 537m, 512m, 477m, 461m cm-
1. 1H-NMR (500 MHz, CDCl3, δ): 8.81 (d, J = 2.8, H-C(2)), 8.11 (d, J = 1.8, H-C(8)), 7.80-
7.70 (m, 2H, H-C(4) and H-C(5)), 7.55-7.50 (m, H-C(6)). 13C-NMR (125 MHz, CDCl3, δ): 
156.25 (d, J = 257.0, C(3)); 145.60 (C(8a)); 142.52 (d, J = 27.2, C(2)); 134.41 (C(7)); 128.73 
(C(6)); 128.53 (C(5)); 129.20 (C(4a)); 128.35 (d, J = 5.1, C(8)); 118.31 (d, J = 17.3, C(4)). 
HRMS: m/z182.01646 corresponds to molecular formula C9H5ClFNH+ (error in ppm: - 1.49). 
3-Fluoro-quinoline (16). 
Amixture of 3-aminoquinoline 14(3.00 g, 20.96 mmol) and48% 
tetrafluoroboric acid (30 mL, 41.93 mmol) was stirred on ice bath. Solution 
of sodium nitrite (1.44 g, 20.96 mmol) in water (6 mL) was added dropwise 
after 15 min. The reaction mixture was stirred as the temperature rose to r.t. Then diazonium 
tetrafluoroborate precipitate was filtered off, washed with cold EtOH and Et2O then dried 
under reduced pressure. Diazonium salt was suspendedin toluene and the mixture was 
warmed 1 h at the 110 oC. 3-Fluoroquinoline 16was obtained after chromatography SiO2, 
eluent: Hex/EtOAc = 9/1,as light-yellow solid (4.9 g, 97%). IR (ATR): 3414w, 3064m, 
2927w, 1652w, 1612s, 1560w, 1498s, 1463s, 1426m, 1371w, 1339s, 1213s, 1155s, 984m, 
957w, 894m, 859w, 782m, 735m, 710w, 611w, 472w cm-1. 1H-NMR (500 MHz, CDCl3, δ): 
8.82 (d, J = 2.8, H-C(2)), 8.13 (d, J = 8.5, H-C(8)), 7.85-7.75 (m, 2H, H-C(4) and H-C(5)), 
7.75-7.65 (m, H-C(7)), 7.65-7.55 (m, H-C(6)). 13C-NMR (125 MHz, CDCl3, δ): 156.25 (d, J = 
255.0, C(3)); 145.40 (C(8a)); 141.54 (d, J = 27.6, C(2)); 129.49 (C(8)); 128.54 (C(7)); 128.42 
(d, J = 5.7, C(4a)); 127.67 (C(6)); 127.27 (d, J = 4.6, C(5)); 118.32 (d, J = 17.2, C(4)). 











Diisopropylamine (1.8 mL, 12.89 mmol) was added to n-
butyllithium/hexane (4.9 mL, 12.28 mmol) in THF (6.5 mL) at -78oC. 
After 30 min a solution 3-fluoro-7-chloroquinoline (2.23 g, 12.28 mmol) in 
5.5 mL of THF was slowly added to solution of the formed LDA at -85 oC. 
The resulting solution was stirred for 4h at -78 oC, and iodine (3.4 g, 13.51 mmol) in 6 mL 
THF was slowly added at -85 oC. Stirring was continued for 2h at -78 oC before the reaction 
was quenched by THF/H2O = 9/1 (10 mL). Extraction with EtOAc, drying over anh.Na2SO4, 
filtration and solvent removal afforded crude product which was purified by multiple 
chromatography: dry-flash SiO2, gradient: Hex/EtOAc = 95/5→9/1,and flash chromatography 
(Biotage SP1 NH column, eluent: Hex/EtOAc = 9/1). Yield: 1.53 g (41%) of 17. IR (ATR): 
3080m, 3031w, 2959w, 2925w, 1837w, 1738w, 1602m, 1585s, 1551s, 1481s, 1441s, 1384w, 
1357s, 1317s, 1307s, 1254m, 1210m, 1179m, 1139m, 1075m, 1018w, 949w, 925s, 895w, 
870m, 851w, 814m, 755m, 642w, 576w, 536m, 509m, 429w cm-1. 1H-NMR (500 MHz, 
CDCl3, δ): 8.60 (s, H-C(2)), 8.11 (d, J = 2.0, H-C(8)), 7.97 (d, J = 8.9, H-C(5)), 7.65-7.60 (m, 
H-C(6)). 13C-NMR (125 MHz, CDCl3, δ): 157.11 (d, J = 255.3, C(3)); 145.36 (C(8a)); 140.80 
(d, J = 30.0, C(2)); 135.37 (C(7)); 132.16 (C(5)); 129.93 (C(6)); 129.20 (C(4a)); 128.63 
(C(8)); 94.90 (d, J = 23.0, C(4)). HRMS: m/z307.91326 corresponds to molecular formula 
C9H4ClFINH+ (error in ppm: - 0.36). 
The compound 18 was also isolated as side product (359 mg, 9.5%).  
7-Chloro-3-fluoro-2-iodoquinoline (18). 
IR (ATR): 3171w, 3071w, 3037s, 2923s, 2853m, 1729w, 1689w, 1603m, 
1481m, 1404m, 1373w, 1330s, 1297w, 1255w, 1191s, 1135w, 1071w, 
1016m, 918m, 866w, 815wcm-1. 1H-NMR (500 MHz, CDCl3, δ): 8.08 (d, J 
= 1.8, H-C(8)), 7.72 (d, J = 8.7, H-C(5)), 7.64 (d, J = 7.1, H-C(4)), 7.55 (dd, J1= 2.0, J2 = 8.8, 
H-C(6)). 13C-NMR (125 MHz, CDCl3, δ): 154.77 (d, J = 256.0, C(3)); 146.73 (C(8a)); 135.35 
(C(7)); 129.27 (C(6)); 128.21 (d, J = 20.0, C(5)); 127.94 (C(8)); 126.36 (C(4a)); 117.50 (d, J 
= 85.2, C(4)); 111.95 (d, J = 120.1, C(2)). HRMS: m/z307.91325 corresponds to molecular 
formula C9H4ClFINH+ (error in ppm: - 0.40). 
3-Fluoro-4-iodoquinoline (19).24 
Diisopropylamine (1 mL, 7.14 mmol) was added to n-butyllithium/hexane 
(2.7 mL, 6.80 mmol) in THF (25 mL) at -78 oC. After 30 min a solution 3-
fluoroquinoline (1.00 g, 6.80 mmol) in 5.5 mL of THF was slowly added to 
the solution of the formed LDA at -85 oC. The resulting solution was stirred for 4h at -78 oC, 
and iodine (1.90 g, 7.14 mmol) in 7 mL THF was slowly added at -85 oC. Stirring was 
continued for 2h at -78 oC before the reaction was quenched THF/H2O = 9/1 (10 mL). 












crude product which was purified by dry-flash chromatography SiO2, gradient: Hex/EtOAc = 
95/5 → 9/1. Yield: 1.30 g (70%)of 19.IR (ATR): 3069m, 2924m, 2854w, 1586s, 1558s, 
1491s, 1455s, 1414m, 1382w, 1339s, 1306s, 1262m, 1213s, 1141s, 1011w, 959w, 920m, 
797w, 754s, 723m, 630w, 506w cm-1. 1H-NMR (500 MHz, CDCl3, δ): 8.61 (s, H-C(2)), 8.09 
(dd, J1 = 0.6, J2 = 8.1, H-C(8)), 8.02 (dd, J1 = 1.5, J2 = 8.4, H-C(5)), 7.75-7.70 (m, H-C(7)), 
7.70-7.62 (m, H-C(6)). 13C-NMR (125 MHz, CDCl3, δ): 157.02 (d, J = 252.7, C(3)); 145.33 
(d, J = 1.8, C(8a)); 139.85 (d, J = 30.7, C(2)); 130.87 (d, J = 5.4, C(5)); 130.62 (C(4a)); 
129.86 (C(8)); 129.15 (d, J = 2.7, C(7)); 129.07 (C(6)); 95.19 (d, J = 21.7, C(4)). HRMS: 
m/z273.95195 corresponds to molecular formula C9H5FINH+ (error in ppm: - 1.46). 
N4-(7-Chloro-3-fluoroquinolin-4-yl)-N1,N1-diethylpentane-1,4-diamine (74). 
Compound 74 was prepared from 7-chloro-3-fluoro-4-
iodoquinoline (300 mg, 0.98 mmol) and 2-amino-5-
diethylaminopentane (378 µL, 1.95 mmol) using Pd(OAc)2 
(8.8 mg, 0.039 mmol), DPEphos (42 mg, 0.078 mmol) and 
K3PO4 (518 mg, 2.44 mmol) by method Hand was and was 
obtained after multiple chromatography: dry-flash SiO2, gradient: CH2Cl2/MeOH(NH3sat.) = 
95/5 → 8/2 and flash chromatography (Biotage SP1 NH column, eluent: Hex/EtOAc = 8/2) as 
colorless foam (329 mg, 54%),softens at 48-50 °C. IR(ATR): 3304m, 3069w, 2970s, 2936m, 
2871w, 2810w, 1595s, 1574s, 1536m, 1488w, 1452m, 1418m, 1380m, 1351m, 1294w, 
1265m, 1221w, 1197w, 1140m, 1078m, 929w, 906w, 877w, 815m, 764w, 735w, 656w, 540w 
cm-1. λmax(ε) = 336 (11554), 252 (16869) nm. 1H-NMR (500 MHz, CDCl3, δ): 8.52 (d, J = 
5.5, H-C(2)), 7.96 (d, J = 2.2, H-C(8)), 7.75 (d, J = 9.1, H-C(5)), 7.42-7.36 (m, H-C(6)), 4.73 
(d, J = 7.7, -NH), 4.20-4.05 (m, 1H, ArNHCH(CH3)-), 2.54 (q, 4H, J = 7.2, -NH(CH2CH3)2), 
2.50-2.43 (m, 2H, -CH2NH(CH2CH3)2), , 1.75-1.55 (m, 4H, ArNHCH(CH3)CH2-, 
ArNHCH(CH3)CH2CH2-), 1.29 (dd, 3H, J1 = 0.9, J2 = 6.3, ArNHCH(CH3)-), 1.01 (t, 6H, J = 
7.0, -NH(CH2CH3)2). 13C-NMR (125 MHz, CDCl3, δ): 146.62 (C(8a)); 143.42 (d, J = 240.1, 
C(3)); 142.45 (d, J = 27.3, C(2)); 135.77 (d, J = 6.3, C(4)); 133.97 (C(7)); 128.96 (C(8)); 
125.95 (C(6)); 121.89 (d, J = 5.4, C(5)); 119.45 (d, J = 4.5, C(4a)); 52.54; 51.34 (d, J = 8.1, 
ArNHCH(CH3)-); 46.78; 36.12; 23.70; 22.30; 11.26. HRMS: m/z338.18020 corresponds to 
molecular formula C18H25ClFN3H+ (error in ppm: + 2.43. Anal. (C18H25ClFN3 × 1/2 H2O) 
Calcd: C, 62.33; H, 7.56; N, 12.11. Found: C, 62.00; H, 7.32; N, 11.85. HPLCpurity (λ = 330 












Compound 76 was prepared from 7-chloro-3-fluoro-2-
iodoquinoline (100 mg, 0.33 mmol) and 2-amino-5-
diethylaminopentane (126 µL, 0.65 mmol) using 
Pd(OAc)2 (2.9 mg, 0.013 mmol), DPEphos (14 mg, 0.026 mmol) and K3PO4 (173 mg, 0.81 
mmol) by method Hand was and was obtained after multiple chromatography: dry-flash SiO2, 
gradient: CH2Cl2/MeOH(NH3sat.) = 95/5 → 8/2,and flash chromatography (Biotage SP1 RP 
column, eluent: MeOH/H2O = 8/2) as yellow viscous oil (76 mg, 70%). IR(ATR): 3440m, 
3288m, 2968s, 2932m, 2871w, 2806w, 1637s, 1609m, 1568m, 1532s, 1492w, 1463m, 1416m, 
1377w, 1345w, 1286w, 1261m, 1190m, 1145m, 1120m, 1098m, 1070m, 969w, 948w, 883m, 
800w, 761w, 721w, 602w, 513w, 475w cm-1. λmax(ε) = 346 (8397), 333 (8354), 243 (37616) 
nm. 1H-NMR (500 MHz, CDCl3, δ): 7.68 (d, J = 2.0, H-C(8)), 7.43 (d, J = 8.4, H-C(5)), 7.37 
(d, J = 11.3, H-C(4)), 7.16 (dd, J1 = 1.6, J = 8.5, H-C(6)), 5.21 (d, J = 6.5, H-N), 4.45-4.35 
(m, 1H, ArNHCH(CH3)-), 2.58 (q, 4H, J = 7.2, -NH(CH2CH3)2), 2.55-2.50 (m, 2H, -
CH2NH(CH2CH3)2), 1.75-1.55 (m, 4H, ArNHCH(CH3)CH2-, ArNHCH(CH3)CH2CH2-), 1.29 
(d, J = 1.3, ArNHCH(CH3)-), 1.04 (t, J = 7.2, -NH(CH2CH3)2). 13C-NMR (125 MHz, CDCl3, 
δ): 148.41 (d, J = 13.6, C(8a)); 147.15 (d, J = 258.1, C(3)); 143.86 (d, J = 2.7, C(2)); 133.87 
(C(7)); 127.78 (d, J = 5.0, C(5)); 125.25 (C(8)); 123.08 (C(6)); 121.32 (d, J = 4.1, C(4a)); 
115.90 (d, J = 15.3, C(4)); 52.63; 46.73 (d, J = 5.4, ArNHCH(CH3)-); 45.84; 34.81; 23.15; 
20.84; 11.06. HRMS: m/z338.17891 corresponds to molecular formula C18H25ClFN3H+ (error 
in ppm: - 1.40).Anal. (C18H25ClFN 3 × 1/2 H2O) Calcd: C, 62.33; H, 7.56; N, 12.11. Found: C, 
62.28; H, 7.69; N, 11.94. HPLCpurity (λ = 330 nm) method A: RT 8.042 min, area 96.24%; 
method B: RT 10.764 min, area 96.01%. 
N'-(7-Chloro-3-fluoroquinolin-4-yl)-N,N-diethylpropane-1,3-diamine (73). 
Compound 73 was prepared from7-chloro-3-fluoro-4-
iodoquinoline (100 mg, 0.32 mmol) and 3-diethylamino-1-
propilamine (105 µL, 0.65 mmol) using Pd(OAc)2 (2.9 mg, 0.013 
mmol), SPhos (10.7 mg, 0.026 mmol) and K3PO4 (178 mg, 0.81 
mmol) by method H and was obtained after multiple chromatography: dry-flash SiO2, 
gradient: CH2Cl2/MeOH(NH3sat.) = 95/5 → 8/2,and flash chromatography (Biotage SP1 NH 
column, eluent: Hex/EtOAc = 85/15) as colorless foam (64 mg, 63%)softens at 47-48°C. 
IR(ATR): 3234m, 3065w, 2970s, 2934m, 2872w, 2822m, 1640w, 1597s, 1574s, 1540m, 
1489w, 1470w, 1454w, 1429m, 1380m, 1360m, 1294w, 1268w, 1246w, 1195m, 1166w, 
1138m, 1077m, 934m, 892m, 812m, 762m, 737w, 654w, 622w, 540w cm-1. λmax(ε) = 337 
(9690), 252 (15073) nm. 1H-NMR (500 MHz, CDCl3, δ): 8.45 (d, J = 6.0, H-C(2)), 7.91 (d, J 










2H, ArNHCH2-), 2.72-2.68 (m, 2H, -CH2NH(CH2CH3)2), 2.65 (q, 4H, J = 7.1, -
NH(CH2CH3)2), 2.04 (bs, H-N), 1.90-1.80 (m, 2H, ArNHCH2CH2-), 1.10 (t, 6H, J = 7.1, -
NH(CH2CH3)2). 13C-NMR (125 MHz, CDCl3): 146.60 (C(8a)); 143.50 (d, J = 226.3, C(3)); 
142.45 (d, J = 27.2, C(2)); 137.28 (d, J = 5.9, C(4)); 133.72 (d, J = 7.2, C(7)); 128.65 (C(8)); 
125.23 (C(6)); 122.74 (d, J = 5.0, C(5)); 119.28 (d, J = 5.9, C(4a)); 53.50; 47.44 (d, J = 9.9, 
ArNHCH2-); 47.03; 25.31; 11.28. HRMS: m/z310.14830 corresponds to molecular formula 
C16H21ClFN3H+ (error in ppm: + 0.71).(+)ESI-HRMS (m/z (%)): 310.14830 (M+H+, 100); 
calculated 310.14808 (error in ppm: 0.71). Anal. (C16H21ClFN3 × 1/2 H2O) Calcd: C, 60.28; 
H, 6.96; N, 13.18. Found: C, 60.65; H, 7.07; N, 12.79. HPLCpurity (λ = 330 nm) method A: 
RT 7.585min, area 99.71%; method B: RT 8.693 min, area 95.30%. 
N'-(7-Chloro-3-fluoroquinolin-2-yl)-N,N-diethylpropane-1,3-diamine  (75). 
Compound 75 was prepared from 7-chloro-3-fluoro-2-
iodoquinoline (100mg, 0.32 mmol) and 3-diethylamino-1-
propilamine (74 µL, 0.46 mmol) using Pd(OAc)2 (2.0 mg, 
0.009 mmol), SPhos (7.5 mg, 0.018 mmol) and K3PO4(124 
mg, 0.57 mmol) by method H and was obtained after multiple chromatography: dry-flash 
SiO2, gradient: CH2Cl2/MeOH(NH3sat.) = 95/5 → 8/2,and flash chromatography (Biotage 
SP1 RP column, eluent; MeOH/H2O = 8/2) as yellow viscous oil (51 mg, 72%). IR(ATR): 
3450w, 3241m, 2970m, 2931m, 2873w, 2815m, 1639m, 1610w, 1563w, 1537s, 1497w, 
1459m, 1416m, 1378w, 1338m, 1292m, 1256m, 1193m, 1146m, 1124m, 1098w, 1070m, 
1032w, 979w, 921w, 885m, 800w, 761w, 739w, 604w, 514w, 476w cm-1. λmax(ε) = 343 
(8682), 332 (8760), 242 (35685) nm. 1H-NMR (500 MHz, CDCl3, δ): 7.69 (d, J = 2.0, H-
C(8)), 7.50-7.40 (bs, 1H, H-N-), 7.41 (d, J = 8.5, H-C(5)), 7.33 (d, J = 11.2, H-C(4)), 7.14 
(dd, J1 = 2.0, J2 = 8.4, H-C(6)), 3.75-3.60 (m, 2H, ArNHCH2-), 2.64 (t, 2H, J = 6.0, -
CH2NH(CH2CH3)2), 2.57 (q, 4H, J = 7.1, -NH(CH2CH3)2), 1.90-1.75 (m, 2H, ArNHCH2CH2-
), 1.07 (t, 6H, J = 7.2, -NH(CH2CH3)2). 13C-NMR (125 MHz, CDCl3, δ): 149.16 (d, J = 14.0, 
C(8a)); 147.58 (d, J = 259.0, C(3)); 145.54 (d, J = 2.7, C(2)); 133.77 (d, J = 7.2, C(7)); 127.77 
(d, J = 5.0, C(5)); 125.03 (C(8)); 122.80 (C(6)); 121.26 (d, J = 4.5, C(4a)); 115.56 (d, J = 
15.4, C(4)); 53.00; 46.83; 41.57; 25.11; 11.53. HRMS: m/z310.14742 corresponds to 
molecular formula C16H21ClFN3H+ (error in ppm: - 2.14).Anal. (C16H21ClFN3× 1/4 H2O) 
Calcd: C, 61.14; H, 6.89; N, 13.37. Found: C, 61.33; H, 6.96; N, 13.40. HPLCpurity (λ = 330 















i) benzyl-chloroformate (1.2 equiv), Et3N (3.0 equiv), CH2Cl2, 3 h, r.t.; ii) TFA/CH2Cl2, 2 h, r.t., 2.5 NaOH,  r.t.; iii) aldehyde (1 equiv), 
Ti(OiPr)4 (1.2 ekv), NaBH4, absolute EtOH, 24 h; iv) H2, Pd(C) (10%), MeOH, 20 psi, r.t., 6 h; v) MW, 4-chloroquinoline/4-quinoline (1 






S44: n=3 (78%) 
S45: n=1, m=1 (95%)
S46: n=2, m=1 (73%)
S47: n=3,m=1 (69%)
S48: n=1, m=2 (55%)
S49: n=2, m=2 (74%)
S50: n=3, m=2 (77%) 
S51: n=1, m=1 (88%)
S52: n=2, m=1 (78%)
S53: n=3, m=1 (92%)
S54: n=1, m=2 (81%)
S55: n=2, m=2 (86%)








68: R1=Cl, R2=F, n=1, m=1 (9.1%)
69: R1=Cl, R2=F, n=2, m=1 (53%)
70: R1=Cl, R2=F, n=3, m=1 (51%)
71: R1=Cl, R2=F, n=2, m=2 (53%)































12: R1=R2=H, n=1, m=1 (72%)
24: R1=R2=H, n=2, m=1 (73%)
26: R1=H, R2=F, n=2, m=1 (49%)
20: R1=Cl, R2=F, n=1, m=1 (6.7%)
25: R1=Cl, R2=F, n=2, m=1 (47%)
32: R1=Cl, R2=F, n=3, m=1 (49%)
35: R1=R2=H, n=1, m=2 (63%)
37: R1=R2=H, n=2, m=2 (77%)
44: R1=R2=H, n=3, m=2 (85%)
39: R1=H, R2=F, n=2, m=2 (48%)
38: R1=Cl, R2=F, n=2, m=2 (24%)
45: R1=Cl, R2=F,n=3, m=2(41%) 
21: R1=Cl, R2=F, n=1, m=1 (61%)
 
 
Benzyl tert-butyl propane-1,2-diylbiscarbamate (S39). 
Compound S39 was prepared from mono-Boc-protected 1,2-
propanediamine (3.30 g, 18.94 mmol) using benzyl-chloroformate (3.2 
mL, 22.72 mmol) and Et3N (5.1 mL, 36.93 mmol) by method Iand was 
obtained after dry-flash chromatography: SiO2, gradient: Hex/EtOAc = 9/1 → 1/1,as colorless 
oil (4.67 g, 80%). IR(ATR): 3356s, 2981m, 2932w, 2880w, 1688s, 1537s, 1453w, 1389w, 
1368w, 1318m, 1271m, 1230m, 1172m, 1065m, 998w, 915w, 865w, 779w, 730w, 695w, 
666w cm-1. 1H-NMR (500 MHz, CDCl3, δ): 7.40-7.28 (m, 5H, -Ph), 5.20-5.00 (m, 3H, -
CH2Ph, H-N), 4.95-4.70 (bs, H-N), 3.85-3.70 (m, 1H, CbzNHCH(CH3)-), 3.25-3.10 (m, 2H, -
CH2NHBoc), 1.42 (s, 9 H, -NHCOO-C(CH3)3), 1.15 (d, 3H, J = 6.7, CH3). 13C-NMR (125 
MHz, CDCl3, δ): 156.64; 156.20; 136.51; 128.48; 128.06; 79.54; 66.58; 48.14; 45.78; 28.31; 








Benzyl tert-butyl butane-1,3-diylbiscarbamate (S40). 
Compound S40 was prepared from mono-Boc-protected 1,3-
butanediamine (488 mg, 2.6 mmol) using benzyl-chloroformate (513 
μL, 5.70 mmol) and Et3N (1.08 mL, 7.8 mmol) by method Iand was obtained after dry-flash 
chromatography: SiO2, gradient: Hex/EtOAc = 9/1 → 1/1,as colorless oil (728 mg, 87%). 
IR(ATR): 3354m, 3040w, 2976m, 2938w, 1745m, 1688s, 1597m, 1533s, 1475m, 1388w, 
1368w, 1331w, 1257s, 1173m, 1113w, 1080w, 1006w, 947w, 875w, 814w, 783w, 756m, 
697w, 647w cm-1. 1H-NMR (500 MHz, CDCl3, δ): 7.40-7.30 (m, 5H, -Ph), 5.09 (s, 2H, -
CH2Ph), 4.66 (bs, H-N), 3.90-3.75 (m, 1H, CbzNHCH(CH3)-), 3.40-3.25 (m, 1H, -
CH2NHBoc 3.05-2.90 (m, 1H, -CH2NHBoc), 1.75-1.60 (m, 1H), 1.55-1.35 (m, 10 H, -
CH2CH2NHBoc,-NHCOO-C(CH3)3), 1.18 (d, 3H, J = 6.7, CH3). 13C-NMR (125 MHz, 
CDCl3, δ): 156.17; 156.01; 136.45; 128.52; 128.01; 79.04; 66.64; 44.61; 37.63; 37.15; 28.40; 
21.40. HRMS: m/z323.19590 corresponds to molecular formula C17H26N2O4H+ (error in ppm: 
- 1.95). 
Benzyl tert-butyl pentane-1,4-diylbiscarbamate (S41). 
Compound S41 was prepared from mono-Boc-protected 1,4-
pentanediamine (2.02 g, 10 mmol) using benzyl-chloroformate 
(3.12 mL, 22 mmol) and Et3N (4.16 mL, 30 mmol) by method I 
and was obtained by dry-flash chromatography: SiO2, gradient: Hex/EtOAc = 9/1 → 1/1,as 
colorless oil (2.3 g, 68%). IR(ATR): 3320s, 2975m, 2942m, 2868w, 1684s, 1541s, 1454m, 
1368w, 1341w, 1277s, 1257s, 1170m, 1108w, 1085w, 993w, 859w, 754w, 730w, 695w cm-1. 
1H-NMR (500 MHz, CDCl3, δ): 7.35-7.20 (m, 5H, -Ph), 5.01 (s, 1H, -CH2Ph), 4.51 (bs, H-N), 
3.70-3.55 (m, 1H, CbzNHCH(CH3)-), 3.10-2.90 (m, 2H, -CH2NHBoc), 1.50-1.30 (m, 13H, 
CbzNHCH(CH3)CH2-, CbzNHCH(CH3)CH2CH2-, -NHCOO-C(CH3)3), 1.07 (d, 3H, J = 6.4, 
CH3). 13C-NMR (125 MHz, CDCl3, δ): 155.98; 155.72; 136.59; 128.50; 128.07; 126.96; 
66.52; 46.92; 40.37; 34.32; 28.39; 26.68; 21.24. HRMS: m/z337.21241 corresponds to 
molecular formula C18H28N2O4H+ (error in ppm: + 0.68). 
Benzyl (2-amino-1-methylethyl)carbamate (S42). 
Compound S42 was prepared from S36 (1.80 g, 5.82 mmol) using 
methodCand was obtained after dry-flash chromatography: SiO2, gradient: 
CH2Cl2/MeOH(NH3sat.) = 95/5 → 8/2,as colorless oil (1.10 g, 91%). 
IR(ATR): 3312m, 3033w, 2968m, 1703s, 1534s, 1454m, 1377w, 1337w, 1253s, 1095m, 
1049m, 914w, 747m, 699m cm-1. 1H-NMR (500 MHz, CDCl3, δ): 7.45-7.25 (m, 5H, -Ph), 
5.20-5.05 (m, 2H, -CH2Ph), 4.97 (bs, H-N), 3.80-3.65 (m, 1H, CbzNHCH(CH3)-), 2.80-2.70 







13C-NMR (125 MHz, CDCl3, δ): 156.12; 136.56; 128.48; 128.04; 66.54; 49.13; 47.26; 18.40. 
HRMS: m/z209.12811 corresponds to molecular formula C11H16N2O2H+ (error in ppm: - 
1.63). 
Benzyl (3-amino-1-methylpropyl)carbamate (S43). 
Compound S43 was prepared from S40 (6.6 g, 20.6 mmol) using method 
C and was obtained after dry-flash chromatography: SiO2, gradient: 
CH2Cl2/MeOH(NH3sat.) = 95/5 → 8/2, as colorless oil (4.40 g, 
96%)softens at 88-90 °C.IR (ATR): 3329m, 3034w, 2967m, 2936m, 1537s, 1454m, 1338w, 
1260s, 1098m, 1056m, 910w, 744w, 698w cm-1. 1H-NMR (500 MHz, CDCl3, δ): 7.40-7.25 
(m, 5H, -Ph), 5.15-5.05 (m, 3H, -CH2Ph, -NH), 3.95-3.80 (m, 1H, CbzNHCH(CH3)-), 2.85-
2.70 (m, 2H, -CH2NH2), 1.65-1.55 (m, 1H, -CH2CH2NH2), 1.55-1.45 (m, 1H, -CH2CH2NH2), 
1.26 (s, 2H-N), 1.17 (d, 3H, J = 6.6, CH3). 13C-NMR (125 MHz, CDCl3, δ): 155.95; 136.65; 
128.46; 128.01; 66.44; 45.14; 40.39; 38.70; 21.33. HRMS: m/z223.14348 corresponds to 
molecular formula C12H18N2O2H+ (error in ppm: - 2.82). 
Benzyl (4-amino-1-methylbutyl)carbamate  (S44). 
Compound S44 was prepared from S41 (2.20 g, 6.5 mmol) using 
method C and was obtained after dry-flash chromatography: SiO2, 
gradient: CH2Cl2/MeOH(NH3sat.) = 95/5 → 8/2,as colorless oil (1.21 
g, 78%). IR (ATR): 3335s, 3058w, 3035w, 2986w, 2934m, 2164w, 1690s, 1566m, 1537s, 
1463m, 1426w, 1386w, 1326m, 1261s, 1120w, 1076m, 1024w, 970w, 912w, 876w, 844w, 
822w, 781w, 751w, 732w, 698w, 643w cm-1. 1H-NMR (500 MHz, CDCl3, δ): 7.45-7.20 (m, 
5H, -Ph), 5.08 (s, 1H, -CH2Ph), 4.72 (bs, H-N), 3.80-3.65 (m, 1H, CbzNHCH(CH3)-), 2.80-
2.60 (m, 2H, -CH2NH2), 1.60-1.35 (m, 6H, CbzNHCH(CH3)CH2-, CbzNHCH(CH3)CH2CH2-, 
2H-N), 1.15 (d, 3H, J = 6.7, CH3). 13C-NMR (125 MHz, CDCl3, δ): 155.78; 136.65; 128.49; 
128.05; 66.47; 46.97; 41.92; 34.42; 29.88; 21.18. HRMS: m/z237.15860 corresponds to 
molecular formula C13H20N2O2H+ (error in ppm: - 4.87). 
Benzyl {2-[(1-adamantylmethyl)amino]-1-methylethyl}carbamate  (S45). 
CompoundS45 was prepared from mono-N-Cbz-protected 1,2-
propanediamine diamine S42 (2.80 g, 13.4 mmol) and adamantane-
1-carboxaldehyde (2.00 g, 12.18 mmol) using Ti(OiPr)4 (5.4 mL, 
18.12 mmol) and NaBH4 (685 mg, 18.12 mmol) using method G and was obtained after dry-
flash chromatography: SiO2, gradient: CH2Cl2/MeOH(NH3sat.) = 9/1 → 7/3,as colorless oil 
(4.1 g, 95%). IR (ATR): 3332m, 3089w, 3063w, 3033w, 2965w, 2901s, 2845s, 2676w, 1703s, 
1532m, 1501m, 1452m, 1403w, 1372w, 1341w, 1311w, 1241m, 1156w, 1069m, 1026w, 
774w, 737w, 698w, 646w, 604w cm-1. 1H-NMR (500 MHz, CDCl3, δ): 7.40-7.25 (m, 5H, -








CH2NHCH2Ad), 2.30-2.15 (m, 2H, -CH2Ad), 1.95 (s, 3H, -Ad), 1.75-1.55 (m, 6H, -Ad), 1.54-
1.40 (m, 6H, -Ad), 1.15 (d, 3H, J = 6.6, CH3). 13C-NMR (125 MHz, CDCl3, δ): 156.15; 
136.76; 128.48; 128.00; 66.43; 62.68; 55.63; 46.52; 40.80; 37.22; 35.56; 28.45; 19.13. 
HRMS: m/z357.25278 corresponds to molecular formula C22H32N2O2H+ (error in ppm: - 
2.44). 
Benzyl {3-[(1-adamantylmethyl)amino]-1-methylpropyl}carbamate (S46). 
Compound S46 was prepared by method G from mono-N-Cbz-
protected 1,3-butanediamine S43 (1.54 g, 6.9 mmol) and 
adamantane-1-carboxaldehyde (948 mg, 5.8 mmol) using 
Ti(OiPr)4 (2.6 mL, 8.66 mmol) and NaBH4 (327 mg, 8.66 mmol) and was obtained after dry-
flash chromatography: SiO2, gradient: CH2Cl2/MeOH(NH3sat.) = 9/1 → 7/3,as colorless oil 
(1.51 g, 73%). IR (ATR): 3319w, 3063w, 3032w, 2901s, 2845s, 2677w, 1707s, 1528m, 
1451m, 1375w, 1343w, 1254m, 1154w, 1088m, 1030w, 979w, 775w, 736w, 697w cm-1. 1H-
NMR (500 MHz, CDCl3): 7.40-7.25 (m, 5H, -Ph), 6.44 (bs, 1H, -NH), 5.15-5.00 (m, 2H, -
CH2Ph), 3.90-3.75 (m, 1H, CbzNHCH(CH3)-), 2.80-2.70 (m, 1H, -CH2NHCH2Ad), 2.70-2.60 
(m, 1H, -CH2NHCH2Ad), 2.23 (ABq, HA, J = 11.3, -CH2Ad), 2.20 (ABq, HB, J = 11.3, -
CH2Ad), 1.92 (s, 3H, -Ad), 1.80-1.55 (m, 7H, -CH2CH2NHCH2Ad,-Ad), 1.55-1.40 (m, 7H, -
CH2CH2NHCH2Ad, -Ad), 1.19 (d, 3H, J = 6.4, CH3). 13C-NMR (125 MHz, CDCl3, δ): 
156.05; 136.89; 128.37; 127.81; 66.20; 62.90; 47.23; 46.56; 40.87; 37.16; 35.36; 33.25; 
28.41; 20.82. HRMS: m/z371.26950 corresponds to molecular formula C23H34N2O2H+ (error 
in ppm: + 0.52). 
Benzyl {4-[(1-adamantylmethyl)amino]-1-methylbutyl}carbamate  (S47). 
Compound S47 was prepared by method G from mono-N-Cbz-
protected 1,4-pentanediamine S44 (1.28 g, 5.42 mmol) and 
adamantane-1-carboxaldehyde (780 mg, 4.75 mmol) using 
Ti(OiPr)4 (2.1 mL, 7.12 mmol) and NaBH4 (269 mg, 7.12 mmol) and was obtained after dry-
flash chromatography: SiO2, gradient: CH2Cl2/MeOH(NH3sat.) = 9/1 → 7/3) as colorless oil 
(1.26 g, 69%). IR(ATR): 3320w, 3033w, 2902s, 2846s, 1703s, 1533m, 1452m, 1342w, 
1252m, 1090m, 911w, 733m, 697w cm-1. 1H-NMR (500 MHz, CDCl3, δ): 7.40-7.20 (m, 5H, -
Ph), 5.08 (s, 1H, -CH2Ph), 3.80-3.60 (m, 1H, CbzNHCH(CH3)-), 2.65-2.50 (m, 2H, -
CH2NHCH2Ad), 2.21 (s, 2H, -CH2Ad), 1.94 (s, 3H, -Ad), 1.78-1.58 (m, 6H, -Ad), 1.58-1.40 
(m, 10H, CbzNHCH(CH3)CH2-, CbzNHCH(CH3)CH2CH2-, -Ad), 1.14 (d, 3H, J = 6.4, CH3). 
13C-NMR (125 MHz, CDCl3, δ): 155.84; 136.72; 128.44; 128.06; 127.96; 66.38; 62.87; 
50.58; 47.02; 40.89; 37.18; 34.54; 33.28; 28.43; 26.09; 21.12. HRMS: m/z385.28474 







Benzyl (2-{[2-(1-adamantyl)ethyl]amino}-1-methylethyl)carbamate (S48). 
Compound S48 was prepared by method G from mono-N-Cbz-
protected 1,2-propanediamine S42 (1.20 g, 5.76 mmol) and 1-
adamantylacetaldehyde (890 mg, 5.00 mmol) using Ti(OiPr)4 
(2.6 mL, 8.64 mmol) and NaBH4 (327 mg, 8.64 mmol) and was obtained after dry-flash 
chromatography: SiO2, gradient: CH2Cl2/MeOH(NH3sat.) = 9/1 → 7/3,as colorless oil (1.38 g, 
55%). IR (ATR): 3325m, 2903s, 2846s, 1716s, 1535m, 1453m, 1348w, 1254m, 1084w, 
736w, 692w cm-1. 1H-NMR (500 MHz, CDCl3, δ): 7.40-7.25 (m, 5H, -Ph), 5.22-5.05 (m, 3H, 
H-N, -CH2Ph), 3.90-3.75 (m, 1H, CbzNHCH(CH3)-), 2.70-2.64 (m, 2H, -
CH2NHCH2CH2Ad), 2.64-2.50 (m, 2H, -CH2CH2Ad), 1.93 (s, 3H, -Ad), 1.75-1.55 (m, 6H, -
Ad), 1.53-1.42 (m, 6H, -Ad), 1.30-1.20 (m, 2H, -CH2Ad), 1.16 (d, 3H, J = 6.4, CH3). 13C-
NMR (125 MHz, CDCl3, δ): 156.08; 136.62; 128.46; 127.99; 66.49; 54.80; 46.55; 44.39; 
44.20; 42.58; 37.09; 31.81; 28.62; 19.08. HRMS: m/z371.26930 corresponds to molecular 
formula C23H34N2O2H+ (error in ppm: - 0.91). 
Benzyl (3-{[2-(1-adamantyl)ethyl]amino}-1-methylpropyl)carbamate  (S49). 
Compound S49 was prepared by method G from mono-N-
Cbz-protected 1,3-butanediamine S43 (1.47 g, 6.63 mmol) 
and 1-adamantylacetaldehyde (1.07 mg, 6.05 mmol) using 
Ti(OiPr)4 (2.7 mL, 9.03 mmol) and NaBH4 (343 mg, 9.03 mmol) and was obtained after dry-
flash chromatography: SiO2, gradient: CH2Cl2/MeOH(NH3sat.) = 9/1 → 7/3,as colorless oil 
(1.71 g, 74%). IR (ATR): 3181w, 2964w, 2902s, 2846s, 1712s, 1559m, 1449m, 1370w, 
1260m, 1095m, 1055w, 1024w, 839w, 768w, 737w, 695w cm-1. 1H-NMR (500 MHz, CDCl3, 
δ): 7.45-7.25 (m, 5H, -Ph), 5.46 (bs, H-N) 5.15-5.05 (m, 2H, -CH2Ph), 3.90-3.75 (m, 1H, 
CbzNHCH(CH3)-), 2.76-2.67 (m, 1H, -CH2NHCH2CH2Ad), 2.67-2.60 (m, 1H, -
CH2NHCH2CH2Ad), 2.60-2.50 (m, 2H, -CH2CH2Ad), 1.93 (s, 3H, -Ad), 1.75-1.57 (m, 6H, -
Ad), 1.58-1.30 (m, 8H, CbzNHCH(CH3)CH2-, -Ad), 1.30-1.20 (m, 2H, -CH2Ad), 1.18 (d, 3H, 
J = 6.6, CH3). 13C-NMR (125 MHz, CDCl3, δ): 155.94; 136.77; 128.43; 127.93; 66.32; 46.61; 
45.96; 44.65; 44.28; 42.59; 37.11; 36.67; 31.80; 28.64; 21.20. HRMS: m/z385.28474 
corresponds to molecular formula C24H36N2O2H+ (error in ppm: - 0.56). 
Benzyl (4-{[2-(1-adamantyl)ethyl]amino}-1-methylbutyl)carbamate  (S50). 
Compound S50 was prepared by method Gfrom mono-N-
Cbz-protected1,4-pentanediamine S44 (1.58 g, 6.68 
mmol) and 1-adamantylacetaldehyde (993 mg, 5.57 
mmol) using Ti(OiPr)4 (2.5 mL, 8.35 mmol) and NaBH4 (316 mg, 8.35 mmol) and was 
obtained after dry-flash chromatography: SiO2, gradient: CH2Cl2/MeOH(NH3sat.) = 9/1 → 








1449s, 1376w, 1344w, 1249s, 1182s, 1087m, 1063m, 1028w, 813w, 774w, 735m, 696s, 
679w, 621w, 596w, 541w, 532w, 525w cm-1. 1H-NMR (500 MHz, CDCl3, δ): 7.45-7.20 (m, 
5H, -Ph), 5.20-5.05 (s, 1H, -CH2Ph), 5.05-4.95 (bs, 1H, -NH), 3.80-3.65 (m, 1H, 
CbzNHCH(CH3)-), 2.65-2.50 (m, 4H, -CH2NHCH2CH2Ad, -CH2CH2Ad), 2.00-1.85 (m, 3H, -
Ad), 1.75-1.65 (m, 6H, -Ad), 1.55-1.40 (m, 10H, CbzNHCH(CH3)CH2-, 
CbzNHCH(CH3)CH2CH2-, -Ad), 1.35-1.20 (m, 2H, -CH2Ad), 1.14 (d, 3H, J = 6.7, CH3). 13C-
NMR (125 MHz, CDCl3, δ): 136.69; 128.46; 127.99; 66.40; 49.78; 46.92; 44.44; 44.22; 
42.59; 37.12; 34.77; 31.81; 28.64; 26.19; 21.09. HRMS: m/z399.29961 corresponds to 
molecular formula C25H38N2O2H+ (error in ppm: - 2.49). 
N1-(1-Adamantylmethyl)propane-1,2-diamine  (S51). 
Compound S51 was prepared by method Jfrom S45 (1.50 g, 4.2 
mmol) using Pd/C 10% (150 mg) and was obtained by dry-flash 
chromatography: SiO2, gradient: EtOAc/[MeOH/(NH3 aq) = 9/1] = 
9/1 → 8/2,as colorless oil (823 mg, 88%). IR (ATR): 3346w, 2901s, 2845s, 2676w, 1583w, 
1451m, 1368w, 1345w, 1312w, 1153w, 1100w, 1052w, 883w, 829w, 768w cm-1. 1H-NMR 
(500 MHz, CDCl3, δ): 3.05-2.90 (m, 1H, NH2CH(CH3)-), 2.65-2.50 (m, 1H, -CH2NHCH2Ad), 
2.40-2.15 (m, 3H, -CH2NHCH2Ad, -CH2Ad), 1.96 (s, 3H, -Ad), 1.75-1.60 (m, 8H, 2H-N, -
Ad), 1.55-1.45 (m, 6H, -Ad), 1.05 (d, 3H, J = 6.2, CH3). 13C-NMR (125 MHz, CDCl3, δ): 
62.79; 59.06; 46.25; 40.86; 37.22; 33.49; 28.44; 21.71. HRMS: m/z223.21688 corresponds to 
molecular formula C14H26N2H+ (error in ppm: - 4.11). 
N1-(1-Adamantylmethyl)butane-1,3-diamine  (S52). 
Compound S52 was prepared by method Jfrom S46 (1.40 g, 3.9 
mmol) using Pd/C10% (140 mg) and was obtained by dry-flash 
chromatography: SiO2, gradient: EtOAc/[MeOH/(NH3 aq) = 9/1] 
= 9/1 → 8/2,as colorless powder softness at 108-110 oC. Yield: 724 mg (78%). IR (ATR): 
3284w, 2902s, 2845s, 2659w, 2574w, 1663w, 1633w, 1520m, 1470m, 1452w, 1425w, 
1405m, 1366w, 1344w, 1311m, 1268w, 1152w, 1101w, 1033w, 948w, 878w, 810w, 764w, 
641w, 593w cm-1. 1H-NMR (500 MHz, CDCl3, δ): 3.05-2.95 (m, 1H, NH2CH(CH3)-), 2.75-
2.60 (m, 2H, -CH2NHCH2Ad), 2.25 (ABq, HA, J = 11.4, -CH2Ad), 2.23 (ABq, HB, J = 11.4, -
CH2Ad), 1.96 (s, 3H, -Ad), 1.75-1.60 (m, 6H, -Ad), 1.60-1.40 (m, 10H, NH2CH(CH3)CH2-, -
NH2, -Ad), 1.08 (d, 3H, J = 6.4, CH3). 13C-NMR (125 MHz, CDCl3, δ): 63.17; 48.77; 46.07; 
40.95; 39.70; 37.23; 33.32; 28.47; 24.48. HRMS: m/z237.23236 corresponds to molecular 










Compound S53 was prepared by method J from S47 (650 mg, 
1.69 mmol) using 10%Pd/C (65 mg) and was obtained by dry-
flash chromatography: SiO2, gradient: CH2Cl2/MeOH(NH3sat.) = 
95/5 → 8/2,as colorless oil (389 mg, 92%). IR(ATR): 2902s, 2846s, 1582w, 1452m, 1367w, 
1315w, 1154w, 1118w, 810w, 753m cm-1. 1H-NMR (500 MHz, CDCl3, δ): 2.95-2.80 (m, 1H, 
NH2CH(CH3)-), 2.65-2.50 (m, 2H, -CH2NHCH2Ad), 2.24 (s, 2H, -NHCH2Ad), 1.96 (s, 3H, -
Ad), 1.75-1.60 (m, 6H, -Ad), 1.60-1.40 (m, 8H, NH2CH(CH3)CH2CH2-, -Ad), 1.40-1.25 (m, 
2H, NH2CH(CH3)CH2-), 1.07 (d, 3H, J = 6.4, CH3). 13C-NMR (125 MHz, CDCl3, δ): 62.95; 
51.11; 46.92; 40.95; 37.86; 37.21; 33.31; 28.46; 26.82; 24.00. HRMS: 
m/z251.24854corresponds to molecular formula C16H30N2H+ (error in ppm: + 1.45). 
N1-[2-(1-Adamantyl)ethyl]propane-1,2-diamine (S54). 
Compound S54 was prepared by method J from S48 (1.15 g, 3.1 
mmol) using 10%Pd/C (115 mg) and was obtained by dry-flash 
chromatography: SiO2, gradient: CH2Cl2/MeOH(NH3sat.) = 95/5 
→ 8/2,as colorless oil (594 mg, 81%). IR (ATR): 3286w, 2902s, 2845s, 1575w, 1450m, 
1374w, 1318w, 1105w, 814w cm-1. 1H-NMR (500 MHz, CDCl3, δ): 3.00-2.90 (m, 1H, 
NH2CH(CH3)-), 2.70-2.50 (m, 3H, -CH2NHCH2CH2Ad, -CH2CH2Ad), 2.45-2.30 (m, 1H, -
CH2NHCH2CH2Ad), 1.93 (s, 3H, -Ad), 1.80-1.60 (m, 6H, -Ad), 1.60-1.40 (m, 8H, 2H-N, -
Ad), 1.35-1.20 (m, 2H, -CH2Ad), 1.06 (d, 3H, J = 6.3, CH3). 13C-NMR (125 MHz, CDCl3, δ): 
58.56; 46.56; 44.68; 44.38; 42.64; 37.14; 31.84; 28.66; 22.12. HRMS: m/z237.23155 
corresponds to molecular formula C15H28N2H+ (error in ppm: - 4.09). 
N1-[2-(1-Adamantyl)ethyl]butane-1,3-diamine (S55). 
Compound S55 was prepared by method J from S49 (1.30 g, 
3.4 mmol) using 10%Pd/C (130 mg) and was obtained by dry-
flash chromatography: SiO2, gradient: CH2Cl2/MeOH(NH3sat.) 
= 95/5 → 8/2,as colorless oil (728 mg, 86%); m.p. = 55-57 oC. IR(ATR): 3334m, 3307m, 
3275m, 3190m, 2966w, 2902s, 2845s, 2657w, 1609w, 1449m, 1385w, 1343w, 1316w, 
1155w, 1119m, 1021w, 985w, 945w, 878w, 812w, 775w, 687w, 477w, 440w cm-1. 1H-NMR 
(500 MHz, CDCl3, δ): 3.05-2.90 (m, 1H, NH2CH(CH3)-), 2.70-2.64 (m, 2H, 
NH2CH(CH3)CH2CH2-), 2.63-2.55 (m, 2H, -NHCH2CH2Ad), 1.93 (m, 3H, -Ad), 1.75-1.60 
(m, 6H, -Ad), 1.60-1.40 (m, 8H, NH2CH(CH3)CH2-, -Ad), 1.40-1.30 (m, 2H-N), 1.30-1.20 
(m, 2H, -CH2Ad), 1.08 (d, 3H, J = 6.2, CH3). 13C-NMR (125 MHz, CDCl3, δ): 47.73; 45.71; 
44.76; 44.47; 42.63; 40.21; 37.14; 31.83; 28.65; 24.50. HRMS: m/z251.24756 corresponds to 









Compound S56 was prepared by method J from S50 (1.2 g, 
3.0 mmol) using 10%Pd/C (120 mg) and was obtained by 
dry-flash chromatography: SiO2, gradient: 
CH2Cl2/MeOH(NH3sat.) = 95/5 → 8/2,as colorless powder softness at 80-81 oC. Yield: 669 
mg (84%). IR(ATR): 3280w, 2902s, 2845s, 2675w, 1639w, 1572w, 1450m, 1374w, 1316w, 
1295w, 1118w, 815w, 744 cm-1. 1H-NMR (500 MHz, CDCl3, δ): 2.95-2.85 (m, 1H, 
NH2CH(CH3)-), 2.70-2.60 (m, 4H, -CH2NHCH2CH2Ad, -NHCH2CH2Ad), 1.93 (m, 3H, -Ad), 
1.75-1.60 (m, 6H, -Ad), 1.60-1.30 (m, 10H, NH2CH(CH3)CH2-, NH2CH(CH3)CH2CH2-, -
Ad), 1.30-1.20 (m, 2H, -CH2CH2Ad), 1.15 (d, 3H, J = 6.7, CH3). 13C-NMR (125 MHz, 
CDCl3, δ): 50.31; 46.88; 44.73; 44.30; 42.64; 37.94; 37.15; 31.84; 28.67; 27.10; 24.01. 
HRMS: m/z265.26374 corresponds to molecular formula C17H32N2H+ (error in ppm: - 0.33). 
N1-(1-Adamantylmethyl)-N2-quinolin-4-ylpropane-1,2-diamine  (12). 
4-Chloroquinoline (405 mg, 1.82 mmol) and amine linker S51 
(298 mg, 1.82 mmol) were mixed in NMP (1.5 mL) in MW 
cuvette under Ar. The reaction mixture was subjected to MW 
irradiation using a Biotage Initiator 2.5 apparatus, 1h, 180 oC. 
Compound 12 was obtained after multiple chromatography: 
dry-flashSiO2, eluent: EtOAc/MeOH/(NH3 aq) 90/9/1 = 95/5, and flash chromatography 
(Biotage SP1-NH column, eluent: Hex/EtOAc = 6/4; RP column, eluent: MeOH/H2O = 
8/2),as colorless foam. Yield: 458 mg, (72%). IR(ATR): 3318m, 3069m, 2965m, 2901s, 
2845s, 2676s, 1676m, 1617m, 1579s, 1532s, 1451s, 1394s, 1371s, 1340m, 1248w, 1223w, 
1185m, 1152m, 1126w, 1048w, 885m, 810m, 762m, 737w, 702w, 651w cm-1. 1H-NMR (500 
MHz, CDCl3, δ): 8.53 (d, J = 5.3, H-C(2)), 7.97 (d, J = 8.3, H-C(8)), 7.79 (m, J = 8.2, H-
C(5)), 7.70-7.55 (m, H-C(7)), 7.47-7.37 (m, H-C(6)), 6.45 (d, J = 5.5, H-C(3)), 6.01 (bs, H-
N), 3.80-3.67 (m, 1H, ArNHCH(CH3)-), 2.85 (d, 2H, J = 5.5, -CH2NHCH2Ad), 2.40-2.33 (m, 
2H, -CH2Ad), 2.05-1.90 (m, 3H, -Ad), 1.85-1.55 (m, 12H, -Ad), 1.30 (d, 3H, J = 6.4, CH3). 
13C-NMR (125 MHz, CDCl3, δ): 150.79; 149.47; 148.36; 129.67; 128.96; 124.45; 119.64; 
119.21 99.16; 62.69; 55.34; 47.30; 40.85; 37.17; 33.65; 28.39; 18.17. HRMS: m/z350.25887 
corresponds to molecular formula C23H31N3H+ (error in ppm: - 0.59).Anal. (C23H31N3  H2O) 
Calcd: C, 75.16; H, 9.05; N, 11.43. Found: C, 75.64; H, 8.98; N, 11.23. HPLCpurity (λ = 330 
nm) method A: RT 0.977 min, area 95.50%; method B: RT 9.286 min, area 95.16%. 
N1-(1-Adamantylmethyl)-N3-quinolin-4-ylbutane-1,3-diamine (24). 
Compound 24 was prepared by method Hfrom amine linker S52 (120 











Pd(OAc)2 (3.79 mg 0.017 mmol), SPhos (13.88 mg, 0.036 mmol) and K3PO4 (224mg, 1.08 
mmol) and was obtained after dry-flash chromatography:SiO2, gradient:EtOAc/[MeOH/(NH3 
aq) = 9/1] = 9/1 → 7/3,as alight yellow foam softens at 160-161 oC. Yield: 114 mg (73%). IR 
(ATR): 3270m, 3070m, 2965m, 2902s, 2846s, 1618s, 1580w, 1539s, 1451s, 1396m, 1395m, 
1373w, 1340m, 1264m, 1151m, 1126m, 1103w, 809m, 763 m, 738m, 703w cm-1. 1H-NMR 
(500 MHz, CDCl3, δ): 8.51 (d, J = 5.3, H-C(2)), 7.95 (dd, J1 = 0.8, J2 = 8.4, H-C(8)), 7.88 (dd, 
J1 = 0.8, J2 = 8.4, H-C(5)), 7.65-7.55 (m, H-C(7)), 7.40-7.30 (m, H-C(6)), 6.87 (bs, H-N), 
6.42 (d, J = 5.6, H-C(3)), 3.95-3.80 (m, 1H, ArNHCH(CH3)-), 2.95-2.85 (m, 1H, -
CH2NHCH2Ad), 2.80-2.70 (m, 1H, -CH2NHCH2Ad), 2.29 (s, 2H, -NHCH2Ad), 2.05-1.95 (m, 
3H, -Ad), 1.95-1.85 (m, 1H, ArNHCH(CH3)CH2-), 1.84-1.60 (m, 8H, ArNHCH(CH3)CH2-, -
Ad, H-N-), 1.58 (m, 6H, -Ad), 1.32 (d, 3H, J = 6.3, CH3). 13C-NMR (125 MHz, CDCl3, δ): 
150.88; 149.60; 148.43; 129.56; 128.87; 124.00; 120.55; 119.14; 98.58; 63.65; 48.12; 47.83; 
41.10; 37.17; 35.46; 33.44; 28.44; 19.15. HRMS: m/z364.27556 corresponds to molecular 
formula C24H33N3H+ (error in ppm: + 2.30).Anal. (C24H33N3  1/2H2O) Calcd: C, 77.37; H, 
9.20; N, 11.28. Found: C, 77.37; H, 9.03; N, 11.18. HPLC purity (λ = 330 nm) method A: RT 
0.953 min, area 99.05%; method B: RT 9.386 min, area 97.27%. 
N1-(1-Adamantylmethyl)-N3-(3-fluoroquinolin-4-yl)butane-1,3-diamine (26). 
Compound 26 was prepared by method Hfrom amine linker 
S52 (880 mg, 3.72 mmol) and 3-fluoro-4-iodoquinoline 19 
(1.00 g, 3.72 mmol) using Pd(OAc)2 (33.4 mg, 0.15 mmol), 
DPEphos (160 mg, 0.30 mmol) and K3PO4 (1.97 g, 9.14 
mmol) and was obtained after multiple chromatography: dry-
flash SiO2, gradient:CH2Cl2/MeOH(NH3sat.) = 95/5 → 7/3 and flash chromatography 
(Biotage SP1 NH column, eluent: Hex/EtOAc = 7/3 and RP column, gradient: MeOH/H2O = 
8/2 → 9/1,as colorless oil (572 mg, 49%). IR (ATR):3265m, 2902s, 2845m, 1601s, 1574s, 
1540s, 1496w, 1451m, 1398m, 1366w, 1345w, 1270w, 1202w, 1148w, 759m cm-1. 1H-NMR 
(500 MHz, CDCl3, δ): 8.51 (d, J = 5.7, H-C(2)), 8.00-7.88 (m, H-C(8) and H-C(5)), 7.60-7.54 
(m, H-C(7)), 7.41-7.35 (m, H-C(6)), , 6.31 (s, H-N), 4.37-4.27 (m, 1H, ArNHCH(CH3)-), 
2.95-2.85 (m, 1H, -CH2NHCH2Ad), 2.85-2.75 (m, 1H, -CH2NHCH2Ad), 2.30 (s, 2H, -
CH2Ad), 2.01-1.96 (m, 3H, -Ad), 1.80-1.60 (m, 9H, ArNHCH(CH3)CH2-, -Ad, H-N-), 1.60-
1.50 (m, 6H, -Ad), 1.30 (dd, J1 = 0.9, J2 = 6.42, -CH3). 13C-NMR (125 MHz, CDCl3, δ): 
146.01 (C(8a)); 143.22 (d, J = 238.3, C(3)); 141.60 (d, J = 27.1, C(2)); 135.80 (d, J = 5.4, 
C(4)); 129.85 (C(8)); 127.90 (C(7)); 124.83 (C(6)); 124.68 (C(4a)); 121.27 (d, J = 5.4, C(5)); 
63.70; 50.44 (d, J = 8.1, CH); 41.06; 37.15; 36.21; 33.33; 28.42; 21.71 (d, J = 2.7, CH3). 






0.83).HPLCpurity (λ = 330 nm) method A: RT 7.545 min, area 99.28%; method B: RT 8.251 
min, area 99.45%.  
N1-(1-Adamantylmethyl)-N2-(7-chloro-3-fluoroquinolin-4-yl)propane-1,2-diamine (20). 
Compound 20 was prepared from amine linker S51 (120 
mg, 0.51 mmol) and 7-chloro-3-fluoro-4-iodoquinoline 17 
(148 mg, 0.48 mmol) in MW (Biotage Initiator 2.5 
apparatus, PrOH, 4h, 180 oC) and was obtained after dry-
flash chromatography SiO2 eluent: CH2Cl2/MeOH(NH3sat.) 
= 95/5, and flash chromatography (Biotage SP1 NH column, eluent: Hex/EtOAc = 7/3 and RP 
column, eluent: MeOH/H2O = 85/15),as colorless viscous oil (13 mg, 6.7%). IR(ATR): 
3331m, 3070w, 2903s, 2846s, 2675w, 1736w, 1598s, 1572s, 1521m, 1477w, 1449m, 1417m, 
1380m, 1344m, 1315w, 1260m, 1192w, 1146w, 1078m, 1001w, 927m, 901w, 879w, 811m, 
761m, 738w, 539w cm-1. λmax(ε) = 334 (7180) nm. 1H-NMR (500 MHz, CDCl3, δ): 8.51 (d, J 
= 5.5, H-C(2)), 7.95 (d, J = 2.0, H-C(8)), 7.79 (d, J = 9.0, H-C(5)), 7.38 (dd, J1 = 2.0, J2= 9.0, 
H-C(6)), 5.83 (d, J = 6.5, H-N), 4.25-4.05 (m, 1H, ArNHCH(CH3)-), 2.90-2.75 (m, 1H, -
CH2NHCH2Ad), 2.39 (ABq, HA, J = 11.5, -CH2Ad), 2.26 (ABq, HB, J = 11.5, -CH2Ad), 1.99 
(s, 3H, -Ad), 1.80-1.60 (m, 6H, -Ad), 1.60-1.50 (m, 6H, -Ad), 1.28 (d, 3H, J = 6.5, CH3). 13C-
NMR (125 MHz, CDCl3, δ): 146.62 (C(8a)); 143.46 (d, J = 239.1, C(3)); 142.40 (d, J = 27.1, 
C(2)); 135.93 (d, J = 5.9, C(4)); 133.92 (d, J = 2.3, C(7)); 128.88 (C(8)); 125.88 (C(6)); 
121.95 (d, J = 5.4, C(5)); 119.71 (d, J = 5.4, C(4a)); 62.98; 55.68; 49.81 (d, ArNHCH(CH3)-, 
J = 7.7); 40.94; 37.21; 33.72; 28.43; 20.15 (d, ArNHCH(CH3)-, J = 3.6). HRMS: 
m/z402.21082 corresponds to molecular formula C23H29ClFN3H+ (error in ppm: + 0.35).Anal. 
(C23H29ClFN3) Calcd: C, 68.73; H, 7.27; N, 10.45. Found: C, 68.39; H, 7.23; N, 10.44. 
HPLCpurity (λ = 330 nm) method A: RT 8.000 min, area 97.70%; method B: RT 10.703 min, 
area 95.31%. 
N1-(1-Adamantylmethyl)-N3-(7-chloro-3-fluoroquinolin-4-yl)butane-1,3-diamine (25). 
Compound 25 was prepared by method H from amine 
linker S52 (135 mg, 0.57 mmol) and 7-chloro-3-fluoro-4-
iodoquinoline 17 (159.6 mg, 0.52 mmol) using Pd(OAc)2 
(5.2 mg, 0.023 mmol), SPhos (18.88 mg, 0.046 mmol) and 
K3PO4 (303 mg, 1.43 mmol) and was obtained after 
multiple chromatography: dry-flash SiO2, gradient: CH2Cl2/MeOH(NH3sat.) = 95/5 → 
8/2,and flash chromatography (Biotage SP1 NH column, eluent: Hex/EtOAc = 7/3 and RP 
column, eluent: MeOH/H2O = 8/2) as colorless viscous oil (101.7 mg, 47%). IR (ATR): 
3280m, 3070w, 2902s, 2846s, 2674w, 1596s, 1572s, 1540m, 1486w, 1450m, 1422m, 1380m, 











761w, 737m, 656w, 539w, 426w cm-1. λmax(ε) = 250 (15462), 337 (9685) nm. 1H-NMR (500 
MHz, CDCl3, δ): 8.48 (d, J = 5.8, H-C(2)), 7.92 (d, J = 1.6, H-C(8)), 7.86 (d, J = 9.0, H-C(5)), 
7.35-7.20 (m, H-C(6)), 6.63 (d, J = 4.6, H-N), 4.40-4.25 (m, 1H, ArNHCH(CH3)-), 3.00-2.85 
(m, 1H, -CH2NHCH2Ad), 2.85-2.70 (m, 1H, -CH2NHCH2Ad), 2.30 (s, 2H, -CH2Ad), 2.05-
1.90 (m, 4H, -Ad, ArNHCH(CH3)CH2-), 1.90-1.60 (m, 8H, ArNHCH(CH3)CH2-, -Ad, H-N-), 
1.60-1.50 (m, 6H, -Ad), 1.30 (d, 3H, J = 6.2, CH3). 13C-NMR (125 MHz, CDCl3, δ): 146.60 
(C(8a)); 143.19 (d, J = 239.1, C(3)); 142.46 (d, J = 27.5, C(2)); 136.12 (d, J = 5.4, C(4)); 
133.76 (d, J = 7.2, C(7)); 128.63 (C(8)); 125.37 (C(6)); 122.94 (d, J = 5.0, C(5)); 119.64 (d, J 
= 5.4, C(4a)); 50.58 (d, J = 8.6, ArNHCH(CH3)-); 47.52; 41.05; 37.08; 35.75; 33.30; 28.36; 
21.60. HRMS: m/z416.22602 corresponds to molecular formula C24H31ClFN3H+ (error in 
ppm: - 0.75).Anal. (C24H31ClFN3 × 2/3 H2O) Calcd: C, 67.35; H, 7.61; N, 9.82. Found: C, 
67.17; H, 7.47; N, 9.74. HPLCpurity (λ = 330 nm) method A: RT 8.589min, area 97.89%; 
method B: RT 11.009 min, area 97.73%. 
N1-(1-Adamantylmethyl)-N4-(7-chloro-3-fluoroquinolin-4-yl)pentane-1,4-diamine (32). 
Compound 32 was prepared by method H from 7-
chloro-3-fluoro-4-iodoquinoline 17 (105 mg, 0.34 
mmol) and amine linker S53 (94 mg, 0.38 mmol) 
using Pd(OAc)2 (3.0 mg, 0.014 mmol), DPEphos 
(14.65 mg, 0.027 mmol) and K3PO4 (180 mg, 0.85 
mmol) and was obtained after multiple chromatography: dry-flash SiO2, gradient: 
CH2Cl2/MeOH(NH3sat.) = 95/5 → 7/3, and flash chromatography (Biotage SP1 NH column, 
eluent: Hex/EtOAc = 7/3 and RP column, gradient: MeOH/H2O = 8/2 → 9/1),as colorless 
foam (74 mg, 49%). IR(ATR): 3301m, 2902s, 2846s, 1596m, 1573s, 1536w, 1450m, 1418m, 
1381m, 1351m, 1296w, 1264m, 1202w, 1147m, 928w, 878w, 814m, 761w, 738m, 657w, 
541w cm-1.λmax(ε) = 252 (18402), 335 (11598) nm. 1H-NMR (500 MHz, CDCl3, δ): 8.50 (d, J 
= 5.5, H-C(2)), 7.95 (d, J = 2.0, H-C(8)), 7.74 (d, J = 9.0, H-C(5)), 7.36 (dd, J1 = 1.5, J2 = 9.0, 
H-C(6)), 4.59 (d, J = 8.0, H-N), 4.20-4.05 (m, 1H, ArNHCH(CH3)-), 2.70-2.55 (m, 2H, -
CH2NHCH2Ad), 2.21 (s, 2H, -CH2Ad), 1.96 (s, 3H, -Ad), 1.80-1.55 (m, 10H, -Ad, 
ArNHCH(CH3)CH2-, ArNHCH(CH3) CH2CH2-), 1.55-1.45 (m, 6H, -Ad), 1.30 (d, 3H, J = 
6.5, CH3). 13C-NMR (125 MHz, CDCl3, δ): 146.51 (C(8a)); 143.23 (d, J = 242.8, C(3)); 
142.37 (d, J = 27.5, C(2)); 135.65 (d, J = 5.4, C(4)); 133.90 (d, J = 2.3, (C(7)); 128.88 (C(8)); 
125.87 (C(6)); 121.75 (d, J = 4.9, C(5)); 119.26 (d, J = 5.0, C(4a)); 62.72; 51.27 (d, J = 9.0, 
ArNHCH(CH3)-,); 50.35; 40.90; 37.13; 35.53; 33.27; 28.37; 26.19; 22.19. HRMS: 
m/z430.24165 corresponds to molecular formula C25H33ClFN3H+ (error in ppm: - 
0.76).HPLCpurity (λ = 330 nm) method A: RT 8.579 min, area 98.70%; method B: RT 9.680 








Amine linker S54 (260 mg, 1.10 mmol) and 4-chloroquinoline 
(180 mg, 1.10 mmol) and were mixed in NMP (1.5 mL) in 
MW cuvette under Ar. The reaction mixture was subjected to 
MW irradiation using a Biotage Initiator 2.5 apparatus, 1h, 
180 oC. Compound 35 was obtained after multiple 
chromatography: dry-flash SiO2, eluent: [EtOAc/MeOH/(NH3 aq) = 90/9/1] = 95/5 and flash 
chromatography (Biotage SP1-NH column, eluent: Hex/EtOAc = 6/4; RP column, eluent: 
MeOH/H2O = 8/2),as light yellow foam softens at 112-113 oC. Yield: 253 mg (63%). IR 
(ATR): 3251m, 3059m, 2962m, 2902s, 2844s, 1708w, 1618w, 1578s, 1543s, 1451s, 1396s, 
1374m, 1343m, 1280w, 1258w, 1159w, 1130w, 1108w, 909w, 807w, 763m, 733w cm-1. 1H-
NMR (500 MHz, CDCl3, δ): 8.53 (d, J = 5.3, H-C(2)), 7.97 (d, J = 8.0, H-C(8)), 7.81-7.76 (m, 
H-C(5)), 7.65-7.59 (m, H-C(7)), 7.46-7.37 (m, H-C(6)), 6.45 (d, J = 5.4, H-C(3)), 5.69 (bs, H-
N), 3.87-3.73 (m, 1H, ArNHCH(CH3)-), 2.91-2.81 (m, 2H, ArNHCH(CH3)CH2-), 2.70-2.61 
(m, 2H, -CH2CH2Ad), 1.92 (s, 3H, -Ad), 1.73-1.57 (m, 7H, -NH,-Ad), 1.55-1.44 (m, 6H, -
Ad), 1.35-1.24 (m, 5H, CH3, -CH2Ad). 13C-NMR (125 MHz. CDCl3, δ): 150.94; 149.21; 
148.52; 129.81; 128.93; 124.45; 119.59; 119.12; 99.13; 54.69; 47.52; 44.79; 44.53; 42.69; 
37.10; 31.91; 28.63; 18.30. HRMS: m/z364.27554 corresponds to molecular formula 
C24H33N3H+ (error in ppm: - 1.37).Anal. (C24H33N3  H2O) Calcd: C, 75.55; H, 9.25; N, 
11.01. Found: C, 75.91; H, 8.82; N, 11.08. HPLC purity (λ = 330 nm) method A: RT 0.998 
min,area 99.11%; method B: RT 9.586 min, area 95.01%. 
N1-[2-(1-Adamantyl)ethyl]-N3-quinolin-4-ylbutane-1,3-diamine (37). 
Compound 37 was prepared by method Hfrom amine linker 
S55 (150 mg, 0.60 mmol) and 4-chloroquinoline (82 mg, 
0.50 mmol) using Pd(OAc)2 (4.48 mg, 0.02 mmol), SPhos 
(16.38 mg, 0.04 mmol) and K3PO4 (265 mg, 1.25 mmol) and 
was obtained after dry-flash chromatography:SiO2, gradient: EtOAc/[MeOH/(NH3 aq) = 9/1] 
= 9/1 → 7/3,as colorless foam softens at 64-66 oC. Yield: 146 mg (77%). IR (ATR): 3250m, 
3069m, 2962m, 2902s, 2844s, 1654w, 1618w, 1543s, 1448m, 1397m, 1373m, 1340m, 1281w, 
1263m, 1182w, 1148m, 1051w, 1025w, 960w, 810m, 764m, 737m, 702w, 651w, 633w cm-1. 
1H-NMR (500 MHz, CDCl3, δ): 8.49 (d, J = 5.4, H-C(2)), 7.94 (d, J = 8.3, H-C(8)), 7.84 (d, J 
= 8.2, H-C(5)), 7.70-7.50 (m, H-Nand H-C(7)), 7.40-7.35 (m, H-C(6)), 6.37 (d, J = 5.5, H-
C(3)), 3.95-3.80 (m, 1H, ArNHCH(CH3)-), 3.15-2.90 (m, 1H, -CH2NHCH2CH2Ad), 2.85-2.75 
(m, 1H, -CH2NHCH2CH2Ad), 2.70-2.60 (m, 2H, -CH2CH2Ad), 2.00-1.85 (m, 4H, -Ad, - 
ArNHCH(CH3)CH2-), 1.80-1.55 (m, 7H, ArNHCH(CH3)CH2-, -Ad), 1.55-1.45 (m, 6H, -Ad), 









150.76; 149.81; 148.35; 129.39; 128.83; 123.99; 120.69; 119.27; 98.21; 48.19; 46.60; 44.79; 
44.45; 42.65; 37.07; 35.05; 31.83; 28.60; 19.21. HRMS: m/z378.29070 corresponds to 
molecular formula C25H35N3H+ (error in ppm: + 0.85).HPLC purity (λ = 330 nm) method A: 
RT 0.999 min, area 97.38%; method B: RT 2.506 min, area 99.48%. 
N1-[2-(1-Adamantyl)ethyl]-N4-quinolin-4-ylpentane-1,4-diamine (44). 
Compound44 was prepared by method H from amine linker 
S56 (242 mg, 0.73 mmol) and 4-chloroquinoline (100 mg, 
0.61 mmol) and using Pd(OAc)2 (5.47 mg, 0.024 mmol), 
SPhos (20 mg, 0.049 mmol) and K3PO4 (324mg, 1.53 mmol) 
and was obtained after dry-flash chromatography:SiO2, gradient: EtOAc/[MeOH/(NH3 aq) = 
9/1] = 9/1 → 7/3,as yellow foam softens at 64-65 oC. Yield: 203 mg (85%). IR (ATR): 
3651w, 3287m, 3067s, 2902s, 2845s, 1618w, 1580s, 1541s, 1450m, 1396m, 1342m, 1261w, 
1225w, 1139w, 808w, 766m, 736w, 652w cm-1. 1H-NMR (500 MHz, CDCl3, δ): 8.52 (d, J = 
5.4, H-C(2)), 7.96 (d, J = 8.5, H-C(8)), 7.78 (d, J = 8.4, H-C(5)), 7.65-7.55 (m, H-C(7)), 7.45-
7.35 (m, H-C(6)), 6.41 (d, J = 5.3, H-C(3)), 5.39 (d, J = 6.1, H-N), 3.80-3.65 (m, 1H, 
ArNHCH(CH3)-), 2.70-2.63 (m, 2H, -CH2NHCH2CH2Ad), 2.63-2.55 (m, 2H, -CH2CH2Ad), 
1.97-1.87 (m, 3H, -Ad), 1.85-1.55 (m, 10H, ArNHCH(CH3)CH2-, ArNHCH(CH3)CH2CH2-, -
Ad), 1.50-1.40 (m, 6H, -Ad), 1.35-1.20 (m, 5H, CH3, -CH2Ad). 13C-NMR (125 MHz, CDCl3, 
δ): 150.88; 148.99; 148.51; 129.78; 128.86; 124.30; 119.54; 118.84; 98.79; 49.67; 48.16; 
44.51; 44.29; 42.57; 37.06; 34.12; 31.78; 28.59; 26.40; 20.20. HRMS: m/z392.30696 
corresponds to molecular formula C26H37N3H+ (error in ppm: + 2.38).Anal.(C26H37N3  H2O) 
Calcd: C, 76.24; H, 9.60; N, 10.26; Found: C, 76.28; H, 9.30; N, 10.19. HPLC purity (λ = 330 
nm) method A: RT 1.000 min, area 98.19%; method B: RT 9.653 min, area 95.14%. 
N1-[2-(1-Adamantyl)ethyl]-N3-(3-fluoroquinolin-4-yl)butane-1,3-diamine (39). 
Compound 39 was prepared by method Efrom 
aminoquinoline S56 (245 mg, 1.05 mmol) and 1-
adamantylacetaldehyde(156 mg, 0.88 mmol) using AcOH 
(121 µL, 1.32 mmol) and NaBH4 (200 mg, 5.28 mmol) 
and was obtained after obtained after flash 
chromatography SiO2, gradient: Hex/EtOAc = 7/3 → 8/2,as colorless viscous oil (167 mg, 
48%). IR(ATR): 3302m, 2904s, 2845s, 1680w, 1600m, 1577m, 1540m, 1449w, 1398m, 
1364w, 1270w, 1200w, 1143w, 762w, 736w cm-1. 1H-NMR (500 MHz, CDCl3, δ): 8.50 (d, J 
= 5.5, H-C(2)), 8.05 (d, J = 8.2, H-C(8)), 7.95 (d, J = 8.2, H-C(5)), 7.63-7.56 (m, H-C(7)), 
7.48-7.42 (m, H-C(6)), 6.21 (bs, H-N), 4.25 (s, 1H, ArNHCH(CH3)-), 3.10-3.03 (m, 2H, 
ArNHCH(CH3)CH2-), 2.85-2.73 (m, 2H, -CH2CH2Ad), 2.11-2.02 (m, 1H, 









1.75-1.53 (m, 6H, -Ad), 1.53-1.38 (m, 8H, -CH2Ad, -Ad), 1.30 (d, 3H, J = 6.4, CH3). 13C-
NMR(125 MHz, CDCl3, δ): 145.93 (C(8a)); 142.76 (d, J = 238.3, C(3)); 141.47 (d, J = 27.1, 
C(2)); 135.88 (d, J = 5.4, C(4)); 129.67 (C(8)); 127.72 (C(7)); 124.55 (C(6)); 121.35 (d, J = 
5.4, C(4a)); 121.15 (d, J = 5.4, C(5)); 50.24 (d, J = 9.0, CH); 46.16; 44.69; 44.46; 42.55; 
36.98; 35.44; 31.72; 28.52; 21.31 (d, J = 3.6, CH3).HRMS: m/z396.28038 corresponds to 
molecular formula C25H34FN3H+ (error in ppm: -1.45).HPLCpurity (λ = 330 nm) method A: 
RT 8.269 min, area 98.81%; method B: RT 8.721 min, area 99.15%. 
N1-[2-(1-Adamantyl)ethyl]-N3-(7-chloro-3-fluoroquinolin-4-yl)butane-1,3-diamine (38). 
Compound 38 was prepared by method H from amine 
linker S55 (123 mg, 0.49 mmol) and 7-chloro-3-
fluoro-4-iodoquinoline 17(137 mg, 0.45 mmol) using 
Pd(OAc)2 (4.0 mg, 0.018 mmol), DPEphos (19.39 mg, 
0.036 mmol) and K3PO4 (239 mg, 1.13 mmol) and 
was obtained after multiple chromatography: dry-flash SiO2, gradient: 
CH2Cl2/MeOH(NH3sat.) = 95/5 → 8/2,and flash chromatography (Biotage SP1 NH column, 
eluent: Hex/EtOAc = 7/3 and RP column, eluent: MeOH/H2O = 8/2),as colorless viscous oil 
(46 mg, 24%). IR(ATR): 3283m, 2974w, 2906s, 2848s, 2779w, 2696w, 2448w, 1570s, 
1493w, 1451w, 1416w, 1380m, 1346m, 1265w, 1194w, 1131m, 1075w, 1014w, 937m, 817m, 
767m, 727m, 638w cm-1. λmax(ε) = 250 (13796), 331 (8004) nm. 1H-NMR (500 MHz, CDCl3, 
δ): 8.46 (d, J = 6.0, H-C(2)), 7.91 (d, J = 2.0, H-C(8)), 7.84 (d, J = 9.5, H-C(5)), 7.48 (bs, H-
N), 7.31 (dd, J1 = 1.5, J2 = 9.0, H-C(6)), 4.35 (bs, 1H, ArNHCH(CH3)-), 3.05-2.95 (m, 1H, -
CH2NHCH2CH2Ad), 2.95-2.85 (m, 1H, -CH2NHCH2CH2Ad), 2.75-2.60 (m, 2H, -
CH2CH2Ad), 2.05-1.90 (m, 4H, -Ad, ArNHCH(CH3)CH2-), 1.75-1.60 (m, 7H, -Ad, 
ArNHCH(CH3)CH2-), 1.55-1.45 (m, 6H, -Ad), 1.45-1.30 (m, 2H, -CH2Ad), 1.32 (d, 3H, J = 
7.0, CH3). 13C-NMR (125 MHz, CDCl3, δ): 146.10 (C(8a)); 143.22 (d, J = 204.5, C(3)); 
142.04 (d, J = 28.5, C(2)); 136.18 (d, J = 4.5, C(4)); 134.52 (d, J = 1.8, C(7)); 128.21 (C(8)); 
126.50 (C(6)); 122.92 (d, J = 5.0, C(5)); 119.70 (d, J = 5.0, C(4a)); 50.06 (d, J = 10.5, 
ArNHCH(CH3)-); 45.40; 43.08; 41.99; 39.72; 36.66; 33.32; 31.61; 28.25; 22.77. HRMS: 
m/z430.24104 corresponds to molecular formula C25H33ClFN3H+ (error in ppm: - 2.19). 
HPLCpurity (λ = 330 nm) method A: RT 5.879 min, area 96.49%; method B: RT 11.796 min, 
area 97.32%.  
N1-[2-(1-adamantyl)ethyl]-N4-(7-chloro-3-fluoroquinolin-4-yl)pentane-1,4-diamine (45). 
Compound 45 was prepared by method H from amine 
linker 56(73 mg, 0.24 mmol) and 7-chloro-3-fluoro-4-











(2.1 mg, 0.009 mmol), DPEphos (4.7 mg, 0.019 mmol) and K3PO4 (117 mg, 0.6 mmol) and 
was obtained after multiple chromatography: dry-flash SiO2, gradient: 
CH2Cl2/MeOH(NH3sat.) = 95/5 → 7/3,and flash chromatography (Biotage SP1 NH column, 
eluent: Hex/EtOAc = 7/3 and RP column, gradient: MeOH/H2O = 8/2 → 9/1) as yellow foam 
(39 mg, 41%).IR(ATR): 3294m, 3069w, 2903s, 2846j, 2676w, 1734w, 1595m, 1574s, 1539m, 
1487w, 1450m, 1419m, 1381m, 1350m, 1294w, 1265m, 1199w, 1142m, 1105m, 1078w, 
928w, 877w, 815m, 763w, 738w, 656w, 540w cm-1. λmax(ε) = 237 (10560), 251 (10259), 331 
(6457), 338(6502) nm. 1H-NMR (500 MHz, CDCl3, δ): 8.48 (d, J = 5.6, H-C(2)), 7.93 (d, J = 
2.0, H-C(8)), 7.76 (d, J = 9.0, H-C(5)), 7.36 (dd, J1 = 2.0, J2 = 9.0, H-C(6)), 4.86 (d, J = 7.8, 
H-N), 4.20-4.05 (m, 1H, ArNHCH(CH3)-), 2.70-2.60 (m, 2H, -CH2NHCH2CH2Ad), 2.70-2.60 
(m, 2H, -CH2CH2Ad), 1.91 (s, 3H, Ad), 1.75-1.55 (m, 10H, Ad, ArNHCH(CH3)CH2-, 
ArNHCH(CH3)CH2CH2-), 1.50-1.40 (m, 6H, Ad), 1.27 (d, 3H, J = 6.3, CH3), 1.30-1.20 (m, 
2H, -CH2Ad). 13C-NMR (125 MHz, CDCl3, δ): 146.56 (C(8a)); 143.24 (d, J = 240.0, C(3)); 
142.43 (d, J = 27.5, C(2)); 135.76 (d, J = 5.9, C(4)); 133.95 (C(7)); 128.87 (C(8)); 125.93 
(C(6)); 121.19 (d, J = 5.0, C(5)); 119.37 (d, J = 5.0, C(4a)); 51.25 (d, J = 8.6, ArNHCH(CH3)-
); 49.57; 44.30; 44.20; 42.56; 37.06; 35.64; 31.78; 28.59; 26.26; 22.27. HRMS: m/z444.25601 
corresponds to molecular formula C26H35ClFN3H+ (error in ppm: - 3.64). HPLCpurity (λ = 
254 nm) method A: RT 4.409 min, area 95.01%; method B: RT 9.856 min, area 95.13%. 
N2-(1-adamantylmethyl)-N1-(7-chloro-3-fluoroquinolin-4-yl)propane-1,2-diamine 
(21). 
Compound 21 was prepared from amine linker S20 (122 mg, 
0.55 mmol) and 7-chloro-3-fluoro-4-iodoquinoline 17(160 mg, 
0.52 mmol) in MW (Biotage Initiator 2.5 apparatus, PrOH, 4h, 
180 oC) and was obtained after multiple chromatography: dry-
flash SiO2, eluent: CH2Cl2/MeOH(NH3sat.) = 95/5, and flash chromatography (Biotage SP1 
RP column, eluent: MeOH/H2O = 9/1) as colorless viscous oil (127 mg, 61%). IR (ATR): 
3322s, 2964w, 2910s, 2845s, 2659w, 1614m, 1598m, 1570m, 1519m, 1476m, 1454m, 1419w, 
1377w, 1354w, 1310m, 1256m, 1211w, 1192w, 1159m, 1135w, 1097m, 1072w, 1054w, 
953w, 922w, 897w, 875w, 809m, 759m, 656w, 577w, 538m, 495w cm-1. λmax(ε) = 237 
(14605), 250 (15056), 336 (9232) nm. 1H-NMR (500 MHz, CDCl3, δ): 8.51 (d, J = 5.5, H-
C(2)), 7.93 (d, J = 2.0, H-C(8)), 7.76 (d, J = 9.0, H-C(5)), 7.34 (dd, J1= 2.0, J2= 9.0, H-C(6)), 
6.06 (s, H-N), 3.80-3.70 (m, 1H, ArNHCH2-), 3.35-3.25 (m, 1H, ArNHCH2-), 2.95-2.85 (m, 
1H, -CH(CH3)NHCH2Ad), 2.43 (ABq, HA, J = 11.4, -CH2Ad), 2.13 (ABq, HB, J = 11.4, -
CH2Ad), 1.99 (s, 3H, -Ad), 1.80-1.64 (m, 6H, -Ad), 1.64-1.45 (m, 6H, -Ad), 1.18 (d, 3H, J = 
6.4, CH3). 13C-NMR (125 MHz, CDCl3, δ): 146.49 (C(8a)); 143.51 (d, J = 239.1, C(3)); 







(C(6)); 121.91 (d, J = 5.4, C(5)); 119.19 (d, J = 5.0, C(4a)); 59.14; 53.12; 49.15 (d, J = 8.1, 
ArNHCH(CH3)-); 40.92; 37.16; 33.38; 29.64; 19.06. HRMS: m/z402.21027 corresponds to 
molecular formula C23H29ClFN3H+ (error in ppm: - 1.03).Anal. (C23H29ClFN3) Calcd: C, 
68.73; H, 7.27; N, 10.45. Found: C, 67.06; H, 6.98; N, 10.18. HPLC purity (λ = 254 nm) 
method A: RT 7.970 min, area 97.00%; method B: RT 9.932 min, area 99.14%. 
N1-(1-Adamantylmethyl)-N2-(7-chloro-3-fluoroquinolin-2-yl)propane-1,2-diamine (68). 
Compound 68 was prepared from amine linker S51 
(166 mg, 0.75 mmol) and 7-chloro-3-fluoro-2-
iodoquinoline 18 (153 mg, 0.50 mmol) in MW 
(Biotage Initiator 2.5 apparatus, PrOH, 4h, 180 oC) and was obtained after multiple 
chromatography: dry-flash SiO2, eluent: CH2Cl2/MeOH(NH3sat.) = 95/5, and flash 
chromatography (Biotage SP1 NH column, eluent: Hex/EtOAc = 7/3 and RP column, eluent: 
MeOH/H2O = 85/15),as colorless viscous oil (18.3 mg, 9.1%). IR(ATR): 3362m, 2902s, 
2846s, 2675w, 1717w, 1637m, 1608m, 1566w, 1528s, 1492w, 1453m, 1451m, 1368w, 
1344m, 1316w, 1260m, 1188m, 1148m, 1118m, 1073w, 976w, 929w, 880m, 801m, 760m, 
602w, 513w cm-1. λmax(ε) = 241 (32222), 331 (7158), 343 (6902) nm. 1H-NMR (500 MHz, 
CDCl3, δ): 7.71 (d, J = 1.8, H-C(8)), 7.43 (d, J = 8.5, H-C(5)), 7.38 (d, J = 11.2, H-C(4)), 7.17 
(dd, J1 = 1.8, J2= 8.4, H-C(6)), 5.68 (d, J = 5.4, H-N), 4.45-4.35 (m, 1H, ArNHCH(CH3)CH2-
), 2.85-2.75 (m, 1H, -CH2NHCH2Ad), 2.34 (ABq, HA, J = 11.7, -CH2Ad), 2.32 (ABq, HB, J = 
11.7, -CH2Ad), 1.93 (s, 3H, -Ad), 1.80-1.55 (m, 6H, -Ad), 1.55-1.40 (m, 6H, -Ad), 1.33 (d, 
3H, J = 6.6, CH3). 13C-NMR (125 MHz, CDCl3, δ): 148.87 (d, J = 13.5, C(8a)); 147.30 (d, J = 
258.6, C(3)); 145.20 (d, J = 2.7, C(2)); 133.90 (d, J = 2.3, C(7)); 127.79 (C(5)); 125.26 
(C(8)); 123.23 (C(6)); 121.48 (d, J = 4.1, C(4a)); 116.01 (d, J = 15.4, C(4)); 62.27; 55.65; 
45.61; 40.66; 37.08; 33.48; 28.34; 18.93. HRMS: m/z402.21021 corresponds to molecular 
formula C23H29ClFN3H+ (error in ppm: - 1.16).Anal. (C23H29ClFN3 × 1/3 H2O) Calcd: C, 
67.72; H, 7.33; N, 10.30. Found: C, 67.72; H, 6.99; N, 10.28. HPLCpurity (λ = 254 nm) 
method A: RT 8.772 min, area 95.58%; method B: RT 10.676 min, area 95.05%. 
N1-(1-Adamantylmethyl)-N3-(7-chloro-3-fluoroquinolin-2-yl)butane-1,3-diamine (69). 
Compound 69 was prepared by method H from amine 
linker S52 (78 mg, 0.33 mmol) and 7-chloro-3-fluoro-
2-iodoquinoline 18 (93 mg, 0.30 mmol) using 
Pd(OAc)2 (2.7 mg, 0.012 mmol), SPhos (9.85 mg, 
0.024 mmol) and K3PO4 (159 mg, 0.75 mmol) and was obtained after multiple 
chromatography: dry-flash SiO2, gradient: CH2Cl2/MeOH(NH3sat.) = 95/5 → 8/2,and flash 
chromatography (Biotage SP1 NH column, eluent: Hex/EtOAc = 7/3 and RP column, eluent: 















3040w, 2901s, 2845s, 2675w, 1637m, 1606w, 1568m, 1531s, 1492w, 1457m, 1416m, 1376w, 
1345m, 1316w, 1289w, 1258m, 1189m, 1147m, 1119m, 1074w, 1005w, 970w, 930w, 882m, 
799m, 760m, 739w, 601w, 512w cm-1. λmax(ε) = 242 (32836), 330 (8319), 341 (7836) nm. 1H-
NMR (500 MHz, CDCl3, δ): 7.68 (d, J = 1.7, H-C(8)), 7.41 (d, J = 8.5, H-C(5)), 7.35 (d, J = 
11.3, H-C(4)), 7.14 (dd, J1 = 1.7, J2 = 8.4, H-C(6)), 6.30 (d, J = 6.4, H-N), 4.55-4.45 (m, 1H, 
ArNHCH(CH3)-), 2.85-2.75 (m, 1H, -CH2NHCH2CH2Ad), 2.75-2.65 (m, 1H, -
CH2NHCH2CH2Ad), 2.27 (ABq, HA, J = 11.4, -CH2Ad), 2.19 (ABq, HB, J = 11.4, -CH2Ad), 
2.00-1.90 (m, 3H, Ad), 1.90-1.80 (m, 1H, ArNHCH(CH3)CH2-), 1.75-1.60 (m, 6H, Ad), 1.57-
1.47 (m, 6H, Ad), 1.32 (d, 3H, J = 6.4, CH3). 13C-NMR (125 MHz, CDCl3, δ): 148.59 (d, J = 
13.1, C(8a)); 147.31 (d, J = 259.0, C(3)); 145.44 (d, J = 2.7, C(2)); 133.78 (d, J = 2.7, C(7)); 
127.71 (d, J = 5.0, C(5)); 125.23 (C(8)); 122.88 (C(6)); 121.27 (d, J = 4.0, C(4a)); 115.76 (d, 
J = 13.33, C(4)); 63.19; 47.52; 45.26; 40.89; 37.20; 35.87; 33.26; 28.47; 20.55. HRMS: 
m/z416.22589 corresponds to molecular formula C24H31ClFN3H+ (error in ppm: - 
1.07).HPLCpurity (λ = 254 nm) method A: RT 8.726min, area 95.12%; method B: RT 11.064 
min, area 95.72%. 
N1-(1-Adamantylmethyl)-N4-(7-chloro-3-fluoroquinolin-2-yl)pentane-1,4-diamine (70). 
Compound 70 was prepared by method H from 
amine linker S53 (67 mg, 0.27 mmol) and 7-
chloro-3-fluoro-2-iodoquinoline 18(75 mg, 0.24 
mmol) using Pd(OAc)2 (2.2 mg, 0.009 mmol), DPEphos (10.34 mg, 0.019 mmol) and K3PO4 
(127 mg, 0.6 mmol) and was obtained after multiple chromatography: dry-flash SiO2, 
gradient: CH2Cl2/MeOH(NH3sat.) = 95/5 → 7/3,and flash chromatography (Biotage SP1 NH 
column, eluent: Hex/EtOAc = 7/3 and RP column, eluent: MeOH/H2O = 8/2 → 9/1),as 
colorless viscous oil (55 mg, 51%). IR(ATR): 3442m, 3323w, 2902s, 2846m, 1637m, 1609w, 
1568w, 1530s, 1492w, 1458m, 1415m, 1345w, 1262w, 1188w, 1146w, 1119w, 1069w, 883w, 
799w, 760w, 733w, 602w, 514w cm-1. λmax(ε) = 242 (35870), 332 (7652), 345 (7674) nm. 1H-
NMR (500 MHz, CDCl3, δ): 7.69 (d, J = 1.5, H-C(8)), 7.42 (d, J = 9.0, H-C(5)), 7.36 (d, J = 
11.5, H-C(4)), 7.16 (dd, J1 = 2.0, J2 = 8.5, H-C(6)), 5.11 (d, J = 6.5, H-N), 4.50-4.30 (m, 1H, 
ArNHCH(CH3)-), 2.70-2.55 (m, 2H, -CH2NHCH2Ad), 2.22 (s, 2H, -CH2Ad), 1.94 (s, 3H, -
Ad), 1.75-1.55 (m, 10H, -Ad, ArNHCH(CH3)CH2-, ArNHCH(CH3)CH2CH2-), 1.55-1.45 (m, 
6H, -Ad), 1.29 (d, 3H, J = 6.5, CH3). 13C-NMR (125 MHz, CDCl3, δ): 148.36 (d, J = 13.5, 
C(8a)); 147.14 (d, J = 258.1, C(3)); 145.37 (d, J = 2.2, C(2)); 133.86 (d, J = 2.2, C(7)); 127.74 
(d, J = 5.0, (C(5)); 125.32 (C(8)); 123.06 (C(6)); 121.29 (d, J = 4.0, C(5)); 115.84 (d, J = 15.2, 
C(4a)); 62.81; 50.62; 45.94; 40.90; 37.18; 34.36; 33.28; 28.44; 26.15; 20.79. HRMS: 







0.67).HPLCpurity (λ = 330 nm) method A: RT 9.631min, area 95.45%; method B: RT 10.444 
min, area 98.16%.  
N1-[2-(1-Adamantyl)ethyl]-N3-(7-chloro-3-fluoroquinolin-2-yl)butane-1,3-diamine (71). 
Compound 71 was prepared by method H from 
amine linker S55(89 mg, 0.36 mmol) and7-
chloro-3-fluoro-2-iodoquinoline 18(99 mg, 0.32 
mmol) using Pd(OAc)2 (2.9 mg, 0.013 mmol), DPEphos (13.79 mg, 0.026 mmol) and K3PO4 
(169 mg, 0.8 mmol) and was obtained after multiple chromatography: dry-flash SiO2, 
gradient: CH2Cl2/MeOH(NH3sat.) = 95/5 → 7/3,and flash chromatography (Biotage SP1 NH 
column, eluent: Hex/EtOAc = 7/3 and RP column, eluent: MeOH/H2O = 8/2 → 9/1),as 
colorless viscous oil (73 mg, 53%). IR(ATR): 3340m, 3233m, 2903s, 2845s, 2676w, 1637m, 
1609w, 1567w, 1533s, 1492w, 1456m, 1415m, 1372w, 1344w, 1258w, 1189m, 1146m, 
1119m, 1073w, 968w, 908w, 882m, 800w, 760w, 733m, 602w, 513w, 476w cm-1. λmax(ε) = 
252 (28029), 347 (8156) nm. 1H-NMR (500 MHz, CDCl3, δ): 7.67 (d, J = 2.0, H-C(8)), 7.43 
(d, J = 8.5, H-C(5)), 7.37 (d, J = 11.0, H-C(4)), 7.16 (dd, J1 = 1.5, J2 = 8.5, H-C(6)), 5.94 (d, J 
= 6.5, H-N), 4.55-4.45 (m, 1H, ArNHCH(CH3)-), 2.83-2.73 (m, 1H, -CH2NHCH2CH2Ad), 
2.73-2.65 (m, 1H, -CH2NHCH2CH2Ad), 2.60-2.53 (m, 1H, -CH2CH2Ad), 2.53-2.45 (m, 1H, -
CH2CH2Ad), 1.95-1.80 (m, 4H, ArNHCH(CH3)CH2-,-Ad), 1.75-1.55 (m, 7H, -Ad, 
ArNHCH(CH3)CH2-), 1.47-1.43 (m, 6H, -Ad), 1.33 (d, 3H, J = 6.5, CH3), 1.20-1.30 (-
CH2Ad). 13C-NMR (125 MHz, CDCl3, δ): 148.64 (d, J = 13.5, C(8a)); 147.22 (d, J = 258.6, 
C(3)); 145.32 (d, J = 2.8, C(2)); 133.91 (d, J = 2.2, C(7)); 127.81(d, J = 4.9, (C(5)); 125.19 
(C(8)); 123.06 (C(6)); 121.30 (d, J = 4.6, C(5)); 115.89 (d, J = 15.4, C(4a)); 46.69; 44.88; 
44.76; 44.36; 42.57; 37.14; 36.81; 31.78; 28.67; 21.07. HRMS: m/z430.24162 corresponds to 
molecular formula C25H33ClFN3H+ (error in ppm: - 0.84).HPLCpurity (λ = 254 nm) method 
A: RT 9.012min, area 95.42%; method B: RT 11.228 min, area 96.01%.  
N1-[2-(1-Adamantyl)ethyl]-N4-(7-chloro-3-fluoroquinolin-2-yl)pentane-1,4-diamine (72). 
Compound 72 was prepared by method H from 
amine linker S56 (89 mg, 0.34 mmol) and 7-
chloro-3-fluoro-2-iodoquinoline 18 (94 mg, 0.30 
mmol) using Pd(OAc)2 (2.7 mg, 0.012 mmol), DPEphos (12.9 mg, 0.024 mmol) and K3PO4 
(159 mg, 0.75 mmol) and was obtained after multiple chromatography: dry-flash SiO2, 
gradient: CH2Cl2/MeOH(NH3sat.) = 95/5 → 7/3,and flash chromatography (Biotage SP1 NH 
column, eluent: Hex/EtOAc = 7/3 and RP column, gradient: MeOH/H2O = 8/2 → 9/1),as 
colorless viscous oil (74 mg, 56%). IR(ATR): 2903s, 2846s, 2676w, 1628m, 1592w, 1514s, 
1463m, 1425m, 1379m, 1331w, 1252m, 1216w, 1196w, 1146m, 1119m, 1070m, 976w, 










(7096) nm. 1H-NMR (500 MHz, CDCl3, δ): 7.69 (d, J = 2.0, H-C(8)), 7.34 (d, J = 8.5, H-
C(5)), 7.38 (d, J = 11.0, H-C(4)), 7.12 (dd, J1 = 2.0, J2 = 8.5, H-C(6)), 5.14 (d, J = 6.5, H-N), 
4.50-4.30 (m, 1H, ArNHCH(CH3)-), 2.70-2.60 (m, 2H, -CH2NHCH2Ad), 2.60-2.50 (m, 2H, -
CH2CH2Ad), 1.92 (s, 3H, -Ad), 1.75-1.55 (m, 10H, ArNHCH(CH3)CH2-, 
ArNHCH(CH3)CH2CH2, -Ad), 1.55-1.45 (m, 6H, -Ad), 1.29 (d, 3H, J = 6.5, CH3), 1.27-1.229 
(d, 2H, -CH2Ad). 13C-NMR (125 MHz, CDCl3, δ): 148.42 (d, J = 13.0, C(8a)); 147.17 (d, J = 
250.0, C(3)); 145.39 (d, J = 2.2, C(2)); 133.65 (d, J = 2.2, C(7)); 127.80 (d, J = 4.5, (C(5)); 
125.30 (C(8)); 123.14 (C(6)); 121.35 (d, J = 4.1, C(5)); 115.92 (d, J = 15.2, C(4a)); 49.84; 
45.83; 44.62; 44.24; 42.61; 37.15; 34.58; 31.83; 28.67; 26.36; 20.82. HRMS: m/z444.25698 
corresponds to molecular formula C26H35ClFN3H+ (error in ppm: - 1.46).HPLCpurity (λ = 254 








i) 1) AQ/DCAQ, AcOHglac, MeOH/CH2Cl2, r.t., 2h 2) NaBH4, rt, 12h; ii) carbonyl compound, 
ZnCl2, NaBH3CN, MeOH, r.t., 48h
55: n=1, R=Cl (85%)
56: n=2, R=Cl (60%)
57: n=3, R=Cl (59%)
62: n=2, R=H (72%)






46: n=1, R=H (73%)
47: n=1, R=Me (87%)
48: n=1, R=iPr (91%)
49: n=2, R=H (65%)
50: n=2, R=Me (97%)
51: n=2, R=iPr (41%)



























Compound 46 was prepared by method E from1-
benzothiophene-2-carbaldehyde (240 mg, 1.48 mmol), 
using amine AQ2 (489 mg, 2.21 mmol). The product 
was purified using column chromatography (dry-flash, SiO2, eluent EtOAc/Hex gradient 9/1 
→ EtOAc, EtOAc/MeOH gradient 95/5 → 6/4 and flash chromatography, Biotage SP1, RP 
column, eluent MeOH/H2O gradient 65/35 → MeOH). Final product 46 was obtained as a 
pale yellow powder (396 mg, 73%). M.p. = 135 – 139 ºC. IR (ATR): 3226m, 3063m, 2946w, 
2836w, 1578s, 1452m, 1374m, 1330w, 1285w, 1254w, 1210w, 1137m, 1080w, 1023w, 965w, 
930w, 895w, 850w, 813w, 778m, 742w, 643w cm-1. 1H NMR (500 MHz, CDCl3, δ): 8.49 (d, 
J = 5.3, H-C(2')), 7.95 (d, J = 2.1, H-C(8')), 7.82-7.79 (m, H-C(7)), 7.76 (d, J = 8.9, H-C(5’)), 
7.70-7.67 (m, H-C(4)), 7.37 (dd, J1 = 8.9, J2 = 2.3, H-C(6’)), 7.35-7.28 (m, H-C(5) and H-
C(6)), 7.16-7.15 (m, H-C(3)), 6.34 (d, J = 5.5, H-C(3')), 5.87 (bs, H-N exchangeable with 
D2O), 4.15-4.13 (m, 2H, -CH2NHCH2CH2NH-), 3.34-3.29 (m, 2H, -CH2NHCH2CH2NH-), 








(125 MHz, CDCl3, δ): 152.01, 149.78, 149.11, 144.98, 139.65, 139.45, 134.74, 128.65, 
125.18, 124.32, 124.11, 123.16, 122.34, 121.56, 121.38, 117.34, 99.12, 48.56, 46.44, 42.09. 
HRMS: m/z 368.09836 corresponds to molecular formula C20H18ClN3SH+ (error in ppm -
0.02). Anal. (C20H18ClN3S×0.25H2O) Calcd: C, 64.50; H, 5.01; N, 11.28; S, 8.61. Found: C, 
64.67; H, 4.95; N, 11.31; S 8.53. HPLC purity (λ = 330 nm): method A: RT 8.938 min, area 
98.51%; method B: RT 8.116 min, area 98.14%. 
N-(1-benzothien-2-ylmethyl)-N'-(7-chloroquinolin-4-yl)-N-methylethane-1,2-
diamine(47). 
Compound 47 was prepared by method K from 46 
(199 mg, 0.543 mmol). The product was purified 
using column chromatography (dry-flash, SiO2, eluent 
EtOAc/Hex gradient 1/1 → EtOAc, EtOAc/MeOH gradient 95/5 → 1/1). Final product 47 
was obtained as yellow oil (180 mg, 87%). IR (ATR): 3395w, 3060w, 2950w, 2846w, 2801w, 
1609m, 1581s, 1527m, 1452m, 1366m, 1330m, 1275w, 1241w, 1206w, 1130w, 1076w, 
1032w, 879w, 809w, 747w cm-1. 1H NMR (500 MHz, CDCl3, δ): 8.49 (d, J = 5.3, H-C(2')), 
7.95 (d, J = 2.1, H-C(5')), 7.86 (d, J = 8.9, H-C(8')), 7.82-7.79 (m, H-C(7)), 7.70-7.67 (m, H-
C(4)), 7.41 (dd, J1 = 8.9, J2 = 2.2, H-C(6')), 7.35-7.28 (m, H-C(5) and H-C(6)), 7.16 (s, H-
C(3)), 6.31 (d, J = 5.4, H-C(3')), 5.94 (bs, H-N exchangeable with D2O), 3.89 (s, 2H, -
CH2N(CH3)CH2CH2NH-), 3.29 (q, 2H, J = 4.6, -CH2N(CH3)CH2CH2NH-), 2.83 (t, 2H, J = 
5.8, -CH2N(CH3)CH2CH2NH-), 2.40 (s, 3H, CH3-N). 13C NMR (125 MHz, CDCl3, δ): 151.94, 
149.79, 149.00, 143.64, 139.66, 139.51, 134.78, 128.54, 125.14, 124.38, 124.28, 123.23, 
122.47, 122.34, 121.62, 117.33, 99.08, 57.52, 53.92, 41.73, 39.63.HRMS: m/z 382.11463 
corresponds to molecular formula C21H20ClN3SH+ (error in ppm 1.86). Anal. (C21H20ClN3S × 
0.5H2O) Calcd: C, 64.52; H, 5.41; N, 10.75; S, 8.20. Found: C, 64.82; H, 5.05; N, 10.88; S, 
8.56. HPLC purity (λ = 254 nm) method A: RT 8.685 min, area 95.12%; (λ = 330 nm) method 
B: RT 7.428 min, area 95.57%. 
N-(1-benzothien-2-ylmethyl)-N'-(7-chloroquinolin-4-yl)-N-isopropylethane-1,2-
diamine(48). 
Compound 48 was prepared by method K from 46 
(184 mg, 0.500 mmol). The product was purified 
using column chromatography (dry-flash, SiO2, eluent 
EtOAc/hexane gradient 1/1 → EtOAc, EtOAc/MeOH 
gradient 9/1 → 7/3). Final product 48 was obtained as pale yellow powder (187 mg, 91%). 
M.p. = 127 ºC. IR (ATR): 3388s, 2960m, 2869w, 2829m, 1608m, 1583s, 1523m, 1477m, 













NMR (500 MHz, CDCl3, δ): 8.47 (d, J = 5.3, H-C(2')), 7.93 (d, J = 2.2, H-C(5')), 7.77-7.73 
(m, H-C(8’) and H-C(7)), 7.65-7.62 (m, H-C(4)), 7.34 (dd, J1 = 8.9, J2 = 2.2, H-C(6')), 7.32-
7.25 (m, H-C(6) and H-C(5)), 7.15-7.13 (m, H-C(3)), 6.29 (d, J = 5.4, H-C(3')), 5.94 (bs, H-N 
exchangeable with D2O), 3.88 (d, 2H, J = 0.8, -CH2N(iPr)CH2CH2NH-), 3.25 (q, 2H, J = 5.0, 
-CH2N(iPr)CH2CH2NH-), 3.13 (sept, 1H, J = 6.6, (CH3)2CH-N), 2.91 (t, 2H, J = 5.8, -
CH2N(iPr)CH2CH2NH-), 1.13 (d, 6H, J = 6.6, (CH3)2CH-N). 13C NMR (125 MHz, CDCl3, δ): 
151.97, 149.84, 149.09, 146.11, 139.75, 139.44, 134.71, 128.60, 125.12, 124.36, 124.14, 
123.07, 122.34, 121.77, 121.59, 117.44, 99.15, 49.10, 48.89, 46.95, 39.87, 17.90. HRMS: m/z 
410.14550 corresponds to molecular formula C23H24ClN3SH+ (error in ppm 0.67). Anal. 
(C23H24ClN3S) Calcd: C, 67.38; H, 5.90; N, 10.25; S, 7.82. Found: C, 67.09; H, 6.28; N, 
10.16; S, 8.09. HPLC purity (λ = 330 nm): method A: RT 9.325 min, area 98.75%; method B: 
RT 7.604 min, area 97.41%. 
N-(1-benzothiophen-2-ylmethyl)-N'-(7-chloroquinolin-4-yl)propane-1,3-diamine (49). 
Compound 49 was prepared by method E from1-
benzothiophene-2-carbaldehyde (314 mg, 1.93 
mmol), using amine AQ3 (682 mg, 2.89 mmol). The 
product was purified using column chromatography (dry-flash, SiO2, eluent EtOAc/Hex 
gradient 9/1 → EtOAc, EtOAc/MeOH gradient 95/5 → 6/4 and flashchromatography, Biotage 
SP1, RP column, eluent MeOH/H2O gradient 75/25 → MeOH). Final product 49 was 
obtained as a pale yellow powder (480 mg, 65%). M.p. = 120 – 122 ºC. IR (ATR): 3648w, 
3266m, 3058w, 2924w, 2843w, 1609w, 1581s, 1537w, 1453w, 1366w, 1331w, 1281w, 
1241w, 1204w, 1138w, 1077w, 878w, 853w, 808w, 748w cm-1. 1H NMR (500 MHz, CDCl3, 
δ): 8.48 (d, J = 5.3, H-C(2')), 7.91-7.89 (m, H-C(8')), 7.79 (d, J = 7.8, H-C(7)), 7.70 (d, J = 
7.3, H-C(4)), 7.57 (d, J = 10.2, H-C(5')), 7.39-7.30 (m, H-C(5) and H-C(6)), 7.16 (bs, H-
C(3)), 7.13-7.08 (m, H-N exchangeable with D2O), 7.05-7.01 (m, H-C(6')), 6.31 (d, J = 5.3, 
H-C(3')), 4.12 (s, 2H, -CH2NHCH2CH2CH2NH-), 3.43-3.38 (m, 2H, -
CH2NHCH2CH2CH2NH-), 2.98-2.94 (m, 2H, -CH2NHCH2CH2CH2NH-), 1.96-1.80 (m, 2H, -
CH2NHCH2CH2CH2NH- and H-N exchangeable with D2O). 13C NMR (125 MHz, CDCl3, δ): 
152.02, 150.25, 149.09, 144.04, 139.62, 139.54, 134.58, 128.41, 124.87, 124.44, 124.24, 
123.25, 122.40, 122.02, 121.98, 117.43, 98.38, 49.34, 48.51, 43.36, 27.54. HRMS: m/z 
382.11399 corresponds to molecular formula C21H20ClN3SH+ (error in ppm 0.29). Anal. 
(C21H20ClN3S×0.25H2O) Calcd: C, 65.27; H, 5.35; N, 10.87; S, 8.30. Found: C, 65.31; H, 
5.30; N, 10.93; S, 8.18. HPLC purity (λ = 330 nm) method A: RT 7.941 min, area 98.67%; (λ 











Compound 50 was prepared by method K from 49 
(201 mg, 0.524 mmol). The product was purified 
using column chromatography (dry-flash, SiO2, eluent 
EtOAc/Hex gradient 1/1 → EtOAc, EtOAc/MeOH 
gradient 95/5 → 1/1). Final product 50 was obtained as yellow oil (202 mg, 97%). IR (ATR): 
3270m, 3060w, 2949m, 2845w, 2804w, 1610m, 1582s, 1539w, 1456w, 1368w, 1333w, 
1138w cm-1. 1H NMR (500 MHz, CDCl3, δ): 8.50 (d, J = 5.4, H-C(2')), 7.91 (d, J = 2.2, H-
C(5')), 7.75-7.72 (m, H-C(7)), 7.69-7.66 (m, H-C(4)), 7.40 (d, J = 8.9, H-C(8')), 7.37-7.29 (m, 
H-C(5) and H-C(6)), 7.16-7.14 (m,H-C(3)), 7.03 (dd, J1 = 8.9, J2 = 2.2, H-C(6')), 6.72 (bs, H-
N exchangeable with D2O), 6.35 (d, J = 5.4, H-C(3')), 3.85 (d, 2H, J = 0.6, -
CH2N(CH3)CH2CH2CH2NH-), 3.45-3.41 (m, 2H, -CH2N(CH3)CH2CH2CH2NH-), 2.65 (t, 2H, 
J = 5.7, -CH2N(CH3)CH2CH2CH2NH-), 2.43 (s, 3H, CH3-N), 1.92 (quin, 2H, J = 5.8, -
CH2N(CH3)CH2CH2CH2NH-). 13C NMR (125 MHz, CDCl3, δ): 152.00, 150.21, 149.15, 
143.00, 139.84, 139.51, 134.59, 128.47, 124.94, 124.39, 124.29, 123.27, 122.95, 122.39, 
121.65, 117.45, 98.57, 58.17, 55.84, 42.74, 42.26, 24.83. HRMS: m/z 396.13031 corresponds 
to molecular formula C22H22ClN3SH+ (error in ppm 1.87). Anal. (C22H22ClN3S×0.5H2O) 
Calcd: C, 65.25; H, 5.72; N, 10.38; S, 7.92. Found: C, 65.73; H, 5.91; N, 10.66; S, 7.75. 




Compound 51 was prepared by method K from 49 
(249 mg, 0.652 mmol). The product was purified 
using column chromatography (dry-flash, SiO2, eluent 
EtOAc/Hex gradient 1/9 → EtOAc, EtOAc/MeOH 
gradient 95/5 → MeOH, EtOAc/MeOH/NH3 gradient 18/1/1 → 9/1/1). Final product 51 was 
obtained as pale yellow powder (115 mg, 41%). M.p. = 86 – 88 ºC. IR (ATR): 3240w, 3060w, 
2964m, 1610m, 1580s, 1534m, 1455m, 1366m, 1330w, 1280w, 1221w, 1169w, 1135w, 
1079w, 1022w, 879w, 853w, 810w, 744m cm-1. 1H NMR (500 MHz, CDCl3, δ): 8.45 (d, J = 
5.4, H-C(2')), 7.86 (d, J = 2.2, H-C(5')), 7.77-7.74 (m, H-C(7)), 7.69-7.65 (m, H-C(4)), 7.39-
7.30 (m, H-C(5) and H-C(6)), 7.17-7.14 (d, J = 9.0, H-C(8') and H-C(3)), 6.87 (dd, J1 = 8.9, J2 
= 2.2, H-C(6')), 6.32 (d, J = 5.4, H-C(3')), 5.96 (bs, H-N exchangeable with D2O), 3.85 (s, 
2H,-CH2N(iPr)CH2CH2CH2NH-), 3.42 (q, 2H, J = 5.7, -CH2N(iPr)CH2CH2CH2NH-), 3.21-













exchangeable with D2O), 1.89-1.82 (m, 2H, -CH2N(iPr)CH2CH2CH2NH-), 1.08 (d, 6H, J = 
6.6, (CH3)2CH-N). 13C NMR (125 MHz, CDCl3, δ): 151.89, 149.82, 149.07, 146.12, 139.79, 
139.59, 134.53, 128.42, 124.77, 124.40, 124.18, 123.14, 122.41, 122.10, 121.39, 117.19, 
98.64, 49.40, 49.15, 47.51, 41.74, 25.45, 17.57. HRMS: m/z 424.16183 corresponds to 
molecular formula C24H26ClN3SH+ (error in ppm 2.25). Anal. (C24H26ClN3S×0.5H2O) Calcd: 
C, 66.57; H, 6.28; N, 9.70; S, 7.41. Found: C, 66.94; H, 6.44; N, 9.54; S, 6.95. HPLC purity 
(λ = 330 nm): method A: RT 8.478 min, area 95.72%; method B: RT 7.472 min, area 95.45%. 
N-(1-benzothiophen-2-ylmethyl)-N'-(7-chloroquinolin-4-yl)butane-1,4-diamine (53). 
Compound 53 was prepared by method E from1-
benzothiophene-2-carbaldehyde (162 mg, 0.999 
mmol), using amine AQ4 (375 mg, 1.52 mmol). 
The product was purified using column chromatography (dry-flash, SiO2, eluent EtOAc/Hex 
gradient 9/1 → EtOAc, EtOAc/MeOH gradient 95/5 → 6/4 and flashchromatography, Biotage 
SP1, RP column, eluent MeOH/H2O gradient 85/15 → MeOH). Final product 53 was 
obtained as pale yellow powder (320 mg, 54%). M.p. = 101 – 104 ºC. IR (ATR): 3436w, 
3283m, 3137w, 3105w, 3062w, 2935m, 2858w, 2180w, 1610w, 1580s, 1537w, 1453m, 
1366w, 1332w, 1136w cm-1. 1H NMR (500 MHz, CDCl3, δ): 8.50 (d, J = 5.5, H-C(2')), 7.94-
7.92 (m, H-C(8')), 7.78 (d, J = 8.0, H-C(5’)), 7.70-7.64 (m, 2H-Ar), 7.35-7.21 (m, 3H-Ar), 
7.14 (s, H-C(3)), 6.36 (d, J = 5.3, H-C(3')), 5.72-5.66 (m, H-N exchangeable with D2O), 4.09 
(s, 2H, -CH2NHCH2CH2CH2CH2NH-), 3.32-3.27 (m, 2H, -CH2NHCH2CH2CH2CH2NH-), 
2.78 (t, 2H, J = 6.6, -CH2NHCH2CH2CH2CH2NH-), 1.86 (quin, 2H, J = 6.8, -
CH2NHCH2CH2CH2CH2NH-), 1.73-1.45 (m, 2H, -CH2NHCH2CH2CH2CH2NH- and H-N 
exchangeable with D2O). 13C NMR (125 MHz, CDCl3, δ): 152.06, 149.82, 149.16, 144.90, 
139.70, 139.53, 134.68, 128.73, 125.05, 124.25, 123.98, 123.11, 122.34, 121.38, 121.18, 
117.22, 98.91, 49.11, 48.35, 43.17, 27.64, 26.25. HRMS: m/z 396.12788 corresponds to 
molecular formula C22H22ClN3SH+ (error in ppm 0.73). Anal. (C22H22ClN3S×0.25H2O) Calcd: 
C, 65.74; H, 5.68; N, 10.45; S, 7.98. Found: C, 65.60; H, 5.61; N, 10.36; S, 7.83. HPLC purity 
(λ = 330 nm): method A: RT 11.020 min, area 98.99%; method B: RT 8.229 min, area 
97.99%. 
N-(1-benzothiophen-3-ylmethyl)-N'-(7-chloroquinolin-4-yl)ethane-1,2-diamine(55). 
Compound 55 was prepared by method E from1-
benzothiophene-3-carbaldehyde (70.0 mg, 0.432 mmol), 
using amine AQ2 (144 mg, 0.648 mmol). The product 
was purified using column chromatography (dry-flash, 
SiO2, eluent EtOAc/Hex gradient 1/9 → EtOAc, EtOAc/MeOH gradient 95/5 → 7/3 and 












Final product 55 was obtained as pale yellow powder (135 mg, 85%). M.p. = 104 – 108 ºC. IR 
(ATR): 3324w, 3219m, 3036m, 2967m, 1583s, 1490w, 1454m, 1427m, 1372m, 1334w, 
1281m, 1242w, 1211w, 1167w, 1136m, 1078w, 898w, 850m, 797w, 761m, 731m, 641w cm-1. 
1H NMR (500 MHz, CDCl3, δ): 8.48 (d, J = 5.3, H-C(2')), 7.92 (d, J = 2.2, H-C(8')), 7.91-7.85 
(m, 2H-Ar), 7.40-7.34 (m, 3H-Ar), 7.30 (s, H-C(2)), 7.24 (dd, J1 = 2.3, J2 = 9.1, H-C(6’)), 6.30 
(d, J = 5.4, H-C(3')), 5.76 (bs, H-N exchangeable with D2O), 4.10 (s, 2H, -
CH2NHCH2CH2NH-), 3.30-3.26 (m, 2H, -CH2NHCH2CH2NH-), 3.10-3.06 (m, 2H, -
CH2NHCH2CH2NH-), 1.74 (bs, H-N exchangeable with D2O). 13C NMR (125 MHz, CDCl3, 
δ): 151.99, 149.71, 149.03, 140.86, 138.21, 134.69, 134.60, 128.58, 125.10, 124.51, 124.09, 
123.68, 123.07, 121.89, 121.23, 117.24, 99.11, 47.16, 46.79, 41.95. HRMS: m/z 368.09643 
corresponds to molecular formula C20H18ClN3SH+ (error in ppm -5.00). HPLC purity (λ = 330 
nm): method A: RT 8.402 min, area 98.48%; method B: RT 7.404 min, area 98.45%. 
N-(1-benzothiophen-3-ylmethyl)-N'-(7-chloroquinolin-4-yl)propane-1,3-diamine (56). 
Compound 56 was prepared by method E from1-
benzothiophene-3-carbaldehyde (90.0 mg, 0.555 
mmol), using amine AQ3 (196 mg, 0.832 mmol). 
The product was purified using column 
chromatography (dry-flash, SiO2, eluent EtOAc/Hex gradient 1/9 → EtOAc, EtOAc/MeOH 
gradient 95/5 → 8/2, flashchromatography, Biotage SP1, NH column, eluent EtOAc/Hex 
gradient 7/3 → EtOAc, EtOAc/MeOH gradient 95/5 → MeOH, Biotage SP1, SiO2 column, 
eluent EtOAc/MeOH+NH3(9/1) gradient 95/5 → 7/3). Final product 56 was obtained as pale 
yellow powder (127 mg, 60%). M.p. = 122 – 123 ºC. IR (ATR): 3298w, 3214m, 3059w, 
2952m, 2888w, 2827w, 1611w, 1581s, 1539m, 1456m, 1426m, 1358w, 1327m, 1277w, 
1224w, 1168w, 1139w, 1112w, 1082w, 893w, 848w, 811w, 764m, 731m, 636w cm-1. 1H 
NMR (500 MHz, CDCl3, δ): 8.46 (d, J = 5.4, H-C(2')), 7.91 (d, J = 8.0, H-C(4)), 7.87 (d, J = 
2.0, H-C(8’), 7.79 (d, J = 8.1, H-C(5’)), 7.44-7.27 (m, 4H-Ar and H-N exchangeable with 
D2O), 6.91 (dd, J1 = 2.0, J2 = 8.8, H-C(6’)), 6.27 (d, J = 5.4, H-C(3')), 4.09 (s, 2H, -
CH2NHCH2CH2CH2NH-), 3.43-3.38 (m, 2H, -CH2NHCH2CH2CH2NH-), 3.04 (t, 2H, J = 5.5, 
2H, -CH2NHCH2CH2CH2NH-), 2.05-1.93 (m, 2H, 2H, -CH2NHCH2CH2CH2NH- and H-N 
exchangeable with D2O). 13C NMR (125 MHz, CDCl3, δ): 151.85, 150.37, 148.84, 140.67, 
138.12, 134.56, 134.45, 128.17, 124.79, 124.62, 124.27, 123.49, 123.04, 121.88, 121.42, 
117.33, 98.23, 49.41, 47.59, 43.81, 27.38. HRMS: m/z 382.11218 corresponds to molecular 
formula C21H20ClN3SH+ (error in ppm -4.57). Anal. (C21H20ClN3S) Calcd: C, 66.04; H, 5.28; 
N, 11.00; S, 8.40. Found: C, 65.69; H, 5.54; N, 10.84; S, 8.00. HPLC purity (λ = 330 nm): 










Compound 57 was prepared by method E from1-
benzothiophene-3-carbaldehyde (80.0 mg, 0.493 
mmol), using amine AQ4 (185 mg, 0.740 mmol). 
The product was purified using column 
chromatography (flash, Biotage SP1, SiO2 column, eluent EtOAc/MeOH+NH3(9/1) gradient 
95/5 → 7/3). Final product 57 was obtained as pale yellow powder (115 mg, 59%). M.p. = 82 
– 85 ºC. IR (ATR): 3304w, 3220m, 3056w, 2927m, 2851w, 2817w, 1582s, 1540m, 1459m, 
1427m, 1365w, 1327m, 1276w, 1255w, 1228w, 1164w, 1136m, 1079w, 898w, 864w, 835w, 
749w, 724w, 638w cm-1. 1H NMR (500 MHz, CDCl3, δ): 8.49 (d, J = 5.4, H-C(2')), 7.92 (d, J 
= 2.0, H-C(8’)), 7.89-7.85 (m, H-C(4)), 7.81-7.78 (m, H-C(7)), 7.58 (d, J = 8.9, H-C(5’)), 
7.40-7.33 (m, 2H-Ar), 7.30 (s, H-C(2)), 7.12 (dd, J1 = 2.0, J2 = 8.9, H-C(6’)), 6.34 (d, J = 5.4, 
H-C(3')), 5.83 (bs, H-N exchangeable with D2O), 4.06 (s, 2H, -CH2NHCH2CH2CH2CH2NH-), 
3.32-3.26 (m, 2H, -CH2NHCH2CH2CH2CH2NH-), 2.81 (t, 2H, J = 6.6, -
CH2NHCH2CH2CH2CH2NH-), 1.88 (quin, 2H, J = 6.8, -CH2NHCH2CH2CH2CH2NH-), 1.80 
(bs, H-N exchangeable with D2O), 1.72 (quin, 2H, J = 6.8, -CH2NHCH2CH2CH2CH2NH-). 
13C NMR (125 MHz, CDCl3, δ): 151.98, 149.96, 149.02, 140.73, 138.22, 134.86, 134.74, 
128.58, 125.01, 124.50, 124.11, 123.04, 122.99, 121.57, 121.23, 117.22, 98.87, 48.91, 47.62, 
43.16, 27.70, 26.34. HRMS: m/z 396.12784 corresponds to molecular formula 
C22H22ClN3SH+ (error in ppm -4.38). HPLC purity (λ = 254 nm) method A: RT 8.153 min, 
area 97.42%; (λ = 330 nm) method B: RT 7.519 min, area 97.71%. 
N-(1-benzothiophen-3-ylmethyl)-N'-(quinolin-4-yl)propane-1,3-diamine(62). 
Compound 62 was prepared by method E from1-
benzothiophene-3-carbaldehyde (115 mg, 0.709 mmol), 
using amine AQ7 (214 mg, 1.06 mmol). The product 
was purified using column chromatography (dry-flash, 
SiO2, eluent EtOAc/Hex gradient 1/1 → EtOAc, EtOAc/MeOH gradient 95/5 → 7/3). Final 
product 62 was obtained as pale yellow oil (177 mg, 72%). IR (film): 3750w, 3673w, 3648w, 
3447s, 2917w, 2845w, 1650w, 1576w, 1557w, 1541w, 1458w, 1433w, 1397w, 1370w, 
1338w, 1132w, 763w, 732w, 617w cm-1. 1H NMR (500 MHz, CDCl3-exchange with D2O, δ): 
8.50 (d, J = 5.5, H-C(2')), 7.94-7.89 (m, 2H-Ar), 7.83-7.80 (m, H-C(8’)), 7.56-7.49 (m, 2H-
Ar), 7.38-7.31 (m, 3H-Ar), 7.14-7.09 (m, H-C(6)), 6.33 (d, J = 5.2, H-C(3')), 4.10 (s, 2H, -
CH2NHCH2CH2CH2NH-), 3.42 (t, 2H, J = 6.0, -CH2NHCH2CH2CH2NH-), 3.02 (t, 2H, J = 
5.6, -CH2NHCH2CH2CH2NH-), 2.00-1.94 (m, 2H, -CH2NHCH2CH2CH2NH-). 13C NMR (125 
MHz, CDCl3, δ): 150.66, 150.26, 147.46, 140.68, 138.17, 134.49, 129.07, 128.85, 124.56, 












HRMS: m/z 348.15179 corresponds to molecular formula C21H21N3SH+ (error in ppm -3.18). 
HPLC purity (λ = 330 nm): method A: RT 8.708 min, area 97.43%; method B: RT 7.815 min, 
area 97.16%. 
N-(1-benzothiophen-3-ylmethyl)-N'-(quinolin-4-yl)butane-1,4-diamine (66). 
Compound 66 was prepared by method E from1-
benzothiophene-3-carbaldehyde (80.0 mg, 0.493 
mmol), using amine AQ8 (159 mg, 0.739 mmol). The 
product was purified using column chromatography 
(dry-flash, SiO2, eluent EtOAc/Hex gradient 2/8 → EtOAc, EtOAc/MeOH gradient 95/5 → 
1/9, and flash, Biotage SP1, NH column, eluent EtOAc/Hex gradient 7/3 → EtOAc, 
EtOAc/MeOH gradient 95/5 → MeOH). Final product 66 was obtained as pale yellow oil 
(101 mg, 57%). IR (ATR): 3307m, 3077m, 2935m, 2859m, 2818m, 1585s, 1547m, 1500s, 
1442m, 1401w, 1376w, 1343w, 1283w, 1257w, 1226w, 1130w, 1035m, 809w, 766m, 733w, 
652w cm-1. 1H NMR (500 MHz, CD3OD, δ): 8.31 (d, J = 5.4, H-C(2')), 8.08-8.04 (m, H-
C(8’)), 7.86-7.83 (m, H-C(4)), 7.82-7.76 (m, 2H-Ar), 7.62-7.58 (m, H-C(7’)), 7.42 (bs, H-
C(2)), 7.41-7.30 (m, 3H-Ar), 6.46 (d, J = 5.7, H-C(3')), 4.00 (s, 2H, -
CH2NHCH2CH2CH2CH2NH-), 3.36 (t, 2H, J = 6.9, -CH2NHCH2CH2CH2CH2NH-), 2.73 (t, 
2H, J = 7.2, -CH2NHCH2CH2CH2CH2NH-), 1.81-1.74 (m, 2H, -CH2NHCH2CH2CH2CH2NH-
), 1.73-1.65 (m, 2H, -CH2NHCH2CH2CH2CH2NH-). 13C NMR (125 MHz, CD3OD, δ): 
152.69, 151.12, 148.80, 141.93, 139.68, 135.53, 130.46, 128.69, 125.55, 125.46, 125.13, 
124.54, 123.76, 122.57, 122.20, 120.26, 99.14, 49.96, 47.56, 43.76, 28.02, 27.21. HRMS: m/z 
362.16853 corresponds to molecular formula C22H23N3SH+ (error in ppm -0.08). HPLC purity 










i) HSCH2CO2Me, Et3N, DMSO, 80 
oC, 2h; ii) 1) KOH, MeOH, H2O, 3h 2) HCl, 0 
oC; iii) DBU, DMAC, 200 oC, 2h, MW; iv) DIBAL, PhMe, 








S62: R1=H, R2=F (74%)
S63: R1=F, R2=H (70%)
S64: R1=Br, R2=H (90%)
S65: R1=H, R2=Br (95%)  
S57: R1=H, R2=F, R=CO2Me (19%)
S58: R1=F, R2=H, R=CO2Me (43%)
S59: R1=F, R2=H, R=CH2OH (82%)
S60: R1=Br, R2=H, R=CO2Me (89%)
S61: R1=H, R2=Br, R=CO2Me (76%)
iv)
S66: R1=H, R2=F (95%)
S67: R1=F, R2=H (93%)
S68: R1=Br, R2=H (98%)
S69: R1=CN, R2=H (86%)
S70: R1=H, R2=Br (98%)




Methyl 6-fluoro-1-benzothiophene-2-carboxylate (S57). 
Compound S57was prepared from2,4-difluorobenzaldehyde (7.91 g, 
55.6 mmol) by method L. The product was purified using column 
chromatography (dry-flash, SiO2, eluent Hex → Hex/EtOAc = 95/5. 
Final product S57was obtained as colorless crystals (2.22 g, 19%). M.p. = 86 – 89 ºC 










2960w, 2847w, 1726s, 1609w, 1567w, 1527m, 1465w, 1434w, 1338w, 1308w, 1250s, 
1193m, 1068w, 1045w, 960w, 908w, 884w, 849w, 803w, 777w, 751w cm-1. 1H NMR (500 
MHz, CDCl3, δ): 8.02 (s, H-C(3)), 7.85-7.80 (m, H-C(4)), 7.55-7.51 (m, H-C(7)), 7.16 (td, J1 
= 2.3, J2 = 9.0, H-C(5)), 3.94 (s, 3H, CH3). 13C NMR (125 MHz, CDCl3, δ): 162.95 (d, J = 
16.2), 161.03, 143.36 (d, J = 10.8), 135.23, 133.18 (d, J = 3.6), 130.08, 126.89 (d, J = 9.0), 
114.48 (d, J = 25.4), 108.69 (d, J = 25.3), 52.52. HRMS: m/z 211.02230 corresponds to 
molecular formula C10H7FO2SH+ (error in ppm -0.27). 
Methyl 5-fluoro-1-benzothiophene-2-carboxylate (S58). 
Compound S58 was prepared from2,5-difluorobenzaldehyde (5.00 g, 
35.2 mmol) by method L. The product was purified using column 
chromatography (dry-flash, SiO2, eluent Hex → Hex/EtOAc = 95/5). 
Final product S58 was obtained as colorless crystals (3.18 g, 43%). M.p. = 68 – 71 ºC 
(Hex/EtOAc=95/5); lit.26 m.p. 75-76 ºC. IR (ATR): 3409w, 3240w, 3087w, 2961w, 2846w, 
2772w, 1717s, 1607w, 1574w, 1527s, 1497w, 1430m, 1327w, 1295w, 1253s, 1204s, 1144w, 
1078w, 1057w, 944w, 876w, 809w, 770w, 750w, 708w, 651w cm-1. 1H NMR (500 MHz, 
CDCl3, δ): 8.00 (s, H-C(3)), 7.80 (dd, J1 = 4.7, J2 = 8.8, H-C(7)), 7.53 (dd, J1 = 2.5, J2 = 9.0, 
H-C(4)), 7.23 (td, J1 = 2.5, J2 = 8.9, H-C(6)), 3.95 (s, 3H, CH3). 13C NMR (125 MHz, CDCl3, 
δ): 162.38 (d, J = 128.2), 159.93, 139.54 (d, J = 9.9), 137.65, 135.73, 129.98 (d, J = 4.5), 
124.08 (d, J = 9.0), 116.19 (d, J = 25.3), 110.56 (d, J = 22.6), 52.6. GC/MS (m/z,%): 210.0 
([M+], 64), 179.0 (100), 151.0 (20), 107.0 (45).  
(5-fluoro-1-benzothiophen-2-yl)methanol(S59). 
CompoundS58 (590mg, 2.8 mmol) was dissolved with stirring in dry 
PhMe (15 mL) under Ar at -70 °C, followed by slow addition of 0.6 M 
DIBAL (19 mL, 11 mmol). Reaction was quenched after 1 h with 
MeOH/H2O (4/1) and the solvent was removed under reduced pressure. The crude mixture 
was dissolved in DCM (40 mL), transferred to a separation funnel, washed with water (2 × 30 
mL) and brine (30 mL), and dried over anh. Na2SO4. After filtration, the solvent was removed 
under reduced pressure. The product was purified using column chromatography (dry-flash, 
SiO2, eluent Hex → Hex/EtOAc = 7/3). Final product S59was obtained as a white powder 
(420mg, 82%). M.p. = 89 – 90 ºC (lit.27 m.p. 94 ºC (iPr2O-hexane). IR (ATR): 3249s, 2932m, 
2352w, 1750w, 1601m, 1576w, 1538m, 1442s, 1362w, 1297w, 1251w, 1192w, 1143s, 1014s, 
947w, 876s, 839w, 812s, 779w, 721w, 693w, 664, 641w, 588w cm-1. 1H NMR (500 MHz, 
CDCl3, δ): 7.72 (dd, J1 = 4.8, J2 = 8.7, H-C(7)), 7.38 (dd, J1 = 2.5, J2 = 9.4, H-C(4)), 7.16 (s, 
H-C(3)), 7.07 (td, J1 = 2.5, J2 = 8.9, H-C(6)), 4.92 (d, 2H, J = 5.2, -CH2OH), 2.02 (t, J = 5.8, 









135.21, 123.54 (d, J = 9.0), 121.51 (d, J = 4.5), 113.08 (d, J = 25.3), 108.98 (d, J = 23.5), 
60.82.GC/MS (m/z,%): 182.0 ([M+], 95), 165. 0 (90), 153.0 (100), 109.0 (53).  
Methyl 5-bromo-1-benzothiophene-2-carboxylate(S60). 
Compound S60 was prepared from5-bromo-2-fluorobenzaldehyde 
(1.00 g, 4.92 mmol) by method L. The product was purified using 
column chromatography (dry-flash, SiO2, eluent Hex → Hex/EtOAc 
= 95/5). Final product S60 was obtained as pale yellow powder (1.19 g, 89%). M.p. = 110 ºC. 
IR (ATR): 3083w, 2999w, 2956w, 1720s, 1554m, 1517s, 1435m, 1310w, 1285m, 1251s, 
1196m, 1168m, 1062m, 949w, 882m, 796m, 750m, 711w, 542w, 479w cm-1. 1H NMR (500 
MHz, CDCl3, δ): 8.02-8.00 (m, H-C(4)), 7.97-7.96 (m, H-C(3)), 7.74-7.71 (m, H-C(7)), 7.54 
(dd, J1 = 1.9, J2 = 8.6, H-C(6)), 3.95 (s, 3H, CH3). 13C NMR (125 MHz, CDCl3, δ): 162.76, 
140.64, 140.17, 135.12, 130.02, 129.43, 127.96, 124.10, 118.91, 52.64. HRMS: m/z 270.9422 
corresponds to molecular formulaC10H7BrO2SH+ (error in ppm -0.32).  
Methyl 6-bromo-1-benzothiophene-2-carboxylate(S61). 
Compound S61 was prepared from4-bromo-2-fluorobenzaldehyde 
(5.00 g, 24.6 mmol) by method L. The product was purified using 
column chromatography (dry-flash, SiO2, eluent Hex → Hex/EtOAc 
= 9/1). Final product S61 was obtained as pale yellow powder (5.10 g, 76%). M.p. = 114 ºC 
(lit.28 m.p. 113-115 ºC). IR (ATR): 3405w, 3068w, 2956w, 2842w, 1805w, 1710s, 1580m, 
1503m, 1429m, 1380m, 1329w, 1307m, 1283s, 1192m, 1169s, 1136m, 1086s, 1062s, 956w, 
917m, 865s, 809s, 751s, 719m, 700w, 641w, 565m, 490w, 456w, 429m, 403w cm-1. 1H NMR 
(500 MHz, CDCl3, δ): 8.02-7.99 (m, H-C(7) and H-C(2)), 7.72 (d, J = 8.4, H-C(4)), 7.51 (dd, 
J1 = 1.7, J2 = 8.6, H-C(5)), 3.94 (s, 3H, CH3). 13C NMR (125 MHz, CDCl3, δ): 162.84, 
143.47, 137.34, 133.90, 130.09, 128.58, 126.54, 125.28, 121.26, 52.60. GC/MS (m/z,%): 
271.9 ([M+], 87), 269.9 (89), 240.9 (100), 210.9 (22), 168.9 (20), 131.9 (41). 
6-fluoro-1-benzothiophene-2-carboxylic acid (S62).29 
Compound S62 was prepared frommethyl ester S57 (247 mg, 1.18 
mmol) by method M. The product was purified using column 
chromatography (dry-flash, SiO2, eluent DCM → DCM/MeOH = 9/1). 
Final product S62 was obtained as white powder (171 mg, 74%). M.p. = 182 – 186 °C. IR 
(ATR): 2811w, 2575w, 1665s, 1604m, 1566w, 1523s, 1468w, 1438m, 1341w, 1319m, 
1279w, 1255m, 1196m, 1177m, 1062w, 921m, 870w, 845w, 806w, 759w cm-1. 1H NMR (500 
MHz, CD3OD, δ): 8.04 (s, H-C(3)), 7.94 (dd, J1 = 5.2, J2 = 8.7, H-C(4)), 7.68 (dd, J1 = 2.4, J2 
= 9.0, H-C(7)), 7.22 (td, J1 = 2.4, J2 = 9.0, H-C(5)). 13C NMR (125 MHz, CD3OD, δ): 165.38, 












9.9), 115.29 (d, J = 24.4), 109.55 (d, J = 25.3). HRMS: m/z 194.99178 corresponds to 
molecular formula [C9H5SFO2-H]- (error in ppm -1.91). 
5-fluoro-1-benzothiophene-2-carboxylic acid(S63). 
Compound S63 was prepared frommethyl ester S58 (1.30 g, 6.2 mmol) 
by method M. The product was purified using column chromatography 
(dry-flash, SiO2, eluent DCM → DCM/MeOH = 7/3). Final product 
S63 was obtained as white powder (850mg, 70%). M.p. = 220-224 °C. IR (ATR): 2966m, 
2848m, 2803m, 2633m, 2565m, 2524m, 1677s, 1603w, 1571w, 1525s, 1446w, 1409m, 
1332w, 1305s, 1271s, 1242w, 1209s, 1147w, 1130w, 1079w, 1055w, 954w, 930w, 882w, 
809w, 760w, 711w, 655w, 598w, 509w cm-1. 1H NMR (500 MHz, CD3OD, δ): 8.00 (s, H-
C(3)), 7.91 (dd, J1 = 4.8, J2 = 8.9, H-C(7)), 7.64 (dd, J1 = 2.5, J2 = 9.2, H-C(4)), 7.27 (td, J1 = 
2.8, J2 = 8.9, H-C(6)). 13C NMR (125 MHz, CD3OD, δ): 166.55, 162.33 (d, J = 240.1), 141.31 
(d, J = 9.9), 139.21, 131.34, 131.06 (d, J = 12.6), 125.39 (d, J = 9.0), 116.94 (d, J = 25.3), 
111.42 (d, J = 22.6). HRMS: m/z 194.99273 corresponds to molecular formula [C9H5SFO2-
H]- (error in ppm 2.98). 
5-bromo-1-benzothiophene-2-carboxylic acid(S64). 
Compound S64 was prepared frommethyl ester S60 (1.19 g, 4.39 
mmol) by method M. The product was purified using column 
chromatography (dry-flash, SiO2, eluent DCM → DCM/MeOH = 9/1). 
Final product S64 was obtained as white powder (1.01 g, 90%). M.p. = 234 – 236 °C (lit.30 
m.p. 235 °C (H2O/EtOH)). IR (ATR): 2977m, 2828m, 2662m, 2557m, 1667s, 1551s, 1517s, 
1439m, 1401w, 1302s, 1265m, 1178s, 1072w, 1042w, 936w, 886m, 799m, 759m, 711w, 
600w, 507w, 473w, 424w cm-1. 1H NMR (500 MHz, CD3OD, δ): 8.11-8.09 (m, H-C(4)), 
8.00-7.97 (m, H-C(3)), 7.84-7.81 (m, H-C(7)), 7.22 (dd, J1 = 1.8, J2 = 8.7, H-C(6)). 13C NMR 
(125 MHz, CD3OD, δ): 165.24, 142.17, 141.96, 137.87, 130.95, 130.54, 129.05, 125.41, 
119.80. HRMS: m/z 254.91145 corresponds to molecular formula [C9H5BrO2S-H]- (error in 
ppm 4.69). 
6-bromo-1-benzothiophene-2-carboxylic acid(S65). 
Compound S65 was prepared frommethyl ester S61 (2.00 g, 7.38 
mmol) by method M. The product was purified using column 
chromatography (dry-flash, SiO2, eluent Hex → Hex/EtOAc = 1/1). 
Final product S65 was obtained as white powder (1.80 g, 95%). M.p. = 260 – 265 °C. IR 
(ATR): 3082m, 2982m, 2839m, 2690m, 2579m, 1664s, 1586m, 1552w, 1513m, 1425m, 
1383w, 1333w, 1316m, 1276w, 1244w, 1181w, 1139w, 1090w, 1051w, 918w, 871w, 803w, 
754w, 564w, 514w cm-1. 1H NMR (500 MHz, CD3OD+CDCl3, δ): 8.08-8.05 (m, H-C(7)), 











(125 MHz, CD3OD+CDCl3, δ): 165.42, 144.71, 138.91, 130.78, 129.35, 127.61, 126.12, 
121.83. HRMS: m/z 254.91154 corresponds to molecular formula [C9H5BrO2S-H]- (error in 
ppm -2.13). 
6-fluoro-1-benzothiophene(S66). 
Compound S66 was prepared fromcarboxylic acid S62 (163 mg, 0.831 mmol) 
by method N. The product was purified using column chromatography (dry-
flash, SiO2, eluent Hex). Final product S66 was obtained as colorless liquid 
(121 mg, 95%). IR (film): 3106w, 3073w, 2927w, 1879w, 1754w, 1697w, 1625w, 1606m, 
1565m, 1530w, 1496w, 1467s, 1392w, 1342w, 1310w, 1251s, 1218s, 1184w, 1118w, 1081w, 
1040w, 912s, 884w, 844m, 811s, 783w, 745w, 689m, 649w cm-1. 1H NMR (200 MHz, 
CDCl3, δ): 7.75 (dd, J1 = 5.3, J2 = 8.7, H-C(4)), 7.55 (dd, J1 = 2.2, J2 = 9.0, H-C(7)), 7.38, 
7.30 (ABq, JAB = 14.1, H-C(2) and H-C(3)), 7.12 (td, J1 = 2.4, J2 = 8.8, H-C(5)). 13C NMR 
(50 MHz, CDCl3, δ): 172.86, 162.94, 125.98 (d, J = 3.6), 124.48 (d, J = 9.1), 123.35, 113.49, 
113.25 (d, J = 23.7), 108.43 (d, J = 24.6). GC/MS (m/z,%): 152.0 ([M+], 100). 
5-fluoro-1-benzothiophene(S67). 
Compound S67 was prepared fromcarboxylic acid S63 (1.40 g, 7.1 mmol) by 
method N. The product was purified using column chromatography (dry-
flash, SiO2, eluent Hex). Final product S67 was obtained as colorless liquid 
(1.00 g, 93%). IR (film): 3907w, 3084w, 3012w, 2927w, 2372w, 2175w, 1879w, 1781w, 
1725w, 1618w, 1582w, 1563m, 1525w, 1501w, 1455w, 1421m, 1319w, 1422m, 1319w, 
1267w, 1248m, 1232w, 1139m, 1092w, 1051w, 942w, 891m, 862s, 833m, 808s, 750s, 694s, 
632w cm-1. 1H NMR (500 MHz, CDCl3, δ): 7.79 (dd, J1 = 4.9, J2 = 8.8, H-C(7)), 7.52 (d, J = 
5.2, H-C(3)), 7.47 (dd, J1 = 2.5, J2 = 9.4, H-C(4)), 7.29 (d, J = 5.2, H-C(2)), 7.13-7.07 (m, H-
C(6)). 13C NMR (125 MHz, CDCl3, δ): 160.8 (d, J = 240.0), 140.58 (d, J = 8.8), 135.12, 
128.78, 123.56 (d, J = 5.0), 123.46, 113.12 (d, J = 23.8), 108.98 (d, J = 22.5). GC/MS 
(m/z,%): 152.0 ([M+], 100). 
5-bromo-1-benzothiophene(S68). 
Compound S68 was prepared fromcarboxylic acid S64 (1.00 g, 3.89 mmol) 
by method N. The product was purified using column chromatography (dry-
flash, SiO2, eluent Hex). Final product S68 was obtained as white powder 
(814 mg, 98%). M.p. = 43 – 44 °C (lit.31 m.p. 47 °C). IR (ATR): 3102m, 2924m, 2850w, 
2176w, 2004w, 1874w, 1775w, 1730w, 1579s, 1545m, 1491m, 1431s, 1404s, 1310m, 1272w, 
1250m, 1223m, 1191s, 1151m, 1090m, 1061s, 940w, 887m, 866m, 811s, 798s, 751s, 727s, 
691s, 546w, 475m, 412w, 402w cm-1. 1H NMR (500 MHz, CDCl3, δ): 7.97-7.95 (m, H-C(4)), 








13C NMR (125 MHz, CDCl3, δ): 141.22, 138.34, 128.14, 127.26, 126.23, 123.76, 123.10, 
118.22. GC/MS (m/z,%): 213.9 ([M+], 100), 133.0 (55), 89.0 (45). 
1-benzothiophene-5-carbonitrile(S69). 
Compound S69 was prepared fromcompound S68 (735 mg, 3.45 mmol) by 
method P. The product was purified using column chromatography (dry-
flash, SiO2, eluent Hex → Hex/EtOAc = 9/1). Final product S69 was 
obtained as colorlesscrystals (472 mg, 86%). M.p. = 67 – 69 °C (Hex/EtOAc=9/1); lit.32 m.p. 
63 °C. IR (ATR): 3107s, 3087m, 2223s, 1777w, 1594w, 1540w, 1429m, 1320m, 1257m, 
1225w, 1134w, 1090m, 1050w, 907m, 823s, 758m, 704s, 623w, 598w, 574w cm-1. 1H NMR 
(500 MHz, CDCl3, δ): 8.15 (s, H-C(4)), 7.97 (d, J = 8.4, H-C(7)), 7.61 (d, J = 5.5, H-C(2)), 
7.57-7.54 (m, H-C(6)), 7.41 (d, J = 5.5, H-C(3)). 13C NMR (125 MHz, CDCl3, δ): 143.80, 
139.31, 129.05, 128.16, 126.14, 123.68, 123.44, 119.36, 107.96. GC/MS (m/z,%): 159.0 
([M+], 100). 
6-bromo-1-benzothiophene(S70). 
Compound S70 was prepared fromcarboxylic acid S65 (1.00 g, 3.89 mmol) 
by method N. The product was purified using column chromatography (dry-
flash, SiO2, eluent Hex). Final product S70 was obtained as white powder 
(811 mg, 98%). M.p. = 53 – 54 °C (lit.30 m.p. 56°C).IR (ATR): 3105w, 3076w, 1576m, 
1541w, 1482w, 1439m, 1377m, 1336m, 1300w, 1246w, 1200w, 1061m, 950w, 866m, 816s, 
744m, 689m, 566m, 427w cm-1. 1H NMR (500 MHz, CDCl3, δ): 8.01 (s, H-C(7)), 7.66 (d, J = 
8.5, H-C(4)), 7.48-7.44 (m, H-C(5)), 7.41, 7.29 (AMq, JAM = 5.5, H-C(2) and H-C(3)). 13C 
NMR (125 MHz, CDCl3, δ): 141.26, 138.32, 127.62, 126.90, 124.96, 124.65, 123.54, 118.14. 
GC/MS (m/z,%): 213.9 ([M+], 100), 211.9 (99), 133.0 (48), 89.0 (38). 
1-benzothiophene-6-carbonitrile(S71). 
Compound S71 was prepared fromcompound S70 (600mg, 2.8 mmol) by 
method P. The product was purified using column chromatography (dry-
flash, SiO2, eluent Hex → Hex/EtOAc = 9/1). Final product S71 was 
obtained as pale yellow powder (380mg, 84%). M.p. = 41 – 42 °C (lit.33 m.p. 41.5-42 °C 
(acetone/ligroin)). IR (ATR): 3818w, 3541w, 3415w, 3102m, 2971w, 2782w, 2621w, 2275w, 
2225s, 2173w, 1907w, 1774w, 1647w, 1594m, 1550w, 1484w, 1454m, 1391m, 1344m, 
1311m, 1259m, 1192m, 1137w, 1084m, 1049w, 959w, 893m, 825s, 777m, 760m, 702m, 
633w, 604m, 510w, 485w, 455, 406w cm-1. 1H NMR (500 MHz, CDCl3, δ): 8.22-8.20 (m, H-
C(7)), 7.90 (d, J = 7.9, H-C(4)), 7.72 (d, J = 5.5, H-C(3)), 7.59 (dd, J1 = 1.2, J2 = 8.2, H-C(5)), 
7.43-7.41 (m, H-C(2)). 13C NMR (125 MHz, CDCl3, δ): 142.40, 139.58, 131.20, 127.27, 














60: n=2, R1=CN, R2=H (72%)
64: n=3, R1=CN, R2=H (52%)
61: n=2, R1=H, R2=CN (55%)
65: n=3, R1=H, R2=CN (55%)
58: n=2, R1=F, R2=H (67%)
63: n=3, R1=F, R2=H (60%)






52: n=3, R=Cl (58%)
67: n=5, R=Cl (59%)















i) MnO2, CH2Cl2, r.t., 1h; ii) 1) AQ/DCAQ, AcOHglac, MeOH/CH2Cl2, rt, 2h 2) NaBH4, r.t., 12h; iii) Cl2CHOMe, 
TiCl4, CH2Cl2, -10 








S73: R1=CN, R2=H (72%)
S74: R1=H, R2=CN (48%)
S75: R1=F, R2=H (81%)





















AlcoholS59 (300 mg, 1.6 mmol) was dissolved in DCM (30 mL) and 
MnO2 (1.40 g, 16 mmol) was added. Resulting mixture was stirred at 
room temperature for 1 h. The mixture was filtrated through Celite, 
solvent was removed under reduced pressure and product S72 was used in the next step 
without further purification. S72 was obtained as white powder (240mg, 82%). M.p. = 117 – 
119 ºC (lit.27 m.p. 122 ºC (EtOH)). IR (ATR): 3449s, 3101w, 3065w, 2921w, 2850w, 2793w, 
1886w, 1671s, 1566w, 1518w, 1440w, 1383w, 1330w, 1282w, 1247w, 1167m, 1115w, 952w, 
868w, 808w, 718w, 657w, 597w, 489w, 418w, 403w cm-1. 1H NMR (500 MHz, CDCl3, δ): 
10.11 (s, 1H, CHO), 7.99 (s, H-C(3)), 7.85 (dd, J1 = 4.8, J2 = 9.0, H-C(7)), 7.60 (dd, J1 = 2.5, 
J2 = 8.9, H-C(4)), 7.28 (td, J1= 2.5, J2 = 8.7, H-C(6)). 13C NMR (125 MHz, CDCl3, δ): 
184.46, 161.01 (d, J = 242.5), 145.52, 139.41, 138.16, 133.47 (d, J = 5.0), 124. 68 (d, J = 8.8), 
117.40 (d, J = 25.0), 111.20 (d, J = 22.5). GC/MS (m/z,%): 180.0 ([M+], 100), 179 (91), 151 
(20), 107 (48).  
3-formyl-1-benzothiophene-5-carbonitrile(S73). 
Compound S73 was prepared fromcompound S69 (393 mg, 2.47 mmol) 
by method O. The product was purified using column chromatography 
(dry-flash, SiO2, eluent Hex → Hex/EtOAc = 3/7). Final product S73 was 
obtained as white powder (331 mg, 72%). M.p. = 107–108 °C. IR (ATR): 3824w, 3317w, 
3084s, 2931w, 2838m, 2744w, 2358w, 2228s, 1907w, 1810w, 1676s, 1597w, 1545w, 1507m, 
1437s, 1387w, 1352w, 1305w, 1259w, 1168m, 1099m, 1041m, 906w, 885w, 861w, 812m, 









9.05 (s, H-C(2)), 8.47 (s, H-C(4)), 8.00 (d, J = 8.5, H-C(7)), 7.70-7.67 (m, H-C(6)). 13C NMR 
(125 MHz, CDCl3, δ): 184.86, 144.65, 144.14, 135.91, 135.11, 129.62, 128.27, 123.43, 
118.74, 110.18. GC/MS (m/z,%): 187.0 ([M+], 76), 186.0 (100), 158.0 (20), 114.0 (40). 
3-formyl-1-benzothiophene-6-carbonitrile(S74). 
Compound S74 was prepared from compound S71 (120mg, 0.75 mmol) 
by method O. The product was purified using column chromatography 
(dry-flash, SiO2, eluent Hex → Hex/EtOAc = 3/7). Final product S74 was 
obtained as a white powder (68 mg, 48%). M.p. = 129 – 132 °C. IR (ATR): 3821w, 3417w, 
3325w, 3096m, 3066m, 2838w, 2750w, 2222m, 1932w, 1797w, 1666s, 1595w, 1494m, 
1458w, 1396m, 1263w, 1191w, 1142m, 1098m, 1044w, 1007w, 902w, 839m, 719w, 650w, 
614w cm-1. 1H NMR (500 MHz, CDCl3+CD3OD, δ): 10.00 (s, 1H, CHO), 8.63 (d, J = 8.4, H-
C(4)), 7.56 (s, H-C(2)), 8.14-8.13 (m, H-C(7)), 7.61 (dd, J1 = 1.4, J2 = 8.4, H-C(5)). 13C NMR 
(125 MHz, CDCl3+CD3OD, δ): 185.36, 147.02, 140.15, 137.98, 135.66, 128.50, 126.99, 
125.31, 118.30, 109.13. GC/MS (m/z,%): 187.0 ([M+], 76), 186.0 (100), 158.0 (20), 114.0 
(40). 
5-fluoro-1-benzothiophene-3-carbaldehyde(S75). 
Compound S75 was prepared from compound S67 (300mg, 2.0 mmol) by 
method O. The product was purified using column chromatography (dry-
flash, SiO2, eluent Hex → Hex/EtOAc = 9/1). Final product S75was 
obtained as white powder (290 mg, 81%). M.p. = 111 – 112 °C (lit.34 m.p. 111-113 °C (50 % 
EtOH)). IR (ATR): 3324w, 3168w, 3089m, 2954w, 2888w, 2832w, 2806w, 2740w, 1670s, 
1628w, 1600m, 1568m, 1502m, 1449m, 1433m, 1385m, 1348w, 1312w, 1286w, 1250m, 
1196m, 1144m, 1090w, 1040w, 912m, 866m, 798m, 737w, 716w, 641w, 626w, 535w, 472w 
cm-1. 1 h NMR (500 MHz, CDCl3, δ): 10.11 (s, 1 h, CHO), 8.41-8.36 (m, H-C(2) and H-C(4)), 
7.82 (dd, J1 = 4.8, J2 = 9.0, H-C(7)), 7.23 (td, J1 = 2.3, J2 = 8.5, H-C(6)). 13C NMR (125 MHz, 
CDCl3, δ): 185.06, 161.60 (d, J = 242.5), 144.89, 136.38 (d, J = 10.0), 136.14 (d, J = 5.0), 
135.72, 123.48 (d, J = 123.48), 115.14 (d, J = 26.2), 110.80 (d, J = 23.8). GC/MS (m/z,%): 
180.0 ([M+], 96), 180.0 (100), 151.0 (21), 107.0 (49). 
6-fluoro-1-benzothiophene-3-carbaldehyde (S76).Compound S76 was prepared from 
compound S66 (350mg, 2.3 mmol) by method O. The product was purified 
using column chromatography (dry-flash, SiO2, eluent Hex → Hex/EtOAc 
= 95/5. Final product S76 was obtained as white powder (160mg, 39%). 
M.p. = 92 – 96 °C. IR (ATR): 3319w, 3110m, 3073w, 2991w, 2843w, 2745w, 1667s, 1622m, 
1601m, 1570m, 1498m, 1470m, 1388m, 1323w, 1242m, 1207m, 1152w, 1129m, 1085w, 
1039w, 896m, 858m, 827m, 715m, 676w, 445w cm-1. 1H NMR (500 MHz, CDCl3, δ): 10.11 












2.5, J2 = 8.9, H-C(5)). 13C NMR (125 MHz, CDCl3, δ): 185.15, 161.24 (d, J = 245.0), 142.73, 
141.37 (d, J = 10.0), 135.95, 131.64, 126.08 (d, J = 8.8), 115.11 (d, J = 22.5), 108.57 (d, J = 
25.0). GC/MS (m/z,%): 180.0 ([M+], 96), 180.0 (100), 151.0 (24), 107.0 (48). 
N-(7-chloroquinolin-4-yl)-N'-[(5-fluoro-1-benzothiophen-2-yl)methyl]butane-1,4-
diamine(52). 
Compound 52was prepared fromaldehyde S72 
(97.4 mg, 0.540 mmol) by method E, using 
amine AQ4 (202 mg, 0.811 mmol). The 
product was purified using column 
chromatography (dry-flash, SiO2, eluent Hex/EtOAc gradient 1/1 → EtOAc, EtOAc/MeOH 
gradient 95/5 → 8/2). Final product 52 was obtained as pale yellow powder (128 mg, 58%). 
M.p. = 105 – 106 ºC. IR (ATR): 3232m, 3062m, 2934m, 2862m, 1582s, 1545m, 1448m, 
1366m, 1332w, 1279w, 1250w, 1204w, 1137w, 1083w, 952w, 900w, 864m, 802m, 765w, 
675w, 639w cm-1. 1H NMR (500 MHz, CD3OD, δ): 8.30 (d, J = 5.7, H-C(2')), 8.07 (d, J = 9.2, 
H-C(5’)), 7.77-7.72 (m, 2H-Ar), 7.40-7.34 (m, 2H-Ar), 7.18 (s, H-C(3)), 7.05 (td, J1 = 2.5, J2 
= 8.9, H-C(6)), 6.48 (d, J = 5.7, H-C(3')), 4.05-4.03 (m, 2H, -CH2NHCH2CH2CH2CH2NH-), 
3.38-3.34 (m, 2H, -CH2NHCH2CH2CH2CH2NH-), 2.71 (t, 2H, J = 7.2, -
CH2NHCH2CH2CH2CH2NH-), 1.79 (quin, 2H, J = 7.3, -CH2NHCH2CH2CH2CH2NH-), 1.72-
1.65 (m, 2H, -CH2NHCH2CH2CH2CH2NH-). 13C NMR (125 MHz, CD3OD, δ): 152.50 (d, J = 
91.2), 152.14, 149.39, 148.07, 142.35, 136.52 (d, J = 25.3), 136.42, 127.35, 125.99, 124.58 
(d, J = 10.0), 124.35, 123.10 (d, J = 3.8), 118.72, 113.54 (d, J = 26.2), 109.51 (d, J = 23.8), 
99.63, 43.81, 27.96, 27.07. HRMS: m/z 414.12065 corresponds to molecular formula 
C22H21ClN3SFH+ (error in ppm 1.20). HPLC purity (λ = 330 nm): method A: RT 7.750 min, 
area 96.09%; method B: RT 7.897 min, area 96.80%. 
N-(7-chloroquinolin-4-yl)-N'-[(5-fluoro-1-benzothien-2-yl)methyl]hexane-1,6-
diamine(67). 
Compound 67 was prepared fromaldehyde 
S72 (73.5 mg, 0.408 mmol) by method E, 
using amine AQ6 (169 mg, 0.608 mmol). 
The product was purified using column 
chromatography (dry-flash, SiO2, eluent Hex/EtOAc gradient 1/1 → EtOAc, EtOAc/MeOH 
gradient 95/5 → 8/2 and flash, Biotage SP1, NH column, eluent EtOAc/Hex gradient 8/2 → 
EtOAc, EtOAc/MeOH gradient 95/5 → MeOH). Final product 67 was obtained as white 
powder (106 mg, 59%). M.p. = 71–74 ºC. IR (ATR): 3226m, 3108m, 3066m, 3011m, 2929m, 
2888m, 2855m, 2832m, 2774w, 1733w, 1700w, 1652w, 1581s, 1546m, 1492w, 1472m, 












906w, 884w, 863m, 808m, 777w, 757w, 736w, 680w, 647w, 600w cm-1. 1H NMR (500 MHz, 
CDCl3, δ): 8.54-8.51 (m, H-C(2')), 7.97-7.95 (m, H-C(8’)), 7.71-7.66 (m, H-C(7)), 7.65-7.62 
(m, H-C(5’)), 7.36-7.31 (m, H-C(4) and H-C(6’)), 7.09 (s, H-C(3)), 7.03 (td, J1 = 2.4, J2 = 8.8, 
H-C(6)), 6.40 (d, J = 5.5, H-C(3')), 4.98 (bs, H-N exchangeable with D2O), 4.06 (s, 2H, -
CH2NHCH2CH2CH2CH2CH2CH2NH-), 3.33-3.26 (m, 2H, -
CH2NHCH2CH2CH2CH2CH2CH2NH-), 2.70 (t, 2H, J = 7.0, -
CH2NHCH2CH2CH2CH2CH2CH2NH-), 1.80-1.65 (m, 2H, -
CH2NHCH2CH2CH2CH2CH2CH2NH- and H-N exchangeable with D2O), 1.60-1.52 (m, 2H, -
CH2NHCH2CH2CH2CH2CH2CH2NH-), 1.50-1.40 (m, 4H, -
CH2NHCH2CH2CH2CH2CH2CH2NH-). 13C NMR (125 MHz, CDCl3, δ): 160.78 (d, J = 
239.2), 152.02, 149.66, 149.07, 148.46, 140.74 (d, J = 9.0), 134.87, 134.84, 128.81, 125.26, 
123.36 (d, J = 9.9), 120.72 (d, J = 9.0), 117.06, 112.50 (d, J = 25.3), 108.54 (d, J = 23.5), 
99.05, 49.20, 49.02, 43.17, 29.91, 28.81, 26.96. HRMS: m/z 442.15060 corresponds to 
molecular formula C24H25ClN3SFH+ (error in ppm -1.93). HPLC purity (λ = 330 nm): method 
A: RT 9.345 min, area 99.36%; method B: RT 8.823 min, area 99.17%. 
N-[(5-fluoro-1-benzothiophen-2-yl)methyl]-N'-(quinolin-4-yl)butane-1,4-diamine (54). 
Compound 54was prepared fromaldehyde S72 
(90.0 mg, 0.499 mmol) by method E, using 
amine AQ8 (161 mg, 0.749 mmol). The product 
was purified using column chromatography (dry-
flash, SiO2, eluent EtOAc/Hex gradient 1/9 → EtOAc, EtOAc/MeOH gradient 95/5 → 8/2 
and flash, Biotage SP1, SiO2 column, eluent EtOAc/MeOH+NH3(9/1) gradient 95/5 → 3/7). 
Final product 54 was obtained as pale yellow oil (101 mg, 54%). IR (ATR): 3435w, 3266m, 
3117w, 3063m, 3012w, 2933m, 2858m, 1580s, 1541m, 1495w, 1443m, 1396w, 1374w, 
1341m, 1282w, 1255w, 1223w, 1206w, 1152w, 1128m, 952w, 864w, 803w, 764w, 737w, 
689w cm-1. 1H NMR (500 MHz, CDCl3, δ): 8.54 (d, J = 5.5, H-C(2')), 7.97 (d, J = 8.5, H-
C(8’)), 7.74 (d, J = 8.5, H-C(5’)), 7.69 (dd, J1 = 4.8, J2 = 8.8, H-C(7)), 7.63-7.57 (m, H-
C(7’)), 7.37-7.33 (m, H-C(4) and H-C(6’)), 7.10 (s, H-C(3)), 7.04 (td, J1 = 2.5, J2 = 8.8, H-
C(6)), 6.40 (d, J = 5.5, H-C(3')), 5.48 (bs, H-N exchangeable with D2O), 4.09 (s, 2H, -
CH2NHCH2CH2CH2CH2NH-), 3.36-3.31 (m, 2H, -CH2NHCH2CH2CH2CH2NH-), 2.78 (t, 2H, 
J = 6.8, -CH2NHCH2CH2CH2CH2NH-), 1.91-1.67 (m, 4H, -CH2NHCH2CH2CH2CH2NH- and 
H-N exchangeable with D2O). 13C NMR (125 MHz, CDCl3, δ): 160.82 (d, J = 239.2), 151.03, 
149.74, 148.38, 147.99, 140.71 (d, J = 9.9), 134.87, 129.89, 128.92, 124.46, 123.41 (d, J = 
9.0), 120.91 (d, J = 4.5), 119.38, 118.75, 112.62 (d, J = 25.3), 108.61 (d, J = 22.6), 98.67, 







C22H22N3SFH+ (error in ppm -0.48). HPLC purity (λ = 330 nm): method A: RT 8.950 min, 
area 97.85%; method B: RT 7.746 min, area 97.41%. 
3-[({3-[(7-chloroquinolin-4-yl)amino]propyl}amino)methyl]-1-benzothiophene-5-
carbonitrile(60). 
Compound 60 was prepared fromaldehyde s73 
(79.6 mg, 0.425 mmol) by method E, using amine 
AQ3 (151 mg, 0.630 mmol). The product was 
purified using column chromatography (dry-flash, 
SiO2, eluent Hex/EtOAc gradient 1/1 → EtOAc, EtOAc/MeOH gradient 95/5 → 8/2). Final 
product 59 was obtained as white powder (124 mg, 72%). M.p. = 129 – 130 ºC. IR (ATR): 
3215m, 3061m, 3013m, 2965m, 2838m, 2225m, 1581s, 1439m, 1367m, 1282w, 1261w, 
1235w, 1137m, 1079w, 897w, 851w, 801w, 768w, 735w cm-1. 1H NMR (500 MHz, CDCl3, 
δ): 8.49 (d, J = 5.2, H-C(2')), 8.14-8.12 (m, H-C(4)), 7.95 (d, J = 8.2, H-C(7)), 7.88 (d, J = 
2.2, H-C(8’)), 7.53 (dd, J1 = 1.6, J2 = 8.2, H-C(6)), 7.49 (s, H-C(2)), 7.35 (d, J = 8.8, H-
C(5’)), 7.00 (dd, J1 = 2.2, J2 = 8.8, H-C(6’)), 6.82 (s, H-N exchangeable with D2O), 6.32 (d, J 
= 5.2, H-C(3’)), 4.10 (s, 2H, -CH2NHCH2CH2CH2NH-), 3.45-3.39 (m, 2H, -
CH2NHCH2CH2CH2NH-), 3.05-3.01 (m, 2H, -CH2NHCH2CH2CH2NH-), 2.02-1.95 (m, 2H, -
CH2NHCH2CH2CH2NH-), 1.82 (bs, H-N exchangeable with D2O). 13C NMR (125 MHz, 
CDCl3, δ): 152.07, 150.04, 149.03, 144.77, 138.13, 134.84, 134.50, 128.56, 126.43, 126.36, 
125.80, 124.74, 123.90, 121.38, 119.19, 117.28, 107.95, 98.55, 49.06, 47.41, 43.26, 27.79. 
HRMS: m/z 407.10826 corresponds to molecular formula C22H19ClN4SH+ (error in ppm -
2.23). HPLC purity (λ = 330 nm) method A: RT 8.036 min, area 98.36%; (λ = 254 nm) 
method C: RT 5.223 min, area 97.09%. 
3-[({4-[(7-chloroquinolin-4-yl)amino]butyl}amino)methyl]-1-benzothiophene-5-
carbonitrile(64). 
Compound 64 was prepared fromaldehyde S73 (118 
mg, 0.630 mmol) by method E, using amine AQ4 
(236 mg, 0.945 mmol). The product was purified 
using column chromatography (dry-flash, SiO2, 
eluent Hex/EtOAc gradient 1/1 → EtOAc, EtOAc/MeOH gradient 95/5 → 8/2 and flash, 
Biotage SP1, NH column, eluent EtOAc/Hex gradient 8/2 → EtOAc, EtOAc/MeOH gradient 
95/5 → MeOH). Final product 64 was obtained as white powder (137 mg, 52%). M.p. = 112 – 
113 ºC. IR (ATR): 3309m, 3270w, 3106w, 3054w, 3005m, 2972w, 2944m, 2875m, 2840w, 
2227m, 1613w, 1579s, 1545m, 1455w, 1432w, 1367w, 1332w, 1308w, 1277w, 1240w, 
1203w, 1140w, 1108w, 1085w, 1047w, 925w, 895w, 865w, 846w, 803m, 761w, 743w, 677w, 















C(2')), 8.22 (s, H-C(8')), 7.95-7.91 (m, H-C(7) and H-C(5')), 7.62-7.58 (m, H-C(4)), 7.56-7.52 
(m, H-C(6')), 7.45 (bs, H-C(2)), 7.25-7.20 (m, H-C(5)), 6.38 (d, J = 5.4, H-C(3’)), 5.44 (bs, H-
N exchangeable with D2O), 4.07 (s, 2H, -CH2NHCH2CH2CH2CH2NH-), 3.35-3.30 (m, 2H, -
CH2NHCH2CH2CH2CH2NH-), 2.82 (t, 2H, J = 6.8, -CH2NHCH2CH2CH2CH2NH-), 1.89 
(quin, 2H, J = 6.8, -CH2NHCH2CH2CH2CH2NH-), 1.74 (quin, 2H, J = 6.9, -
CH2NHCH2CH2CH2CH2NH-), 1.60 (bs, H-N exchangeable with D2O). 13C NMR (125 MHz, 
CDCl3 + CD3OD, δ): 151.14, 150.49, 148.18, 144.82, 138.05, 135.08, 134.46, 127.20, 126.38, 
126.20, 125.83, 125.06, 123.78, 121.68, 119.28, 117.05, 107.41, 98.48, 46.91, 42.72, 27.18, 
26.01. HRMS: m/z 421.12435 corresponds to molecular formula C23H21ClN4SH+ (error in 
ppm -1.11). HPLC purity (λ = 330 nm): method A: RT 8.920 min, area 99.20%; method B: 
RT 8.539 min, area 96.73%. 
3-[({3-[(7-chloroquinolin-4-yl)amino]propyl}amino)methyl]-1-benzothiophene-6-
carbonitrile(61). 
Compound 61 was prepared fromaldehyde S74 
(58.5 mg, 0.312 mmol) by method E, using 
amine AQ3 (111 mg, 0.469 mmol). The product 
was purified using column chromatography (dry-
flash, SiO2, eluent Hex/EtOAc gradient 1/1 → EtOAc, EtOAc/MeOH gradient 95/5 → 75/25, 
flash, Biotage SP1, NH column, eluent EtOAc/Hex gradient 8/2 → EtOAc, EtOAc/MeOH 
gradient 95/5 → MeOH and flash, Biotage SP1, SiO2 column, eluent 
EtOAc/MeOH+NH3(9/1) gradient 95/5 → 1/1). Final product 61 was obtained as white 
powder (70.3 mg, 55%). M.p. = 48 – 50 ºC. IR (film): 3256m, 3058m, 2945m, 2849m, 2226s, 
1916w, 1610s, 1581s, 1537s, 1454s, 1367, 1331m, 1281m, 1264m, 1242m, 1199m, 1169w, 
1139m, 1078w, 1052w, 899m, 878m, 851m, 818s, 766m, 736s, 702m, 646w, 606w, 503w, 
458w, 432w cm-1. 1H NMR (500 MHz, CDCl3, δ): 8.51-8.48 (m, H-C(2')), 8.22-8.19 (m, H-
C(8')), 7.92-7.89 (m, H-C(7)), 7.86 (d, J = 8.4, H-C(5')), 7.61 (s, H-C(2)), 7.51-7.47 (m, H-
C(6')), 7.36-7.32 (m, H-C(4)), 7.00-6.90 (m, H-C(5) and H-N exchangeable with D2O), 6.32 
(d, J = 5.5, H-C(3’)), 4.12 (s, 2H, -CH2NHCH2CH2CH2NH-), 3.45-3.40 (m, 2H, -
CH2NHCH2CH2CH2NH-), 3.05-3.02 (m, 2H, -CH2NHCH2CH2CH2NH-), 2.02-1.96 (m, 2H, -
CH2NHCH2CH2CH2NH-), 1.77 (bs, H-N exchangeable with D2O). 13C NMR (125 MHz, 
CDCl3, δ): 152.04, 141.01, 140.55, 134.97, 128.07, 127.62, 126.84, 124.79, 122.37, 121.46, 
118.98, 117.26, 107.98, 98.48, 49.22, 47.42, 43.50, 27.70. HRMS: m/z 407.10922 
corresponds to molecular formula C22H19ClN4SH+ (error in ppm 0.13). HPLC purity (λ = 330 













Compound 65 was prepared fromaldehyde S74 
(62.7 mg, 0.335 mmol) by method E, using amine 
AQ4 (125 mg, 0.502 mmol). The product was 
purified using column chromatography (dry-flash, 
SiO2, eluent Hex/EtOAc gradient 1/1 → EtOAc, EtOAc/MeOH gradient 95/5 → 8/2). Final 
product 65 was obtained as white powder (88.2 mg, 65%). M.p. = 62 – 65 ºC. IR (ATR): 
3296m, 3125m, 3052m, 2938s, 2863m, 2821m, 2222m, 1611m, 1580s, 1538m, 1455m, 
1371m, 1326m, 1282w, 1256w, 1199w, 1139w, 1080w, 1022m, 907w, 874w, 855w, 823m, 
800m, 606w cm-1. 1H NMR (500 MHz, CDCl3, δ): 8.53-8.50 (m, H-C(2')), 8.19-8.17 (m, H-
C(7)), 7.95-7.89 (m, H-C(7) and H-C(5')), 7.61-7.56 (m, H-C(2) and H-C(6') and H-C(4)), 
7.22-7.19 (m, H-C(5)), 6.38 (d, J = 5.5, H-C(3’)), 5.48 (bs, H-N exchangeable with D2O), 
4.09-4.06 (m, 2H, -CH2NHCH2CH2CH2CH2NH-), 3.35-3.30 (m, 2H, -
CH2NHCH2CH2CH2CH2NH-), 2.81 (t, 2H, J = 6.8, -CH2NHCH2CH2CH2CH2NH-), 1.88 
(quin, 2H, J = 6.8, -CH2NHCH2CH2CH2CH2NH-), 1.73 (quin, 2H, J = 6.9, -
CH2NHCH2CH2CH2CH2NH-), 1.64 (bs, H-N exchangeable with D2O). 13C NMR (125 MHz, 
CDCl3, δ): 152.03, 141.16, 140.60, 135.44, 134.81, 128.79, 127.72, 127.57, 126.71, 125.12, 
122.63, 120.89, 119.18, 117.13, 107.79, 98.97, 49.14, 47.53, 43.14, 27.70, 26.45. HRMS: m/z 
421.12558 corresponds to molecular formula C23H21ClN4SH+ (error in ppm 1.81). HPLC 
purity (λ = 330 nm) method A: RT 10.621 min, area 98.74%; (λ = 254 nm) method B: RT 
7.777 min, area 95.86%. 
N-(7-chloroquinolin-4-yl)-N'-[(5-fluoro-1-benzothiophen-3-yl)methyl]propane-1,3-
diamine(58). 
Compound 58 was prepared fromaldehyde S75 (181 
mg, 1.00 mmol) by method E, using amine AQ3 (353 
mg, 1.50mmol). The product was purified using 
column chromatography (dry-flash, SiO2, eluent 
EtOAc/Hex gradient 1/9 → EtOAc, EtOAc/MeOH gradient 95/5 → 4/6, flash, Biotage SP1, 
NH column, eluent EtOAc/Hex gradient 8/2 → EtOAc, EtOAc/MeOH gradient 95/5 → 
MeOH and flash, Biotage SP1, SiO2 column, eluent EtOAc/MeOH+NH3(9/1) gradient 95/5 
→ 7/3). Final product 58 was obtained as a white powder (269 mg, 67%). M.p. = 133 – 134 
ºC. IR (ATR): 3240m, 3060w, 2953w, 2852w, 1607m, 1579s, 1535m, 1435m, 1360w, 
1329m, 1279w, 1251w, 1230w, 1205w, 1137w, 1104w, 1082w, 913w, 850w, 800w, 761w, 
718w, 665w, 642w cm-1. 1H NMR (500 MHz, CDCl3, δ): 8.50-8.47 (m, H-C(2')), 7.90-7.88 















(s, H-C(2)), 7.35 (d, J = 9.0, H-C(5’)), 7.17-7.09 (m, H-C(6) and H-N exchangeable with 
D2O), 7.01-6.97 (m, H-C(6’)), 6.32 (d, J = 5.5, H-C(3’)), 4.06 (s, 2H, -
CH2NHCH2CH2CH2NH-), 3.45-3.40 (m, 2H, -CH2NHCH2CH2CH2NH-), 3.06-3.02 (m, 2H, -
CH2NHCH2CH2CH2NH-), 2.01-1.94 (m, 2H, -CH2NHCH2CH2CH2NH-), 1.69 (bs, H-N 
exchangeable with D2O). 13C NMR (125 MHz, CDCl3, δ): 160.88 (d, J = 240.1), 152.04, 
150.24, 149.05, 139.37 (d, J = 9.0), 135.98, 134.48 (d, J = 22.5), 128.48, 125.89, 124.81, 
124.17 (d, J = 9.9), 121.61, 117.36, 113.51 (d, J = 25.3), 107.28 (d, J = 22.5), 98.39, 49.36, 
47.64, 43.68, 27.60. HRMS: m/z 400.10388 corresponds corresponds to molecular formula 
C21H19ClFN3SH+ (error in ppm -1.56). Anal. (C21H19ClFN3S) Calcd: C, 63.07; H, 4.79; N, 
10.51; S, 8.02. Found: C, 63.09; H, 4.77; N, 10.30; S, 7.72. HPLC purity (λ = 330 nm): 
method A: RT 8.998 min, area 98.73%; method B: RT 8.544 min, area 99.17%. 
N-(7-chloroquinolin-4-yl)-N'-[(5-fluoro-1-benzothiophen-3-yl)methyl]butane-1,4-
diamine(63). 
Compound 63 was prepared fromaldehyde S75 (181 
mg, 1.00 mmol) by method E, using amine AQ4 (376 
mg, 1.51 mmol). The product was purified using 
column chromatography (dry-flash, SiO2, eluent 
EtOAc/Hex gradient 1/9 → EtOAc, EtOAc/MeOH gradient 95/5 → 1/1, flash, Biotage SP1, 
NH column, eluent EtOAc/Hex gradient 8/2 → EtOAc, EtOAc/MeOH gradient 95/5 → 
MeOH and flash, Biotage SP1, SiO2 column, eluent EtOAc/MeOH+NH3(9/1) gradient 95/5 
→ 1/1). Final product 63 was obtained as a white powder (251 mg, 60%). M.p. = 110 – 113 
ºC. IR (ATR): 3228m, 3063w, 2945w, 2855w, 2810w, 1579s, 1543m, 1490w, 1433m, 1366w, 
1330w, 1279w, 1245w, 1225w, 1196w, 1161w, 1134w, 1078w, 954w, 898w, 854w, 806w, 
782w, 640w, 619w, 543w, 483w, 452w, 423w cm-1. 1H NMR (500 MHz, CDCl3, δ): 8.50 (d, 
J = 5.2, H-C(2')), 7.94-7.91 (m, H-C(8')), 7.77 (dd, J1 = 4.8, J2 = 8.7, H-C(7)), 7.59 (d, J = 
8.9, H-C(5’)), 7.51-7.46 (m, H-C(4)), 7.38 (s, H-C(2)), 7.18-7.14 (m, H-C(6’)), 7.10 (td, J1 = 
2.4, J2 = 8.8, H-C(6)), 6.36 (d, J = 5.3, H-C(3’)), 5.65 (bs, H-N exchangeable with D2O), 4.00 
(s, 2H, -CH2NHCH2CH2CH2CH2NH-), 3.32-3.27 (m, 2H, -CH2NHCH2CH2CH2CH2NH-), 
2.80 (t, J = 6.6, 2H, -CH2NHCH2CH2CH2CH2NH-), 1.88 (quin, 2H, J = 6.8, -
CH2NHCH2CH2CH2CH2NH-), 1.75-1.55 (m, 2H, -CH2NHCH2CH2CH2CH2NH- and H-N 
exchangeable with D2O). 13C NMR (125 MHz, CDCl3, δ): 160.74 (d, J = 240.1), 152.01, 
149.82, 149.08, 139.46 (d, J = 9.0), 135.97, 134.81, 134.74 (d, J = 9.0), 128.68, 125.43, 
125.02, 123.98 (d, J = 9.0), 121.05, 117.18, 113.29 (d, J = 24.4), 107.47 (d, J = 22.6), 98.91, 
48.99, 47.67, 43.14, 27.69, 26.40. HRMS: m/z 414.11939 corresponds to molecular formula 
C22H21ClFN3SH+ (error in ppm -1.85). HPLC purity (λ = 330 nm) method A: RT 9.136 min, 









Compound 59 was prepared fromaldehyde S76 
(161 mg, 0.888 mmol) by method E, using amine 
AQ3 (314 mg, 1.33 mmol). The product was 
purified using column chromatography (dry-flash, 
SiO2, eluent EtOAc/Hex gradient 1/9 → EtOAc, EtOAc/MeOH gradient 95/5 → 4/6, flash, 
Biotage SP1, NH column, eluent EtOAc/Hex gradient 8/2 → EtOAc, EtOAc/MeOH gradient 
95/5 → MeOH and flash, Biotage SP1, SiO2 column, eluent EtOAc/MeOH+NH3(9/1) 
gradient 95/5 → 3/7). Final product 59 was obtained as a white powder (194 mg, 54%). M.p. 
= 149 – 150 ºC. IR (ATR): 3433w, 3294m, 3210m, 3067m, 3015m, 2927m, 2853m, 1606m, 
1581s, 1539m, 1466m, 1430w, 1369w, 1330w, 1282w, 1251w, 1208w, 1168w, 1139w, 
1109w, 1080w, 896w, 854w, 807w, 761w, 737w, 683w, 646w cm-1. 1H NMR (500 MHz, 
CDCl3, δ): 8.50-8.47 (m, H-C(2')), 7.90 (bs, H-C(8')), 7.74-7.70 (m, H-C(4)), 7.60-7.56 (m, 
H-C(7)), 7.37-7.33 (m, H-C(5')), 7.30 (s, H-C(2)), 7.22 (bs, H-N exchangeable with D2O), 
7.07-7.01 (m, H-C(5)), 7.00-6.96 (m, H-C(6’)), 6.31 (d, J = 5.2, H-C(3’)), 4.08 (s, 2H, -
CH2NHCH2CH2CH2NH-), 3.45-3.40 (m, 2H, -CH2NHCH2CH2CH2NH-), 3.06-3.03 (m, 2H, -
CH2NHCH2CH2CH2NH-), 2.01-1.95 (m, 2H, -CH2NHCH2CH2CH2NH-), 1.76 (bs, H-N 
exchangeable with D2O). 13C NMR (125 MHz, CDCl3, δ): 160.70 (d, J = 243.7), 151.97, 
150.31, 141.61 (d, J = 9.9), 134.71, 134.12, 128.39, 124.83, 122.98, 122.46 (d, J = 10.0), 
121.70, 117.33, 113.28 (d, J = 23.5), 109.07 (d, J = 25.3), 98.36, 49.37, 47.69, 43.75, 27.52. 
HRMS: m/z 400.10427 corresponds to molecular formula C21H19ClFN3SH+ (error in ppm -
0.56). HPLC purity (λ = 330 nm) method A: RT 9.049 min, area 95.99%; (λ = 254 nm) 
method B: RT 7.455 min, area 97.07%. 
N-(quinolin-4-yl)propane-1,3-diamine (AQ7). 
1H NMR (500 MHz, CD3OD, δ): 8.35 (d, J = 5.7, H-C(2)), 8.09-8.06 (m, H-C(8)), 7.77 (d,J = 
8.0, H-C(5)), 7.64-7.60 (m, H-C(6)), 7.45-7.40 (m, H-C(5)), 6.52 (d, J = 5.5, H-C(3)), 3.43 (t, 
2H, J = 7.1, ArNHCH2-), 2.80 (t, 2H, J = 6.9, ArNHCH2CH2CH2-), 1.90 (quin, 2H, J = 7.1, 
ArNHCH2CH2-).13C NMR (125 MHz, CD3OD, δ): 152.77, 151.41, 149.07, 130.57, 128.98, 
125.72, 122.28, 120.46, 99.32, 41.81, 40.48, 32.40. HRMS: m/z 202.13373 corresponds to 
molecular formula C12H15N3H+ (error in ppm -0.73). 
N-(quinolin-4-yl)butane-1,4-diamine (AQ8). 
1H NMR (200 MHz, CD3OD, δ): 8.31 (d, J = 14.0, H-C(2)),8.11-8.04 (m, H-C(8)),7.82-7.75 
(m, H-C(5)),7.63-7.53 (m, H-C(6)),7.44-7.34 (m, H-C(5)),6.42 (d, J = 14.0, H-C(3)), 3.30 (t, 
2H, J = 18.5, ArNHCH2-), 2.65 (t, 2H, J = 16.8, ArNHCH2CH2CH2CH2-), 1.80-1.47 (m, 4H, 









128.87, 125.56, 122.26, 120.33, 99.16, 43.81, 42.32, 31.39, 26.88.HRMS: m/z 216.14910 
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